Mutual fund-related information provided on this platform are generated exclusively by Mirae Asset Sharekhan's internal Product Team, utilizing data and insights backed by reputable Third-Party Research Rating agencies. Please note that these outputs and product selections are independent and do not fall under the purview, supervision, or editorial control of the Mirae Asset Sharekhan Research Team. Investors should read all scheme-related documents (SID/KIM) carefully before investing in Mutual Funds and consult a professional advisor to ensure alignment with their financial goals and risk profile.
| Date | Report Title | Sectors | Analyst | Action |
|---|---|---|---|---|
| Oct 22 2026 |
Recovery yet to fully materialise
Wipro guided Q3FY27 IT Services revenue growth at -1.5% to +0.5% q-o-q in constant currency
|
Manav Medewala | ||
| Oct 22 2026 |
Soft Q2; Specialty chemicals to support H2 growth
Q2FY27 numbers missed our estimates, on reversal of gains in PFB business
|
Aditya Arora | ||
| Oct 22 2026 |
Steady Q2, policy headwinds shrink valuations
Q2 numbers were steady, though policy changes and higher interest rates pose risks;
|
Vijay Singh Gour | ||
| Oct 22 2026 |
Strong execution reflected in valuations
Demand across AI infrastructure, semiconductors, telecom, and AI/EI-led solutions remains robust, supporting stronger growth ahead.
|
Manav Medewala | ||
| Oct 22 2026 |
Record Q2; guidance raised as fee engine accelerates
Stock trades at 24x/20.4x its FY27E/FY28E EV/EBITDA, respectively. We maintain a Buy with a revised PT of Rs. 928.
|
Kruttika Prabhudesai | ||
| Oct 21 2026 |
NCR foray opens fresh growth avenue
We stay positive on the stock and assign a PT of Rs. 2,122. This is based on strong launch momentum, steady rentals and a healthy balance sheet.
|
Akshay Raghunath Shetty | ||
| Oct 21 2026 |
Q2 braves rising costs
Management expects to enter H2FY27 with better prices, enhanced capacity and the benefit of operating leverage
|
Akshay Raghunath Shetty | ||
| Oct 21 2026 |
Large deal ramp-up fuels growth; Nagarro integration key catalyst
We view the Nagarro acquisition as the key catalyst to watch, given its potential to drive cross-selling opportunities, scale benefits
|
Manav Medewala | ||
| Oct 21 2026 |
Growth path steady; yet stock’s run out of steam
FY27 revenue guidance retained at ~Rs. 2,500 crore, with EBITDA margin seen at ~25% +/- 2%.
|
Akshay Raghunath Shetty | ||
| Oct 21 2026 |
Growth to recover in H2
Margins would stay in line with FY26 levels. However, higher margin AI revenues should support gradual margin expansion with faster revenue conversion, partly offset by continued investments in AI cap
|
Manav Medewala | ||
| Oct 21 2026 |
Steady Q2, Outlook positive despite policy headwinds
AUM surged to Rs. 584,564 up 26.5% y-o-y, but NIM fell to 9.12% due to rise in the borrowing costs on sequential basis.
|
Vijay Singh Gour | ||
| Oct 19 2026 |
Strong premium demand; new launches to drive pre-sales
Dahlias’ ultra-luxury continues to see strong demand, with prices increasing 10% during the quarter.
|
Akshay Raghunath Shetty | ||
| Oct 19 2026 |
Record profit, but valuations cap upside
NII grew 26% y-o-y led by a strong 22% loan growth, while NIM was broadly stable q-o-q at 3.32%.
|
Sameer Suhas Sawant | ||
| Oct 19 2026 |
Q2 braves headwinds
NIM rose 36 bps y-o-y to 9.33% due to lower cost of borrowings. Asset quality improved.
|
Vijay Singh Gour | ||
| Oct 19 2026 |
Growth Accelerates, Margins Improve
TECHM remains confident of further rise in gross margins despite higher utilisation levels and recent headcount additions.
|
Manav Medewala | ||
| Oct 19 2026 |
Steady quarter; margins on the mend
Other income fell 17.1% y-o-y as treasury gains slumped, though fee income was healthy and grew 16% y-o-y.
|
Sameer Suhas Sawant | ||
| Oct 19 2026 |
FCNR fuels growth, margin dip temporary
PAT of Rs. 14,843 crore grew 20.1% y-o-y, 3.6% above our estimate, helped by low provisions; GNPA declined 18 bps q-o-q to 1.20% and NNPA eased 5 bps to 0.30%.
|
Sameer Suhas Sawant | ||
| Oct 19 2026 |
Steady quarter, margins have bottomed out
PAT grew 4.7% y-o-y to Rs 19,510 crore, 2.0% above our estimate; excluding trading gains, PAT grew 12.6%.
|
Sameer Suhas Sawant | ||
| Oct 19 2026 |
Asset quality shines, business traction garners momentum
Asset quality improved, with GNPA and NNPA fell 12 bps and 4 bps q-o-q, and net credit cost falling to 0.45%.
|
Sameer Suhas Sawant | ||
| Oct 16 2026 |
Jio Platforms Limited
Jio Platforms Limited is the digital and telecom arm of Reliance Industries built on a proprietary technology stack that the company designed
|
Manav Medewala | ||
| Oct 16 2026 |
Strong performance amid noisy headlines
OPM fell 139 bps to 14.4% versus our expectations of 14%. FMEG margins reached 10% vs a flat trend in Q2FY26.
|
Ankit Soni | ||
| Oct 16 2026 |
Strong volume-led quarter; brand push paying off
Stock trades at 60.4x/53.4x its FY27E/FY28E EPS, respectively. We retain a Buy rating with a revised PT of Rs. 1,437.
|
Kruttika Prabhudesai | ||
| Oct 16 2026 |
Growth returns, regulatory overhang lingers
PAT grew 13.6% y-o-y to Rs. 508 crore, but fell sequentially as stronger sales meant higher new business strain.
|
Sameer Suhas Sawant | ||
| Oct 15 2026 |
Better Q2, but not out of woods yet
PAT grew 15.5% y-o-y to Rs. 946 crore, beating our estimate of Rs. 697 crore, chiefly fuelled by higher capital gains.
|
Sameer Suhas Sawant | ||
| Oct 14 2026 |
Regulatory developments warrant caution; Downgrade to Hold
The IRDAI consultation paper on distribution economics is still evolving, and margins may ease mildly in H2FY27 as a high protection base kicks in.
|
Sameer Suhas Sawant | ||
| Oct 13 2026 |
Mixed bag Q2; strong AUM growth eyed
PAT slightly exceeded estimates, rising 9.2% y-o-y and 2.5% q-o-q to Rs. 275 crore.
|
Vijay Singh Gour | ||
| Oct 13 2026 |
ValueGuide Equity - October 2026
Eyeing value in volatile times
|
Mirae Asset Research Team | ||
| Oct 13 2026 |
Eyeing value in volatile times
Dalal Street has been beset with a barrage of worries lately – geopolitical tensions, oil on the boil, inflationary concerns, trade tariff woes and a lot more. And yet, what seems as a troublesome pha
|
Mirae Asset Research Team | ||
| Oct 13 2026 |
Strong execution, Limited Headroom
We introduce FY29 earnings and roll forward our valuation to Sep’28 on EPS of Rs 78, accordingly we raise our price target to Rs 1,310, valuing the stock at 17x with a HOLD rating
|
Manav Medewala | ||
| Oct 09 2026 |
Attractive yields cushion margin stress
Continued investments, higher external consultant fees and rising project and software costs would stress near-term margins.
|
Manav Medewala | ||
| Oct 09 2026 |
Q2FY2027 NBFCs, Insurance, AMC & Diversified Financials Results Preview
Strong growth persists; margins under pressure
|
Vijay Singh Gour | ||
| Oct 09 2026 |
Q2FY2027 Capital Goods Results Preview
Strong order inflows; execution and margins remains key
|
Ankit Soni | ||
| Oct 09 2026 |
Q2FY2027 Automobile Results Preview
Growth intact, margins under watch
|
Dhruv Joshi | ||
| Oct 08 2026 |
Q2FY2027 Pharma & Healthcare Results Preview
Embarking on fresh growth phase
|
Thomas Abraham | ||
| Oct 08 2026 |
Q2FY2027 Consumer Goods Results Preview
Strong sales growth, but cost pressure remains
|
Kruttika Prabhudesai | ||
| Oct 08 2026 |
Q2FY2027 Chemicals Results Preview
In a selective growth phase
|
Aditya Arora | ||
| Oct 08 2026 |
Q2FY2027 Metals & Mining Results Preview
Steeling up for strong Q2
|
Netra Deshpande | ||
| Oct 08 2026 |
Q2FY2027 Cement Results Preview
Steady volumes; margins face pressure
|
Akshay Raghunath Shetty | ||
| Oct 08 2026 |
Q2FY2027 Banking Results Preview
Robust credit growth to drive earnings
|
Sameer Suhas Sawant | ||
| Oct 08 2026 |
Capacity doubling to unlock the next leg of growth
JTL is doubling pipe capacity to ~2 million tonnes by FY28, with a major focus on value-added products (VAPs), including galvanised, colour-coated and API-grade products.
|
Akshay Raghunath Shetty | ||
| Oct 07 2026 |
Mint St turns up the heat
The RBI ended a long pause, hiking the repo rate by 25 bps to 5.5% and shifted its stance to calibrated tightening given persistent inflation.
|
Sameer Suhas Sawant | ||
| Oct 06 2026 |
Strong growth after base scare
CV sales soared on rising mining, infrastructure and commercial operations across the country.
|
Automobiles | Dhruv Joshi | |
| Oct 06 2026 |
Q2FY2027 IT Results Preview
Another muted quarter, deferred recovery
|
Manav Medewala | ||
| Sep 24 2026 |
Growth engine accelerating, profitability to follow
We initiate with a BUY rating on Karnataka Bank with a PT of Rs 415, ~22% above the CMP
|
Sameer Suhas Sawant | ||
| Sep 16 2026 |
National Stock Exchange of India Limited
Established in November 1992, NSE stands as the nation’s premier capital market infrastructure provider.
|
Vijay Singh Gour | ||
| Sep 11 2026 |
Optic fibres to add growth spark
Strong demand in the OFC space bodes well for its long-term growth
|
Ankit Soni | ||
| Sep 10 2026 |
ValueGuide Equity - September 2026
Coursing through a transition
|
Mirae Asset Research Team | ||
| Sep 10 2026 |
Coursing through a transition
August cleared the picture on how investor preferences within Indian markets are changing. The benchmark indices may not tell the full story. Benchmark indices ended August in the red, bringing a two-
|
Mirae Asset Research Team | ||
| Sep 03 2026 |
Preparing for festive season inventory
CV growth cycle is rising, two-wheeler players are seen riding the export wave besides robust domestic demand; only PV players face supply constraints.
|
Automobiles | Dhruv Joshi | |
| Sep 03 2026 |
Eyeing a high-margin growth mix
At CMP, Gravita trades at a 28x/21x multiple on FY27E/FY28E EPS. We maintain a Buy rating with a PT of Rs. 2,100.
|
Netra Deshpande | ||
| Aug 31 2026 |
Precision in every revolution
Rolex affirms guidance for mid-teens revenue growth while newer products would drive up margins.
|
Dhruv Joshi | ||
| Aug 24 2026 |
Record order win boosts growth prospects
At CMP, Welspun Corp trades at a 19x/15x multiple on FY27E/FY28E EV/EBITDA, we maintain a Buy rating with a revised PT of Rs. 2800.
|
Netra Deshpande | ||
| Aug 21 2026 |
Q1FY2027 Pharma & Healthcare Results Review
India pharma & CDMO cushion us pain; hospitals ride the volume wave
|
Thomas Abraham | ||
| Aug 21 2026 |
Q1FY2027 Consumer Goods Results Review
Growth prospects intact, margin risks persist
|
Kruttika Prabhudesai | ||
| Aug 21 2026 |
Q1FY2027 Metals & Mining Results Review
Growth steady; long-term outlook stable
|
Netra Deshpande | ||
| Aug 21 2026 |
Q1FY2027 NBFCs, Insurance, AMCs, and Diversified Financials Results Review
NBFCs & AMCs shine; insurers a mixed bag
|
Vijay Singh Gour | ||
| Aug 21 2026 |
Q1FY2027 Automobiles Results Review
Strong volumes; relief expected from H2
|
Dhruv Joshi | ||
| Aug 20 2026 |
Multiple tailwinds offset weak US biz
India formulations biz revenue rose ~20% y-o-y, while global revenue rose 34% y-o-y; driving growth
|
Thomas Abraham | ||
| Aug 20 2026 |
Core hospitals power Q1; HealthCo to break even by Q3FY27
Apollo Hospitals delivered a strong Q1FY27, with healthy growth across revenue, EBITDA and PAT.
|
Thomas Abraham | ||
| Aug 19 2026 |
Q1FY2027 Capital Goods and Power Results Review
Orderbook stays strong; margins seen stressed in the short run
|
Ankit Soni | ||
| Aug 19 2026 |
Robust growth continues; FY27 store expansion on track
Q1FY27 consolidated revenue grew 58% y-o-y to Rs. 997 crore, driven by rapid store expansion, healthy customer traction, and 56% y-o-y volume growth.
|
Kruttika Prabhudesai | ||
| Aug 19 2026 |
Profitability brightens Q1; Outlook healthy
Q1FY27 saw healthy profitability gains, led by steady legacy performance and improving Heubach operations, while Rieco remained hit by execution issues.
|
Aditya Arora | ||
| Aug 18 2026 |
Cost pressures persist
Domestic volumes continue to shine, while export volumes declined by 18% y-o-y during Q1FY27.
|
Dhruv Joshi | ||
| Aug 18 2026 |
JLR headwinds weigh heavily
Guidance remains unchanged despite a challenging Q1 indicating a stronger H2 .
|
Dhruv Joshi | ||
| Aug 18 2026 |
Record output; tepid sales
Consolidated net profit for the Q1FY27 was Rs. 1,976 crore, up 0.4% y-o-y and down 2.5% q-o-q.
|
Netra Deshpande | ||
| Aug 17 2026 |
Strong Q1; margins expand
Consolidated revenue grew 19.7% y-o-y to Rs. 370 crore, supported by double-digit growth across product categories and network expansion.
|
Kruttika Prabhudesai | ||
| Aug 17 2026 |
Q1FY2027 Banking Results Review
Loan growth holds firm, margins ease
|
Sameer Suhas Sawant | ||
| Aug 17 2026 |
Record ramp-up underscores demand tailwinds
The rapid ramp-up also strengthens confidence in the scaling trajectory of upcoming assets like the Gurugram hospital.
|
Thomas Abraham | ||
| Aug 17 2026 |
Growth momentum persists
Health domestic demand, product launches, stable exports and increasing EV penetration to help company grow in FY27 and beyond.
|
Dhruv Joshi | ||
| Aug 17 2026 |
Outlook remains strong
Revenues grew 14% y-o-y supported by execution from RoH and manufacturing of helicopters and engines
|
Ankit Soni | ||
| Aug 17 2026 |
Electronics segment led the performance
Revenues grew 13% y-o-y, lagging estimates on a tepid show by the consumer durables segment.
|
Ankit Soni | ||
| Aug 17 2026 |
Q1FY2027 IT Results Review
Recovery gaining pace, execution critical
|
Manav Medewala | ||
| Aug 17 2026 |
Volumes strong, value-added products to drive margins
We remain positive on the stock and revised PT to Rs. 110, considering the current challenging environment and growth factors.
|
Akshay Raghunath Shetty | ||
| Aug 17 2026 |
Strong start to FY27; Popeyes emerges as second growth engine
We maintain a Buy rating with a revised PT of Rs. 580.
|
Kruttika Prabhudesai | ||
| Aug 14 2026 |
Stellar Q1, outlook getting better
We maintain a positive view with unchanged PT of Rs. 260. The stocks trade at an attractive valuation of 0.6x FY28 BV.
|
Vijay Singh Gour | ||
| Aug 14 2026 |
Margins miss mark; H2 recovery hopes limit downside
Q1FY27 performance was weak on profitability, with revenue growing 3.0% y-o-y to Rs. 773 crore,
|
Kruttika Prabhudesai | ||
| Aug 14 2026 |
MEA market to drive growth
We maintain a Buy with a revised PT of Rs. 2,350, valuing it at 20x its FY28 EPS. Stock trades at a P/E of ~19x/16x its FY27E/28E EPS.
|
Ankit Soni | ||
| Aug 14 2026 |
Margins intact, riding steadily on growth path
Increasing wallet share of existing OEMs, premiumisation and scaling of business across categories aided strong Q1 numbers.
|
Dhruv Joshi | ||
| Aug 14 2026 |
Low-cost inventory gains power Q1
We believe company to benefit from the OFC sector tailwinds. We maintain a Buy rating for a revised PT of Rs 1,450. At CMP, the stock trades at a valuation of 18x on FY27 earnings.
|
Ankit Soni | ||
| Aug 14 2026 |
Paints biz in focus; long-term outlook robust
We retain Buy with a revised SOTP-based PT of Rs. 3681, supported by sustained momentum in paints and improving operating leverage.
|
Akshay Raghunath Shetty | ||
| Aug 13 2026 |
On a strong growth path
Management indicated that Carysil is currently sitting on its highest-ever export order book, supported by Home Depot
|
Akshay Raghunath Shetty | ||
| Aug 13 2026 |
Investment phase continues; growth steady but profitability recovery delayed
Q1FY27 revenue growth was steady, but profitability remained weak as higher depreciation, finance cost and investments in newer platforms weighed on earnings.
|
Kruttika Prabhudesai | ||
| Aug 13 2026 |
Weakness persists
Exports remained weak amid a prolonged industry downturn, and steady pricing pressure further weighed on performance,
|
Aditya Arora | ||
| Aug 13 2026 |
Healthy Q1; Stretched valuations limit upside
We maintain a Hold rating with a PT of Rs. 5,000, as current valuations largely reflect the company’s long-term growth
|
Aditya Arora | ||
| Aug 13 2026 |
Margins hit by adverse product mix
Revenue grew 19% y-o-y, beating estimates. Exports/ domestic sales surged 11%/27%, respectively.
|
Ankit Soni | ||
| Aug 13 2026 |
Strong Q1; growth momentum accelerates with margin expansion
Stock trades at 40.9x/33.2x its FY27E/FY28E EPS, respectively. We stay Positive on the stock and expect an upside of 15%.
|
Kruttika Prabhudesai | ||
| Aug 12 2026 |
Q1 – A tactical, transient pause
Q1FY27 revenue grew 9% y-o-y to Rs. 344.6 crore, EBITDA up 6.5% y-o-y to Rs. 149.7 crore and PAT up 19% y-o-y to Rs. 57.3 crore.
|
Kruttika Prabhudesai | ||
| Aug 12 2026 |
Steady Q1; eyeing a diversified play
Consolidated revenue declined 15.6% y-o-y to Rs. 971.63 crore and 10.4% q-o-q due to sluggish demand
|
Netra Deshpande | ||
| Aug 12 2026 |
Lacklustre Q1, yet downside limited
Management refrained from margin guidance but stated that they would inch up from Q3 and peak only after FY28.
|
Ankit Soni | ||
| Aug 12 2026 |
Resilient show in challenging times
We maintain a Buy with a revised PT of Rs 1,750. Stock is valued at ~15x/13x FY27E/28E P/E.
|
Ankit Soni | ||
| Aug 12 2026 |
Well-balanced ride
Robust demand turned Q1 numbers stellar, while operational efficiency and price hikes arrested the fall in margins caused by raw material price
|
Dhruv Joshi | ||
| Aug 12 2026 |
Healthy Q1; RM costs stress margins
We maintain a Buy with a revised PT of Rs. 1,270.
|
Kruttika Prabhudesai | ||
| Aug 11 2026 |
Opportunity amid volatility
July brought in a ray of optimism in these challenging times - with the narrative gradually shifting from concerns around inflation and global uncertainty to improving domestic fundamentals.
|
Mirae Asset Research Team | ||
| Aug 11 2026 |
AI monetisation offsets hiring headwinds
We believe current valuations already reflect most near-term growth drivers, limiting further upside. Accordingly, we downgrade the stock to HOLD.
|
Manav Medewala | ||
| Aug 11 2026 |
Strong Q1; launch line-up strong
We retain a Buy rating with a revised PT of Rs. 498 (44x FY28E EPS of Rs 11.6), on account of refinancing-led margin visibility and a strong H2 launch pipeline.
|
Thomas Abraham | ||
| Aug 11 2026 |
Q1 growth broad-based, one-offs aid margins
Stock trades at 72.2x/59.8x its FY27E/FY28E earnings, respectively. We maintain a Buy with an unchanged PT of Rs. 5,671.
|
Kruttika Prabhudesai | ||
| Aug 11 2026 |
Growth story stays gleamy
Sky Gold & Diamonds trades at a 28x/20x multiple on FY27E/FY28E EPS. We maintained a Buy rating with a revised PT of Rs. 920.
|
Netra Deshpande | ||
| Aug 11 2026 |
ValueGuide Equity - August 2026
Opportunity amid volatility
|
Mirae Asset Research Team | ||
| Aug 11 2026 |
Soft Q1, profitability stays resilient
Despite soft Q1 numbers and EPS cuts, negative credit costs, asset quality will lead for healthy return ratios, hence we maintain positive view with a revised SoTP PT of Rs. 500.
|
Vijay Singh Gour | ||
| Aug 11 2026 |
Growth, margins and profitability all click
We maintain a Buy with a revised PT of Rs. 1,265.
|
Sameer Suhas Sawant | ||
| Aug 11 2026 |
Strong growth prospects
We maintain a Buy rating for a PT of Rs 2,600, expecting company to maintain a strong long-term growth trajectory.
|
Ankit Soni | ||
| Aug 11 2026 |
Strong Q1; volume recovery encouraging, margin watch remains
We maintain Buy on the stock with a revised PT of Rs. 6,353.
|
Kruttika Prabhudesai | ||
| Aug 11 2026 |
Margins recovery seen in H2
While we remain cautious, we retain a positive view with a revised PT of Rs 1,800.
|
Ankit Soni | ||
| Aug 10 2026 |
Strong Q1; Chennai scales up faster than expected
Q1FY27 revenue grew 44% y-o-y to Rs. 243 crores, EBIDTA grew 39% y-o-y with EBIDTA margin standing s
|
Kruttika Prabhudesai | ||
| Aug 10 2026 |
Cost pressures bite, yet expansion story intact
Management reiterated its long-term capacity target of 30 MTPA by FY30.
|
Akshay Raghunath Shetty | ||
| Aug 10 2026 |
Set for a smooth ride ahead
FY27 margin guidance stays at 14-16% led by easing commodity price inflation, price hikes, wider scale and an improving product mix.
|
Dhruv Joshi | ||
| Aug 10 2026 |
Robust Q1 Performance Driven by Broad-Based Growth
APAT stood at Rs 128.4 crore, up 7.5% q-o-q (+21.7% y-o-y), with PAT margin at 17.2% (+69bps q-o-q/+19bps y-o-y).
|
Manav Medewala | ||
| Aug 10 2026 |
Eye on debt cuts; outlook bright
We remain positive and assign a PT of Rs. 740.
|
Ankit Soni | ||
| Aug 10 2026 |
Strong Q1FY27
Stock trades at 70.7x/55.1x its FY27E/FY28E EV/EBITDA, respectively. We maintain a Buy with a revised SOTP-based PT of Rs. 3,390.
|
Kruttika Prabhudesai | ||
| Aug 07 2026 |
Strong domestic show offsets dull global scene
Management is expected to renew its focus on international patients, as Q1 is largely seen as a one-off.
|
Thomas Abraham | ||
| Aug 07 2026 |
Revenue in-line, PAT missed due to margin compression
We stay positive on stock with an unchanged PT of Rs. 2,020 based on FY28E EPS of 61.0. TruBridge integration remains the key watchpoint.
|
Manav Medewala | ||
| Aug 07 2026 |
Capacity expansion to drive growth
Quarterly revenue came in at record highs, rising 33.5% y-o-y, while EBITDA grew 54% y-o-y
|
Akshay Raghunath Shetty | ||
| Aug 07 2026 |
Supply chain disruptions impacted performance
Q1 numbers were a mixed bag as revenue beat estimates but margins disappointed.
|
Ankit Soni | ||
| Aug 07 2026 |
FY27 launches to help meet pre-sales target
We stay Positive with a price target of Rs. 800, backed by steady residential demand and continued scale-up of the rental portfolio.
|
Akshay Raghunath Shetty | ||
| Aug 07 2026 |
Fastened to growth
We value the company at 31x its EPS of FY28E and maintain a positive rating while raising PT to Rs. 1,251.
|
Dhruv Joshi | ||
| Aug 07 2026 |
Steady domestic momentum, US overhang persists
Led by the rising share of innovative drugs, we maintain a Buy rating with a PT of Rs.2,253, valuing the stock at 34x FY28E EPS of Rs.58.8.
|
Thomas Abraham | ||
| Aug 07 2026 |
Strong Q1FY27, ARPU gains & Africa growth drive momentum
We maintain a Buy with an SOTP-based price target of Rs 2,350; valuation rolled forward to Mar’28.
|
Manav Medewala | ||
| Aug 06 2026 |
Domestic demand tailwinds continue
Sequential performance reflected seasonal trends with passenger vehicles recovering and tractor volumes facing a temporary post-sowing cyclical pullback.
|
Automobiles | Dhruv Joshi | |
| Aug 06 2026 |
Record Q1, regulatory reset bites
Stock trades at 35xFY28E EPS, we stay positive on the stock and revise PT to Rs. 4100.
|
Sameer Suhas Sawant | ||
| Aug 06 2026 |
CDMO, HPP and specialty chemicals delivered strong growth, driving consolidated revenue growth of 44
We maintain our BUY rating on NFIL and raise our TP to Rs 8,850.
|
Aditya Arora | ||
| Aug 06 2026 |
Supply-chain challenges hit volumes, long-term outlook intact
We maintain our BUY rating with a price target of Rs 680.
|
Aditya Arora | ||
| Aug 06 2026 |
Soft Q1, outlook improving
We maintain a positive view with a revised PT of Rs. 1350 on strong AUM growth, improvement in NIMs and steady asset quality.
|
Vijay Singh Gour | ||
| Aug 05 2026 |
Music segment makes Q1 a melody
We value the stock on a P/E multiple of 42x on FY28E EPS of Rs 15.1 and a price target of Rs. 640.
|
Manav Medewala | ||
| Aug 05 2026 |
Strong start to FY27; guidance intact with upside bias
Stock trades at 50.6x/44.2x its FY27E/FY28E EPS, respectively. We retain a Buy rating with a revised PT of Rs. 986.
|
Kruttika Prabhudesai | ||
| Aug 05 2026 |
Extended pause; data to guide rate re-calibration
Stable rates should continue to support NIM visibility across banks, NBFCs and other rate-sensitive sectors like housing, infrastructure, etc.
|
Sameer Suhas Sawant | ||
| Aug 05 2026 |
Multimodal expansion to drive growth
Revenue rose 9.6% y-o-y to Rs. 1,248.5 crore, operating profit up 11.7% y-o-y to Rs. 135.2 crore.
|
Akshay Raghunath Shetty | ||
| Aug 05 2026 |
Domestic growth strong; margin pressure persists on input inflation and mix
Strategic investments remained the key growth driver, rising 61% on a like-to-like basis and contributing 18% of domestic business.
|
Kruttika Prabhudesai | ||
| Aug 05 2026 |
Diversified portfolio cushions weak summer demand
Consolidated revenue grew 66.9% y-o-y to Rs. 1,437 crore, led by consolidation of Comfort Click and healthy growth in non-seasonal domestic portfolios.
|
Kruttika Prabhudesai | ||
| Aug 05 2026 |
Strong deal wins ensure revenue visibility
Deal wins remain robust with $ 1,146.2 million, up 90.8% q-o-q (120.1% y-o-y), largely driven by $650 million from a global US technology leader.
|
Manav Medewala | ||
| Aug 05 2026 |
Capex announcements and margins upgrade
Revenue rose 23% y-o-y, beating our estimates majorly driven by higher realisations due to price hikes and very minimal volume growth.
|
Ankit Soni | ||
| Aug 05 2026 |
5 Curated Stock Ideas for August 2026
Corporate earnings is the flavour on the street and we bring you a curated bouquet of five stocks that could give your portfolio an edge. Each idea combines technical and fundamental growth drivers.
|
Mirae Asset Research Team | ||
| Aug 04 2026 |
Strong Q1; operating resilience braves geopolitical headwinds
Operational performance remained healthy despite West Asia-related disruptions, with same-store RevPAR growing 9.6% y-o-y to Rs. 5,219/night and occupancy improving to 79.3%.
|
Kruttika Prabhudesai | ||
| Aug 04 2026 |
Expanding AI adoption
Revenue fell 0.8% q-o-q (up 20.6% y-o-y) to Rs 845.2 crore; license and implementation revenues saw steady traction.
|
Manav Medewala | ||
| Aug 04 2026 |
CDMO mix shift drives margin beat in Q1FY27
Q1FY27 numbers very strong, with revenue up 24.3% y-o-y, PAT up 65.5% y-o-y, and EBITDA margin rising to 38.5%.
|
Thomas Abraham | ||
| Aug 04 2026 |
Robust Q1, Outlook bright
Consolidated PAT grew 43.3% y-o-y and 16.9% q-o-q led by strong momentum in the lending businesses.
|
Vijay Singh Gour | ||
| Aug 04 2026 |
India momentum accelerates
Stock trades at 10.1x/8.5x its FY27E/FY28E EV/EBIDTA, respectively. We maintain a Buy with a revised PT of Rs. 105.
|
Kruttika Prabhudesai | ||
| Aug 04 2026 |
Patient volume gush powers Q1
Q1FY27 was a record quarter, with revenue rising 26.5% y-o-y to Rs.1,304.05 crore, while EBITDA grew 23.5% to Rs.315.3 crore.
|
Thomas Abraham | ||
| Aug 04 2026 |
Capacity expansion and Focus on VAP to boost profitability
Consolidated revenue/EBITDA/PAT beat estimates by 11% / 1.1% / 2.0%, respectively.
|
Akshay Raghunath Shetty | ||
| Aug 03 2026 |
A muted quarter
With stock prices, order book visibility and premium multiples having already run up, we maintain a Hold rating; for a price target of Rs 4,300
|
Ankit Soni | ||
| Aug 03 2026 |
Strong Q1; capacity expansions to drive growth
Revenue rose 7% to Rs. 370.88 crore., compared with Rs. 370.52 crore, total revenue increased 6% to Rs. 391.13 crore.
|
Netra Deshpande | ||
| Aug 03 2026 |
Lending business scaling, quality improving in insurance segment
Consolidated PAT rose 12% y-o-y to Rs. 3,132 crore as total income grew 19% y-o-y to Rs. 42,037 crore.
|
Vijay Singh Gour | ||
| Aug 03 2026 |
Volume growth healthy, medium-term outlook intact
Revenue was broadly in line with our estimate, while EBITDA and PAT missed estimates by 7.6% and 21%, respectively, due to hight operating costs caused by spike in fuel costs.
|
Akshay Raghunath Shetty | ||
| Aug 03 2026 |
Volumes firm, new hospitals in ramp-up mode
ARPOB rose 6% y-o-y to Rs. 67,256 and occupancy improved 3 pps y-o-y to 41.2%, led by mature hospitals at 45% occupancy, and 34.4% occupancy for new hospitals.
|
Thomas Abraham | ||
| Aug 03 2026 |
Strong show in challenging times
We retain a Buy rating with a PT of Rs. 16,300, factoring in a 24%/6% revenue/PAT CAGR (FY26–28E). Stock trades at 49x FY27E and 34x FY28E earnings.
|
Ankit Soni | ||
| Aug 03 2026 |
Higher costs dent profitability
Stock trades at 31.1x, 24.5x, 21.1x it’s FY26, FY27E and FY28E earnings respectively. We stay positive rating on the stock for a PT of Rs. 16,221.
|
Dhruv Joshi | ||
| Aug 03 2026 |
Tax shock weighs on cigarettes; other segments sustain momentum
Stock trades at 17.6x/16.3x its FY27E/FY28E EPS, respectively. We maintain a Buy with a revised PT of Rs. 341.
|
Kruttika Prabhudesai | ||
| Jul 31 2026 |
On a strong growth path
Stock trades at 14x/11.7x its FY27E/FY28E EV/EBIDTA, respectively. We stay Positive and expect an upside of 27% over the next 12 months.
|
Kruttika Prabhudesai | ||
| Jul 31 2026 |
Decent profitability in mixed bag Q1
We maintain a HOLD rating with a revised PT of Rs. 600, as the growth-versus-margin trade-off remains the key monitorable
|
Vijay Singh Gour | ||
| Jul 31 2026 |
Margin trend continues; Maintain Hold
We retain a Hold rating on Honeywell with a revised PT of Rs.41,000. The stock is expected to report a revenue/PAT CAGR of 12%/22%, respectively,
|
Ankit Soni | ||
| Jul 31 2026 |
Healthy Q1; subsidiary listing to unlock value
CIL trades at 4.8x/4.3x FY27E/FY28E EV/EBITDA; Buy maintained with revised PT of Rs. 530.
|
Netra Deshpande | ||
| Jul 31 2026 |
Temporary volatility, structural growth drivers unchanged
Q1FY27 delivered a strong beat aided by product mix optimization, inventory gains and forex tailwinds despite supply chain disruptions and lower volumes
|
Aditya Arora | ||
| Jul 31 2026 |
Tighter purse-strings brighten Q1
Revenue grew 23% y-o-y and 6% q-o-q to Rs 41,959 crore led by strong volume growth across the automobile and farm divisions.
|
Dhruv Joshi | ||
| Jul 31 2026 |
PAT surges on lower costs; robust operating profits
We project a 26.2% PAT CAGR over FY26–FY28 and maintain a BUY rating with a revised PT of Rs. 1,250 on strong profitability growth
|
Vijay Singh Gour | ||
| Jul 31 2026 |
Strong top line, margin pressure from North America
We value the stock at 1-year fwd avg P/E on FY28E EPS of Rs. 64.7 and retain our Buy rating with a PT of Rs. 1,623.
|
Thomas Abraham | ||
| Jul 31 2026 |
Price hikes power Q1
We retain a Buy with a unchanged PT of Rs. 430, given a positive business outlook factoring in strong growth from the electricals & electronics businesses.
|
Ankit Soni | ||
| Jul 30 2026 |
Margins slide on RM inflation; Recovery hinges on 2H27
Revenue grew 28% y-o-y to Rs 696 crore, supported by higher AO volumes and export benefits from a weak rupee. However, EBITDA margin fell 497 bps y-o-y to 24.5% due to sharp raw material inflation and
|
Aditya Arora | ||
| Jul 30 2026 |
Healthy Q1; non-lead businesses next growth engine
Revenue rose 42% y-o-y and 26% q-o-q to Rs. 1,475 crore. Copper segment generated Rs. 376 crore in revenue, compared to Rs. 51.78 crore a year ago.
|
Netra Deshpande | ||
| Jul 30 2026 |
Q1 a steady cruise
Best-ever Q1, with record volumes and EBITDA for VECV led by strong demand.
|
Dhruv Joshi | ||
| Jul 30 2026 |
FY27 growth path intact
Operating performance was strong, with consolidated revenue growing 10.6% y-o-y to Rs. 3,764 crore, driven by broad-based growth across India and global businesses.
|
Kruttika Prabhudesai | ||
| Jul 30 2026 |
Retain caution despite robust Q1
We maintain our HOLD rating while raising our price target to Rs 376.
|
Aditya Arora | ||
| Jul 30 2026 |
Sparkling Q1; premiumisation drives earnings momentum
Stock trades at 66x/53.7x its FY27E/FY28E earnings, respectively. We retain a Buy with a revised PT of Rs. 5,010.
|
Kruttika Prabhudesai | ||
| Jul 29 2026 |
Capacity additions to drive growth
Revenue grew 6% led by positive performances across segments. Adj EBITDA decline 3% y-o-y and adjusted PAT was higher 11%.
|
Ankit Soni | ||
| Jul 29 2026 |
Polymer prices stabilising; long-term outlook strong
Revenue grew 4% y-o-y on better realisations and a favourable product mix, even as volume fell 14% y-o-y on channel destocking.
|
Akshay Raghunath Shetty | ||
| Jul 29 2026 |
Margins brighten Q1
Consolidated revenue grew 16.5% y-o-y to Rs. 1,581 crore, driven by healthy growth in KFC India,
|
Kruttika Prabhudesai | ||
| Jul 29 2026 |
Reinvesting margin gains to fuel growth
Stock trades at 40.3x/36.1x its FY27E/FY28E EPS, respectively. We maintain a Buy with a revised PT of Rs. 2,426.
|
Kruttika Prabhudesai | ||
| Jul 29 2026 |
Margins expanded despite lower volumes
The net profit (attributable to the parent’s owners) in Q1FY27 increased by 120.8% y-o-y to Rs. 1,644 crore and was down 10.4% q-o-q.
|
Netra Deshpande | ||
| Jul 29 2026 |
Earnings beat estimates; growth rides on multiple drivers
GNPA rose 13 bps y-o-y and 24 bps q-o-q to 3.29%, though credit costs remained controlled at 1.58%.
|
Vijay Singh Gour | ||
| Jul 29 2026 |
Weak revenue visibility
Maintain HOLD with a price target of Rs 320.
|
Manav Medewala | ||
| Jul 29 2026 |
Execution stays steady; RoA, asset quality shining
We maintain a Buy with an revised PT of Rs. 275.
|
Sameer Suhas Sawant | ||
| Jul 29 2026 |
Bubbly Q2; strong volumes beat dull weather
We stay Positive and expect an upside of 32% over the next 12 months, implying a price target of Rs. 561.
|
Kruttika Prabhudesai | ||
| Jul 29 2026 |
Strong Q1; growth at multi-quarter high
Stock trades at 41.5x/37.2x its FY27E/FY28E EPS, respectively. We retain a Buy with a revised PT of Rs. 2503.
|
Kruttika Prabhudesai | ||
| Jul 29 2026 |
Record Disbursements and Solid Asset Quality Drive Momentum; Outlook Strong
Hence, we maintain a Positive view with a revised price target of Rs. 250.
|
Vijay Singh Gour | ||
| Jul 29 2026 |
Resilient performance amid volatile times
|
Ankit Soni | ||
| Jul 28 2026 |
Residential demand Intact; Palava data center to unlock long-term value
We maintain a “Positive” view with a revised PT of Rs. 1,465, on a strong pipeline and steady demand.
|
Akshay Raghunath Shetty | ||
| Jul 28 2026 |
Robust Q1; management commentary bright
Strong deal ramp-ups, accelerated Encora integration, and operating leverage opportunities support sustained growth and margin expansion.
|
Manav Medewala | ||
| Jul 28 2026 |
Manipal Hospitals
At Rs.560-590 per share, Manipal is being offered at ~80x FY26 PAT on post-issue equity.
|
Thomas Abraham | ||
| Jul 28 2026 |
Core earnings better, one-offs power PAT
At CMP, Welspun Corp trades at 14x/13x multiple on FY27E/FY28E EV/EBITDA, we maintain a Buy rating with a revised PT of Rs. 1850.
|
Netra Deshpande | ||
| Jul 28 2026 |
Asset quality stress easing; AUM growth to speed up
Hence, we upgrade to Buy from Hold with a price target of Rs. 620, trading at an attractive 1.6x FY28E P/BV.
|
Vijay Singh Gour | ||
| Jul 28 2026 |
Sustained growth guidance
With a promising order pipeline, we retain a Buy rating with a revised PT of Rs. 510. At CMP, the stock trades at 41x/35x its FY2027/FY2028 earnings estimates
|
Ankit Soni | ||
| Jul 27 2026 |
Steady capacity additions and higher demand led the growth
We maintain a Buy rating with an unchanged PT of Rs. 430; valuations are reasonable given strong long-term growth prospects
|
Ankit Soni | ||
| Jul 27 2026 |
CDMO biz drives Q1 earnings, growth drivers intact
Q1FY27 numbers were stellar, with revenue rising 29.1% y-o-y and PAT more than doubling
|
Thomas Abraham | ||
| Jul 27 2026 |
JP integration starts; capacity expansion plans on track
We maintain a Buy rating with a price target of Rs. 2,350; At CMP, Dalmia trades at a reasonable 11.7x/9.8x FY27E/FY28E EV/EBITDA.
|
Akshay Raghunath Shetty | ||
| Jul 27 2026 |
Margin pressure persists amid subsidy and raw material headwinds
We maintain a Buy rating with a PT of Rs 2,380 based on 25x FY28E EPS, led by a better business mix
|
Aditya Arora | ||
| Jul 27 2026 |
Growth businesses put up strong show, margin expansion continues
Stock trades at 56.1x/47.8x its FY27E/FY28E EPS, respectively. We maintain a Buy with a revised PT of Rs. 1,321.
|
Kruttika Prabhudesai | ||
| Jul 27 2026 |
In-line Q1; eyeing steady growth and consolidation
NII beat estimates by 4.0% as NIM expanded on improved portfolio yields and lower funding costs.
|
Vijay Singh Gour | ||
| Jul 27 2026 |
Premiumisation intact; supply chain disruption hits margins
Stock trades at 53.5x/35.5x FY27E/FY28E EPS; Positive stance maintained with PT of Rs. 718.
|
Kruttika Prabhudesai | ||
| Jul 27 2026 |
Exceptionally Strong Q1; stable margins hold key
We maintain PT at Rs. 7,716 based on 27x FY28 EPS. FY27 should benefit from favourable pricing, while FY28 growth should be driven by higher utilisation and new products.
|
Aditya Arora | ||
| Jul 27 2026 |
Core performance intact, credit-off take garners traction
The bank is poised to post steady ROA of ~1% mark for FY27. We maintain a Buy rating with unchanged PT of Rs175.
|
Sameer Suhas Sawant | ||
| Jul 27 2026 |
Mixed bag Q1, one-off dents profitability
Overall, we believe banks financials are healthy and profitability to be maintained at respectable levels going ahead. We maintain BUY with unchanged PT of Rs. 320.
|
Sameer Suhas Sawant | ||
| Jul 27 2026 |
Robust performance; growth-profitability flywheel intact
With improving profitability prospects, the bank is set to pose healthy performance over medium term. We maintain BUY with unchanged PT of Rs1225.
|
Sameer Suhas Sawant | ||
| Jul 27 2026 |
Strong performance and solid lineup ahead in FY27
We maintain a Buy rating with a price target of Rs 1,250.
|
Manav Medewala | ||
| Jul 24 2026 |
Long-term growth concerns persist
Revenue grew 10.6% y-o-y to Rs. 2,621crores led by strong performance in the domestic business of the company.
|
Dhruv Joshi | ||
| Jul 24 2026 |
Steady performance in Q1
Revenue rose 7.6% q-o-q and 25.2% y-o-y to Rs 565.1 crore; excluding MST and SweetRush, growth was 11% y-o-y
|
Manav Medewala | ||
| Jul 24 2026 |
FY27 Outlook Turns Cautious as Organic Growth Weakens
We slash our FY28E EPS estimate by 2.5%, lower target P/E to 14x on FY28E EPS of Rs. 79.2, revise the PT to Rs. 1,110, and downgrade to HOLD.
|
Manav Medewala | ||
| Jul 23 2026 |
Sequential recovery underway, GLP-1 India delay a setback
Q1FY27 net revenue fell 5.6% y-o-y to Rs. 8,070.5 crore, though this marked a 7.4% sequential improvement over Q4FY26.
|
Thomas Abraham | ||
| Jul 23 2026 |
On a robust growth path
We remain positive on Sunteck Realty, with a revised PT of Rs. 444, supported by a strong launch pipeline, robust cash flows and attractive valuation.
|
Akshay Raghunath Shetty | ||
| Jul 23 2026 |
All-round beat in Q1; H2 outlook better
Q1FY27 numbers beat estimates, led by robust growth in PFB and better-than-seasonal performance in the chemical segment.
|
Aditya Arora | ||
| Jul 23 2026 |
Revenue growth offsets cost pressures
Revenues grew by 17.5% y-o-y and 7% q-o-q to Rs. 2,681 crores led by strong performance in automotive technologies division
|
Dhruv Joshi | ||
| Jul 23 2026 |
Volumes, margins shine despite higher brand spends
Q1FY27 numbers were strong, with net sales growing 25.4% y-o-y to Rs. 6,363.3 crore
|
Kruttika Prabhudesai | ||
| Jul 23 2026 |
Strong AUM growth leads to market share gains
Structural growth story continues, aided by consistent market share gains, Maintain BUY with revised PT of Rs. 1,315.
|
Sameer Suhas Sawant | ||
| Jul 23 2026 |
Indian Pharma & US Tariffs: A Bird’s eye view
A similar route could plausibly be explored by generic manufacturers, several of which have already announced or expanded US manufacturing investments.
|
Pharmaceuticals | Thomas Abraham | |
| Jul 23 2026 |
Robust Q1; margin levers ahead
We retain a Buy rating with a revised PT of Rs. 480, given the visible turnaround and improving profitability.
|
Akshay Raghunath Shetty | ||
| Jul 23 2026 |
Order book momentum builds; execution holds the key to recovery
We maintain a Buy rating and revise PT to Rs. 2,000 (13x FY28E EPS of Rs 155.1).
|
Manav Medewala | ||
| Jul 22 2026 |
On a sharp growth run
Revenue rose 38% y-o-y and 9% q-o-q to Rs.13,896 crore, led by healthy volume growth of 28% y-o-y an
|
Dhruv Joshi | ||
| Jul 22 2026 |
Exports and operational efficiency protect margins
Revenue grew 37% y-o-y and 8% q-o-q to Rs. 17,244 crore as volumes grew 29% y-o-y and 5% q-o-q, aided by price hikes, which helped improve realisations.
|
Dhruv Joshi | ||
| Jul 22 2026 |
Indo-MIM
Indo-MIM is being offered at ~42.7x to 44.9x FY26 PAT on post-issue equity
|
Ankit Soni | ||
| Jul 22 2026 |
Stellar PAT beat, return ratios to gain strength
PAT beat estimates by 16.4%, surging 69.8% y-o-y and 3.0% q-o-q to Rs. 899 crore.
|
Vijay Singh Gour | ||
| Jul 22 2026 |
Domestic biz shines; asset-light growth accelerates
Stock trades at 23.8x/20.1x its FY27E/FY28E EV/EBITDA, respectively. We maintain a Buy rating with a revised PT of Rs. 860.
|
Kruttika Prabhudesai | ||
| Jul 22 2026 |
Q1 trumps seasonality
We reduce our FY28E EPS to Rs 2.9 valuing the company at 18x to arrive at a price target of Rs 52 with a Buy rating on the stock.
|
Manav Medewala | ||
| Jul 21 2026 |
Launch momentum stays strong
We remain positive on the stock with a revised PT of Rs. 2,122 on strong project launch momentum, healthy rentals and a comfortable balance sheet.
|
Akshay Raghunath Shetty | ||
| Jul 21 2026 |
Strong Q1; Growth trajectory intact
We maintain a Buy rating with a revised price target of Rs. 14,200, supported by strong volume growth, capacity expansion and improving acquired assets.
|
Akshay Raghunath Shetty | ||
| Jul 21 2026 |
Healthy Q1, IT transformation to drive operational efficiencies
We maintain a Buy rating with a PT of Rs. 1,100.
|
Vijay Singh Gour | ||
| Jul 21 2026 |
Better realisations, favourable product mix power Q1
At CMP, JSW Steel trades at 10.5x/8.2x for FY27E/FY28E EV/EBITDA. We maintain our Buy rating with PT of Rs. 1500.
|
Netra Deshpande | ||
| Jul 20 2026 |
Stable operating metrics and lower provisions propel PAT
Sharp 44.7% y-o-y decline in provisions drove up PAT by 25.6% y-o-y to Rs. 4,123 crore, ~3.8% ahead of estimates.
|
Sameer Suhas Sawant | ||
| Jul 20 2026 |
Growth trajectory improves, modest operational show
GNPA and NNPA ratios rose by 2 bps and 3 bps, q-o-q, respectively to 1.17% and 0.41% respectively,
|
Sameer Suhas Sawant | ||
| Jul 20 2026 |
Strong Q1, yet valuations limit upside
Advances grew 15.0% y-o-y, while deposits grew 11.4% y-o-y.
|
Vijay Singh Gour | ||
| Jul 20 2026 |
Business growth strong; margins contract
NII rose 8.0% y-o-y despite NIM contraction on account of uptick in growth momentum for Q1FY27.
|
Sameer Suhas Sawant | ||
| Jul 20 2026 |
Firing on all cylinders
Continued momentum in government and private capex, besides real estate sector’s growth augurs well. We expect revenue/PAT to clock a CAGR of 24%/30%, respectively from FY26-28, with a good RoCE of 36
|
Ankit Soni | ||
| Jul 20 2026 |
Benign credit cost helps PAT beat estimates
Overall, the bank is well place to put stable operational performance in FY27, thus we maintain a Buy with an unchanged PT of Rs. 130.
|
Sameer Suhas Sawant | ||
| Jul 20 2026 |
Q1 fires on all cylinders
We maintain a Buy with revised PT of Rs. 1,750.
|
Sameer Suhas Sawant | ||
| Jul 17 2026 |
Weak Q1
We maintain a Hold rating and price target of Rs. 185, based on a 13x FY28E EPS of Rs. 14.1.
|
Manav Medewala | ||
| Jul 17 2026 |
Retail Shines, Reserve Bites
With near-term earnings visibility reduced and the risk-reward more balanced after a period of outperformance.
|
Vijay Singh Gour | ||
| Jul 17 2026 |
Strong start to FY27
Accordingly, we raise our target price to Rs 1,700 on better than expected revenue growth, valuing the stock at 19x on FY28E EPS of Rs 89, retaining our buy rating.
|
Manav Medewala | ||
| Jul 16 2026 |
Protection segment powers VNB growth; margins
Strategic focus remains centred on growing absolute VNB over margin maximisation, ensuring sustainable profitability across changing market cycles
|
Sameer Suhas Sawant | ||
| Jul 16 2026 |
Broad-based growth; resilient margins
We maintain a Buy rating with a revised PT of Rs. 715 as long-term growth prospects remain intact as banking channel volumes revive and margins stay stable.
|
Sameer Suhas Sawant | ||
| Jul 15 2026 |
Improving growth and margins largely priced
However, considering that much of the improvement is already reflected in valuations, we retain a HOLD rating on the stock, valuing the stock at 3,600 on FY28E EPS of 155.7.
|
Manav Medewala | ||
| Jul 14 2026 |
Designed to shine
We initiate coverage on Sky Gold & Diamonds (SKYGOLD) with a Buy, assigning a price target of Rs. 850. Stock trading at 22.6x/16.8x its FY27E/FY28E earnings.
|
Netra Deshpande | ||
| Jul 14 2026 |
Growth largely priced in; upside limited
Adjusting for slightly higher margins in Q1FY27, we raise our price target to Rs 1,300 on FY28E EPS of 76.3, valuing the stock at 17x with a HOLD rating.
|
Manav Medewala | ||
| Jul 14 2026 |
Q1FY2027 Automobile Results Preview
In a strong growth phase; macro risks persist
|
Dhruv Joshi | ||
| Jul 13 2026 |
Stellar Q1; long-term growth path intact
PAT stood at Rs. 916 crore, beating estimates by 6.4%, growing by 30.7% y-o-y and 13.2% q-o-q.
|
Vijay Singh Gour | ||
| Jul 13 2026 |
Resilience amid crosswinds
June 2026 was a reminder that markets rarely follow a straight path. It was a month where optimism and caution took turns driving sentiment. While global headlines kept investors on edge, India’s unde
|
Mirae Asset Research Team | ||
| Jul 13 2026 |
SBI Funds Management Limited
India’s largest asset management company by quarterly average AUM is coming out with its IPO, entirely structured as an Offer for Sale
|
Sameer Suhas Sawant | ||
| Jul 13 2026 |
Q1FY2027 Pharma & Healthcare Results Preview
Pharma at an inflection point while hospitals continue to grow
|
Thomas Abraham | ||
| Jul 13 2026 |
Q1FY2027 Consumer Goods Results Preview
Gradual, broad-based normalisation
|
Kruttika Prabhudesai | ||
| Jul 13 2026 |
Steady start for F27
We maintain a Buy rating and raise PT to Rs 4,450 (19.5x FY28E EPS of Rs 231.6).
|
Manav Medewala | ||
| Jul 13 2026 |
Q1FY2027 NBFCs, Insurance, AMC & Diversified Financials Results Preview
NBFCs and diversified players face resilient Q1; AMCs to see mixed nos
|
Vijay Singh Gour | ||
| Jul 13 2026 |
ValueGuide Equity - July 2026
Resilience amid crosswinds
|
Mirae Asset Research Team | ||
| Jul 10 2026 |
Q1FY2027 Metals & Mining Results Preview
Firm realizations to keep earnings growth intact
|
Netra Deshpande | ||
| Jul 10 2026 |
Q1FY2027 Chemicals Results Preview
Eyeing a mixed bag quarter
|
Aditya Arora | ||
| Jul 10 2026 |
No major surprises, recovery momentum building
At 13.0x/12.6x FY27/FY28 earnings, valuations remain attractive. We retain Buy with a Rs2,400 target price (15x FY28E EPS of Rs162.8).
|
Manav Medewala | ||
| Jul 09 2026 |
Q1FY2027 Banking Results Preview
Business growth to accelerate, profitability to stay stable
|
Sameer Suhas Sawant | ||
| Jul 09 2026 |
Q1FY2027 Cement Results Preview
Higher Input Costs to Weigh on Profitability
|
Akshay Raghunath Shetty | ||
| Jul 07 2026 |
Q1FY2027 IT Results Preview
Growth, Multiple and Valuation Reset
|
Manav Medewala | ||
| Jul 03 2026 |
Macro headwinds ease
With the West Asia crisis cooling off, correction in fuel prices, easing of supply chain and raw material price concerns along with strong domestic demand, all factors lead to a help with positive tra
|
Automobiles | Dhruv Joshi | |
| Jul 02 2026 |
A Scrap to Sustainability growth story
Pondy Oxides & Chemicals Ltd (POCL) is poised for a steady growth run, led by capacity expansions, regulatory tailwinds and thrust on the copper recycling business.
|
Aditya Arora | ||
| Jul 01 2026 |
Eyeing a wider “affluent” pool
We maintain a Buy with an unchanged PT of Rs. 500
|
Sameer Suhas Sawant | ||
| Jun 30 2026 |
Closer to $5-bn revenue goal
Accordingly, we assign a 30x FY28E P/E multiple and arrive at a revised price target of Rs 5,200, while retaining a Buy rating.
|
Manav Medewala | ||
| Jun 30 2026 |
Business restructuring to unlock value
We expect revenue, operating profit and net profit CAGR of 15%, 18% and 30%, respectively, over FY26–FY28E. At 47.2x/40.6x FY27E/FY28E earnings, we maintain a Buy rating with a revised PT of Rs. 1,750
|
Akshay Raghunath Shetty | ||
| Jun 24 2026 |
A Goal for Global Growth
The US-Iran war has been one of the most important geopolitical events affecting global financial markets.
|
Mirae Asset Research Team | ||
| Jun 22 2026 |
Expansion to drive growth and margins
Management guided for an over 17-18% volume growth and OPM of 10.5-11% for FY27.
|
Ankit Soni | ||
| Jun 22 2026 |
Inventurus Knowledge Solutions Ltd
We initiate coverage with a Buy rating and a PT of Rs. 2,020 (32x FY28E EPS).
|
Manav Medewala | ||
| Jun 22 2026 |
Sagility Ltd
Sagility is a pure-play BPO services provider with an exclusive focus on the US healthcare market and is primed to benefit from the huge outsourcing opportunities arising from that market
|
Manav Medewala | ||
| Jun 22 2026 |
A pill to bill growth story
A significant growth opportunity in the US healthcare industry, warrants initiation of coverage on Sagility and IKS – two companies positioned to capitalise on the growing opportunities in the US heal
|
IT & ITES | Manav Medewala | |
| Jun 11 2026 |
ValueGuide Equity - June 2026
Wading through stormy times
|
Mirae Asset Research Team | ||
| Jun 11 2026 |
Wading through stormy times
May was a month of mayhem, after a sharp recovery in April. At a time, when domestic GDP growth was steady and SIP flows were at all-time highs, a cocktail of headwinds rocked the markets - Soaring cr
|
Mirae Asset Research Team | ||
| Jun 11 2026 |
Unichem ramp-up holds key; valuations favourable
We value the stock closer (marginally above) to its historic average + 1-SD standard deviation, at 32x on FY28E EPS of Rs. 57.8 and retain a Buy rating and a price target of Rs. 1,850.
|
Thomas Abraham | ||
| Jun 10 2026 |
5 Curated Stock Ideas for June 2026
Corporate earnings is the flavour on the street and we bring you a curated bouquet of five stocks that could give your portfolio an edge. Each idea combines technical and fundamental growth drivers.
|
Mirae Asset Research Team | ||
| Jun 09 2026 |
Aggressive capex additions on the back increased order inflow
We value the stock at 52x on FY28E EPS of Rs. 143.9 and arrive at PT of Rs. 7,482 and retain Buy rating.
|
Thomas Abraham | ||
| Jun 08 2026 |
Q4FY2026 Metals & Mining Results Review
Steady growth persists; constructive outlook in the long run
|
Netra Deshpande | ||
| Jun 08 2026 |
Valuations at a premium; business improving
With CDMO business aiding in margin improvements, we increase the valuation multiple to 60x and reta
|
Thomas Abraham | ||
| Jun 08 2026 |
Q4FY2026 Consumer Discretionary Results Review
Mixed bag Q4
|
Kruttika Prabhudesai | ||
| Jun 05 2026 |
Navigating global headwinds; attracting foreign flows
The RBI kept the repo rate unchanged at 5.25% at its June monetary policy and maintained a neutral stance.
|
Sameer Suhas Sawant | ||
| Jun 05 2026 |
Mixed Q4; focus shifts to execution
We continue to value the stock at 40x on FY28E EPS of 11.7 and retain a price target of Rs. 467 with a Buy rating.
|
Thomas Abraham | ||
| Jun 04 2026 |
Q4FY2026 Capital Goods and Power Results Review
Data centre boom in spotlight
|
Ankit Soni | ||
| Jun 03 2026 |
Demand continues, but signs of stress visible
Despite global headwinds, Indian automakers continue to register good dispatches in May 2026
|
Automobiles | Dhruv Joshi | |
| Jun 03 2026 |
Q4FY2026 Consumer Goods Results Review
Steady Q4; near-term outlook cautious
|
Kruttika Prabhudesai | ||
| Jun 03 2026 |
Robust Q4; Organon deal a key monitorable
Q4FY26 numbers were robust, with consolidated net profit rising 26% y-o-y, though earnings slipped q-o-q.
|
Thomas Abraham | ||
| Jun 02 2026 |
Multiple growth engines at play
We stay Positive and expect an upside of 38% over the next 12 months. Stock trades at 11x/10x its FY27E/FY28E EV/EBIDTA, respectively.
|
Kruttika Prabhudesai | ||
| Jun 02 2026 |
Robust numbers; growth momentum to sustain
Stock trades at 14x/10x its FY27E/FY28E EV/EBIDTA, respectively. We maintain a Positive view and revise PT to Rs. 300 (Upside of 25%).
|
Kruttika Prabhudesai | ||
| Jun 02 2026 |
Steady Q4, operating efficiencies improving
We maintain a positive view with an unchanged PT of Rs. 110 (a 21% upside) backed by expanding balance sheet, improving operating efficiencies and profitability.
|
Vijay Singh Gour | ||
| Jun 02 2026 |
Mixed bag quarter, battery segment ramping up
With battery segment still ramping up, we expect it to start contributing meaningfully only in FY29. We downgrade the stock to HOLD with a PT of Rs 3,880.
|
Aditya Arora | ||
| Jun 02 2026 |
Strong show in tough times
We maintain a Buy rating with a price target of Rs. 2,130.
|
Dhruv Joshi | ||
| Jun 02 2026 |
Transformation into new geographies unlocks growth value
At CMP, NMDC trades at 5.8x/6x of FY27E/FY28E EV/EBITDA. We maintain a Buy rating with a revised PT of Rs.105.
|
Netra Deshpande | ||
| Jun 02 2026 |
Q4FY2026 Cement Results Review
Volume-led growth; margins to be stressed in near term
|
Akshay Raghunath Shetty | ||
| Jun 01 2026 |
Steady Q4; positive growth outlook
Stock trades at 34x/27x its FY27E/FY28E EPS, respectively. We stay Positive on the stock with an upside of 32% in 12 months.
|
Kruttika Prabhudesai | ||
| Jun 01 2026 |
New hospitals contibuting well to long term growth
We value the stock at 35x, and arrive at a price target of Rs. 1,036, and retain our Buy rating.
|
Thomas Abraham | ||
| Jun 01 2026 |
Decent Q4; outlook positive
Stock trades at 33x/28x its FY27E/FY28E EPS and 21x/18x its FY27E/FY28E EV/EBITDA, respectively. We retain Buy with a revised PT of Rs. 1,175.
|
Kruttika Prabhudesai | ||
| Jun 01 2026 |
Consistent performer
We expect a 17%/16% CAGR in revenue/PAT (for FY26-28E). We see the business to benefit from data centers, healthcare, infrastructure.
|
Ankit Soni | ||
| Jun 01 2026 |
Strong Q4
Stock trades at 50x/44x its FY27E/FY28E EPS, respectively. We maintain a Buy rating with a revised PT of Rs. 2,965.
|
Kruttika Prabhudesai | ||
| May 29 2026 |
Q4 on expected lines, capex to fuel medium term growth
Q4FY26 numbers were strong as in-patient and outpatient volumes saw strong growth.
|
Thomas Abraham | ||
| May 29 2026 |
Capacity expansion to drive growth
We retain a Buy rating with a PT of Rs. 906, on strong multi-year earnings visibility.
|
Akshay Raghunath Shetty | ||
| May 29 2026 |
Powering through in tough times
Strong domestic demand and rising contribution of exports boost volumes to all time. Defence and EV business provide support.
|
Dhruv Joshi | ||
| May 27 2026 |
Near-medium term outlook bleak; downgrade to Hold
In view of the near to medium term uncertainty, we downgrade the stock from Buy to Hold with a revised SOTP-based PT of Rs. 70.
|
Kruttika Prabhudesai | ||
| May 27 2026 |
Strong Q4; Valuation upside limited
The valuation run-up does not leave room for significant upside in the current market scenario. Thus, we retain a neutral rating with a target price of Rs. 302.
|
Thomas Abraham | ||
| May 27 2026 |
Global biz, acquisitions key to long-term growth
We value the stock at 24x, near the historic average 1-year fwd P/E, with an FY28E EPS of Rs.49.7. We retain a Hold rating and revise our price target upwards to Rs. 1,193.
|
Thomas Abraham | ||
| May 26 2026 |
On a growth track
The stock trades at 26.8x/20.2x FY27/FY28 EPS. We remain positive on the stock, and revised our TP to Rs. 1,374.
|
Akshay Raghunath Shetty | ||
| May 26 2026 |
Strong Q4, return ratios improving
We maintain a positive view on the stock with a revised price target of Rs. 260 as it trades at an attractive 0.6x FY28E BV.
|
Vijay Singh Gour | ||
| May 26 2026 |
Decent Q4; eyeing rapid growth and market share gains
Stock trades at 26x/23x its FY27E/FY28E EPS, respectively. We maintain Buy on the stock with a revised PT of Rs. 1,260.
|
Kruttika Prabhudesai | ||
| May 26 2026 |
Eyeing balanced growth
Stock trades at 39x/35x its FY27E/FY28E EPS, respectively. We maintain a Buy with a revised PT of Rs. 2,340.
|
Kruttika Prabhudesai | ||
| May 26 2026 |
Robust order book brightens outlook
We maintain a Buy with a revised PT of Rs. 1,900, valuing it at 20x its FY28 EPS. Stock trades at a P/E of ~19x/16x its FY27E/28E EPS.
|
Ankit Soni | ||
| May 26 2026 |
Capacity boost to power growth
We maintain a Buy rating with a revised PT of Rs. 450. Valuation of 1.7x/1.6x its FY27E/28 P/BV is reasonable given strong long-term growth prospects; Stock offers a decent dividend yield as well.
|
Ankit Soni | ||
| May 25 2026 |
Soft Q4; outlook stays bright
Stock trades at 7x/6x its FY27E/FY28E EV/EBITDA, respectively. We stay Positive with a 29% upside.
|
Kruttika Prabhudesai | ||
| May 25 2026 |
Seasonality, geopolitical disruptions hit Q4
Stock trades at 19x/17x its FY27E/FY28E EPS, respectively. We maintain a Buy with a revised PT of Rs. 520.
|
Kruttika Prabhudesai | ||
| May 25 2026 |
Capacity expansions plans intact
We maintain our Buy rating while lowering our price target to Rs. 770, reflecting moderation in near-term performance due to cost pressure.
|
Akshay Raghunath Shetty | ||
| May 25 2026 |
Firing on all cylinders
We maintain a Buy rating with an SOTP-based price target of Rs. 8,830.
|
Dhruv Joshi | ||
| May 25 2026 |
Mixed bag Q4, AUM growth story intact
We stay positive with unchanged PT of Rs. 260 on strong AUM/PAT CAGR, robust sanction pipeline, continued asset quality improvement and healhty return ratios.
|
Vijay Singh Gour | ||
| May 25 2026 |
Strong asset quality offsets disbursement decline
PFC-REC merger will boost financial scale and lower borrowing costs.
|
Vijay Singh Gour | ||
| May 25 2026 |
Navigating near-term headwinds, structural positive intact
We reduce our price target to Rs 1,360 and lower the valuation multiple given emerging AI-led disruptions.
|
Manav Medewala | ||
| May 25 2026 |
Quality on growth along with strong margin performance
The company is demonstrating high-quality, sustainable growth along with strong margin profile. Maintain BUY with revised PT of Rs. 2,000.
|
Sameer Suhas Sawant | ||
| May 25 2026 |
Revenues stay robust braving global headwinds
At CMP, Welspun Corp trades at an 11x/10x multiple on FY27E/FY28E EV/EBITDA, we maintain a Buy rating with revised PT of Rs. 1500.
|
Netra Deshpande | ||
| May 25 2026 |
Growth prospects stay strong
We expect the company to deliver a strong revenue/PAT CAGR growth of 26%/55% respectively over FY26-28E. At CMP, the stock trades at a P/E of 27x/19x its FY2027E/FY2028E EPS, presenting an attractive
|
Ankit Soni | ||
| May 25 2026 |
Cigarette, agri business to stay stressed in near term
Stock trades at 19x/17x its FY27E/FY28E EPS, respectively. We maintain a Buy with a revised PT of Rs. 355.
|
Kruttika Prabhudesai | ||
| May 22 2026 |
Margins surprise; Maintain Hold
We retain a Hold rating on Honeywell with a revised PT of Rs. 39,000. The stock is expected to report a revenue/PAT CAGR of 12%/22%, respectively, over FY2026-FY2028E.
|
Ankit Soni | ||
| May 22 2026 |
Robust Q4; strategic expansions to drive growth
We value the stock at ~45x FY28E EPS of Rs.215, implying a price target of Rs. 9,677, with a Buy rating.
|
Thomas Abraham | ||
| May 22 2026 |
Paints biz in focus; long-term outlook robust
We retain Buy with a revised SOTP-based PT of Rs. 3,530, supported by sustained momentum in paints and improving operating leverage.
|
Akshay Raghunath Shetty | ||
| May 22 2026 |
Q4FY2026 IT Results Review
AI dims tier 1 cos’ performance; mid-tier shine
|
Manav Medewala | ||
| May 22 2026 |
Muted Q4; near-term outlook bleak
Stock trades at 15x/13x its FY27E/FY28E consolidated EV/EBIDTA, respectively. We maintain a Buy rating with a revised PT of Rs. 545.
|
Kruttika Prabhudesai | ||
| May 21 2026 |
Bright times ahead
We maintain a Buy with an unchanged PT of Rs. 1,850, on rising polymer prices and improving demand outlook.
|
Akshay Raghunath Shetty | ||
| May 21 2026 |
Sustained Growth Guidance
With a promising order pipeline, we retain a Buy rating with a revised PT of Rs. 510. At CMP, the stock trades at 41x/35x its FY2027/FY2028 earnings estimates.
|
Ankit Soni | ||
| May 21 2026 |
On a weak footing
We maintain a Hold rating with a PT of Rs 3,100.
|
Aditya Arora | ||
| May 20 2026 |
India biz hit by muted seasonal demand
Long-term OPM guidance maintained at 17-18% under normal seasonal conditions.
|
Kruttika Prabhudesai | ||
| May 20 2026 |
Growth outlook intact
We reduce our estimates due to a lower-than-expected guidance but maintain a Buy rating with a lower price target of Rs 8,800.
|
Ankit Soni | ||
| May 20 2026 |
KFC drives growth; Pizza Hut weighs on performance
Stock trades at 12x/9x its FY27E/FY28E EV/EBITDA, respectively. We maintain Hold with a revised PT of Rs. 135 on near-term concerns.
|
Kruttika Prabhudesai | ||
| May 20 2026 |
New launches, strong demand to smoothen ride
We maintain a Buy rating with an SOTP-based price target of Rs. 419.
|
Dhruv Joshi | ||
| May 20 2026 |
Europe and Emerging Markets shine, price erosion a current headwind in US
We continue to value the stock at 18.5x on FY28E earnings and retain our HOLD rating with a revised target price of Rs. 1,415.
|
Thomas Abraham | ||
| May 20 2026 |
Robust outlook visible in enquiry pipeline
We reiterate a Buy rating with a revised PT of Rs. 750, modeling a 14% revenue and 21% PAT CAGR through FY28E.
|
Ankit Soni | ||
| May 19 2026 |
India biz shines
Stock trades at 9x/8x its FY27E/FY28E EV/EBIDTA, respectively. We maintain a Buy with a revised PT of Rs. 85.
|
Kruttika Prabhudesai | ||
| May 19 2026 |
Resilient margins; revenue impacted by geopolitical headwinds
At CMP, RMTL trades at a 25.5x/22.7x multiple on FY27E/FY28E EPS, we maintain our Buy rating with PT of Rs. 2900.
|
Netra Deshpande | ||
| May 19 2026 |
Promoter stake strategy in focus
We maintain a BUY rating with an SOTP-based price target of Rs 2,350.
|
Manav Medewala | ||
| May 19 2026 |
Q4FY2026 Banking Results Review
Growth momentum strong, stress on book eases
|
Sameer Suhas Sawant | ||
| May 19 2026 |
Muted Q4; faster execution a key monitorable
The stock trades at 25x its FY2028E EPS. With the strong order book with a strong inquiry pipeline, we maintain our Buy rating with a price target of Rs. 5,500 factoring a revenue/ PAT CAGR growth of
|
Ankit Soni | ||
| May 19 2026 |
Outlook remains strong
We maintain a Buy with a revised PT of Rs 1,500. Stock is valued at ~16x/13x FY27E/28E P/E. Key catalysts include asset monetisation and reduced promoter pledges.
|
Ankit Soni | ||
| May 19 2026 |
Capex plans to power growth
Strong capex expectations brightens earnings visibility. Hence, we maintain a Buy with an unchanged PT of Rs. 350. At CMP, it trades at 2.6x/2.4x its FY26/27 P/BV.
|
Ankit Soni | ||
| May 19 2026 |
Riding a long growth runway
We value the stock at 45x on FY28E EPS of Rs 33.2, with a Buy rating and price target of Rs 1,494, contingent on a steady ramp-up over the next 2-3 quarters.
|
Thomas Abraham | ||
| May 18 2026 |
On a strong growth path
Management eyes mid-double-digit room revenue growth for FY27, driven by mid-high single-digit RevPAR growth.
|
Kruttika Prabhudesai | ||
| May 18 2026 |
Sectoral tailwinds and higher steel prices inflecting margins
At CMP, SAIL trades at 6.3x/6.1x for FY27E/FY28E EV/EBITDA, we upgrade our rating to Buy with revised PT of Rs. 220.
|
Netra Deshpande | ||
| May 18 2026 |
Music vertical surprises on strong margin
We maintain a Buy rating with a price target of Rs 450 valuing the company at 30x P/E on FY28E EPS.
|
Manav Medewala | ||
| May 18 2026 |
Strong growth momentum to sustain
Stock trades at 46x/30x its FY27E/FY28E EPS, respectively. We stay Positive and maintain PT at Rs. 715.
|
Kruttika Prabhudesai | ||
| May 18 2026 |
High-end products to drive growth
We maintain our BUY rating for a TP of Rs 2,000, expecting company to maintain a strong long-term growth trajectory.
|
Ankit Soni | ||
| May 18 2026 |
Near-term headwinds to delay recovery
Revenue grew 5.1% q-o-q (up 22.2% y-o-y) to Rs. 525.2 crore, below expectations as a few clients slashed year-end budgets amid macro uncertainties.
|
Manav Medewala | ||
| May 18 2026 |
Weak Q4, yet outlook promising
Tata Power has a well-planned strategy to shift towards clean energy and targets a 2.5x rise in PAT by FY2030E over FY2024.
|
Ankit Soni | ||
| May 18 2026 |
Demand remains strong, supply concerns loom
We maintain a Buy rating with a PT of Rs. 439.
|
Dhruv Joshi | ||
| May 15 2026 |
Launches lined up for FY27
We stay Positive on the stock and revise the price target to Rs. 800, led by sustained residential momentum and continued scaling up of the rental portfolio.
|
Akshay Raghunath Shetty | ||
| May 15 2026 |
Forging a steady growth path
At CMP, JSW Steel trades at 9.1x/7.2x for FY27E/FY28E EV/EBITDA, we maintain our BUY rating with revised PT of Rs.1500.
|
Netra Deshpande | ||
| May 15 2026 |
Robust Q4; niche products drive growth
We value the stock at 22x on FY28E EPS of Rs. 121.3 to arrive at price target of Rs. 2,669.
|
Thomas Abraham | ||
| May 15 2026 |
Firing on multiple cylinders
We maintain a Buy rating with a PT of Rs. 4,086.
|
Dhruv Joshi | ||
| May 14 2026 |
Strong Q4; growth momentum to sustain
Consolidated revenues grew 14% y-o-y, EBITDA margins stood flat y-o-y at 35.2%, while adjusted PAT grew 15% y-o-y.
|
Kruttika Prabhudesai | ||
| May 13 2026 |
Positive outlook going forward
We retain a Buy with a revised PT of Rs. 430, given a positive business outlook factoring in the strong growth from the electricals & electronics businesses.
|
Ankit Soni | ||
| May 13 2026 |
Steady Q4
Stock trades at 39x/35x its FY27E/FY28E earnings, respectively. We maintain a Buy rating with an unchanged PT of Rs. 560.
|
Kruttika Prabhudesai | ||
| May 13 2026 |
Positive outlook going forward
We retain a Buy with a revised PT of Rs. 430, given a positive business outlook factoring in the strong growth from the electricals & electronics businesses.
|
Ankit Soni | ||
| May 13 2026 |
Mobile volumes drag the overall performance
We retain a Buy rating with Rs. 13,000 PT, factoring 24%/6% revenue/PAT CAGR (FY26–28E). Stock trades at 49x FY27E and 34x FY28E earnings.
|
Ankit Soni | ||
| May 13 2026 |
Healthy Q4; outlook bright
Stock trades at 65x/55x its FY27E/FY28E EPS, respectively. We maintain a Buy with an unchanged PT of Rs. 1,425.
|
Kruttika Prabhudesai | ||
| May 12 2026 |
On a launch spree in FY27
Revenue was in line with our estimates, while EBITDA/PAT lagged by 6.2%/5.6% versus our forecasts.
|
Akshay Raghunath Shetty | ||
| May 12 2026 |
Good Q4; Chennai ramp-up on track
Stock trades at 10x/7x its FY27E/FY28E EV/EBIDTA, respectively. We maintain a Buy with a revised PT of Rs. 650.
|
Kruttika Prabhudesai | ||
| May 12 2026 |
Deleveraged Balance Sheet, Strong Cash Generation
Q4 saw 31 million footfalls (y-o-y growth of 1.5%) with an average ticket price of Rs. 315 (y-o-y growth of 22.4%) and spend per head of Rs. 165 (up 32.3% y-o-y).
|
Manav Medewala | ||
| May 12 2026 |
AI-led growth run
We factor in a ~19.5% revenue CAGR over FY26–FY28E, and value the company at 40x FY28E earnings, implying a price target of Rs 1,900, with inorganic growth providing a further upside.
|
Manav Medewala | ||
| May 12 2026 |
Robust Q4 on most parameters
The bank is poised to post steady return ratios and respectable growth. We thus maintain a Buy rating with revised PT of Rs175.
|
Sameer Suhas Sawant | ||
| May 12 2026 |
AI focus to broaden growth horizons
Accordingly, we increase our price target to Rs 885 at 24x P/E on FY28E EPS with a Buy rating.
|
Manav Medewala | ||
| May 12 2026 |
Order inflow prospects stay strong; execution a key catalyst
With stock prices, order book visibility and premium multiples having already run up, we maintain a Hold rating;. Thermax trades at ~64x/49x its FY2027E and FY2028E EPS.
|
Ankit Soni | ||
| May 12 2026 |
Good Q4; positive guidance maintained
Stock trades at 62x/48x its FY27E/FY28E earnings, respectively. We maintain a Buy with an unchanged PT of Rs. 4,950.
|
Kruttika Prabhudesai | ||
| May 11 2026 |
Comeback amid Chaos
After the rout in March, April turned out to be the strongest month for the benchmark indices in over two years. The Nifty rose 7.46% and the Sensex 6.90% in April, clocking their best show since Dece
|
Mirae Asset Research Team | ||
| May 11 2026 |
Soft Q4; recovery to be gradual
Stock trades at 47x/40x its FY27E/FY28E EPS, respectively. We maintain Buy on the stock with a revised PT of Rs. 6,550.
|
Kruttika Prabhudesai | ||
| May 11 2026 |
Operational performance and growth remains strong
Overall, the outlook for the bank remains positive supported by healthy business momentum and stable operating metrics. We maintain BUY with unchanged PT of Rs. 320.
|
Sameer Suhas Sawant | ||
| May 11 2026 |
ValueGuide Equity - May 2026
Comeback amid Chaos
|
Mirae Asset Research Team | ||
| May 11 2026 |
Mixed bag Q4
Overall, Q4 was a mixed bag, even as the long-term outlook remains stable considering the bank’s strong balance sheet. We maintain a Buy rating with a revised PT of Rs. 1200.
|
Sameer Suhas Sawant | ||
| May 08 2026 |
Backward integration improves efficiency
RMIL acquisition consolidated from March 12, 2026, adding Rs. 51.78 crore to Q4 revenue.
|
Netra Deshpande | ||
| May 08 2026 |
Strong Q4; outlook positive
The stock trades at 59x/47x its FY27E/FY28E earnings, respectively. We retain a Buy with a revised PT of Rs. 4,050.
|
Kruttika Prabhudesai | ||
| May 08 2026 |
Adding muscle for a steady ride
We maintain a Buy rating with a PT of Rs. 12,500.
|
Dhruv Joshi | ||
| May 08 2026 |
On an expansion spree
Rising per-capita income, better insurance penetration, an ageing population and other tailwinds place India’s private hospitals at a critical juncture, as the market for quality tertiary care widens
|
Healthcare Services | Thomas Abraham | |
| May 08 2026 |
Trade volumes fuel growth
The stock trades at 31xFY28E EPS, we stay positive on the stock and revise PT to Rs. 4400.
|
Sameer Suhas Sawant | ||
| May 08 2026 |
Summer Season to drive the growth
Stock trades at 48x/40x its FY2027/FY2028 EPS, respectively. We retain a Buy rating with a revised PT of Rs. 2,000.
|
Ankit Soni | ||
| May 08 2026 |
Better patient mix, new hospitals to sustain growth momentum
Yatharth Hospitals remains on a strong growth trajectory, as patient mix improves
|
Thomas Abraham | ||
| May 08 2026 |
Niche player, strong financials to support expansion plans
Rainbow Children’s Medicare is yet another convincing long term investment pick
|
Thomas Abraham | ||
| May 08 2026 |
Consistent performance, strategic expansion to drive growth
Global Health Ltd (Medanta) looks attractive as a long-term investment because it combines a strong brand with an expansion strategy.
|
Thomas Abraham | ||
| May 08 2026 |
Brand value and presence warrants premium valuation
The company presents a compelling investment case as India’s leading private healthcare provider
|
Thomas Abraham | ||
| May 07 2026 |
Turnaround still uncertain amid weak revenue visibility
As a recovery may be prolonged, we reduce our price target on the stock to Rs 380 with a HOLD rating, valuing the stock at 15x on FY28E EPS
|
Manav Medewala | ||
| May 07 2026 |
Racing ahead in top gear
We maintain a Buy rating with an SOTP based PT of Rs. 4120 (25% upside).
|
Dhruv Joshi | ||
| May 07 2026 |
Refrigerants continue to do the heavy lifting
We remain positive on SRF given multiple tailwinds. We maintain a Buy rating with a SOTP-based TP of Rs 3,170.
|
Aditya Arora | ||
| May 07 2026 |
On a consistent growth track
We expect revenue/PAT to clock a CAGR of 25%/31%, respectively from FY26-28, with a good RoCE of 35%. Hence, we maintain a Buy rating with a PT of Rs 9.800..
|
Ankit Soni | ||
| May 06 2026 |
Healthy Q4; guidance optimistic
Q4FY26 revenue grew 22.1% y-o-y, while OPM fell 114 bps y-o-y to 15.6%, leading to PAT growth of 18.3%.
|
Kruttika Prabhudesai | ||
| May 06 2026 |
5 Curated Stock Ideas for May 2026
Corporate earnings is the flavour on the street and we bring you a curated bouquet of five stocks that could give your portfolio an edge
|
Mirae Asset Research Team | ||
| May 06 2026 |
Growth prospects remain intact
OPM rose 64 bps to 11%, led by healthy gross profit margins expansion.
|
Ankit Soni | ||
| May 06 2026 |
Steady quarter, strong margin, brighter outlook ahead
Revenue grew 1.7% q-o-q (21.2% y-o-y) to $489 million and by 2% in CC terms. Rupee revenue rose 5.2% q-o-q (30% y-o-y) to Rs. 4,450 crore, led by healthcare & hitech and govt outside India. EBIT margi
|
Manav Medewala | ||
| May 06 2026 |
Growth visibility amid volatile times
We maintain a Buy with a revised PT of Rs. 4,700, on strong order prospects and healthy earnings growth outlook.
|
Ankit Soni | ||
| May 06 2026 |
Domestic markets, forex gains and other income comfort Q4
Consolidated revenue grew 11% y-o-y and 10% q-o-q to Rs. 1693 crore in Q4FY26, while for FY26 it rose 6% y-o-y to Rs. 6289 crore.
|
Dhruv Joshi | ||
| May 06 2026 |
Mixed Bag quarter, long term outlook stable
Long-term growth outlook remains stable, while near term uncertainties warrant caution and thus we maintain a Buy with a revised PT of Rs. 130.
|
Sameer Suhas Sawant | ||
| May 06 2026 |
Strong Q4; Growth story in full swing
Consolidated PAT grew 31.5% y-o-y and 20.6% q-o-q as businesses grew strongly.
|
Vijay Singh Gour | ||
| May 06 2026 |
Weak Q4; dull outlook warrants downgrade
We downgrade the stock from Buy to Hold with a revised PT of Rs. 285 on weak Q4 numbers and a bleak outlook.
|
Kruttika Prabhudesai | ||
| May 06 2026 |
FY27 begins on tough note; Long-term levers intact
Short-term woes but a strong long-term growth story make us cautiously optimistic; We value the stock 15x FY28 EV/EBITDA to get a PT of Rs. 570 with a Buy rating.
|
Aditya Arora | ||
| May 05 2026 |
Sluggish Q4; all eyes on FY27
We maintain a Hold rating with a PT of Rs 340.
|
Aditya Arora | ||
| May 05 2026 |
Focus on sustaining margins
We maintain a Buy rating with a revised PT of Rs. 2,327, capacity ramp up visibility, and structural demand drivers.
|
Akshay Raghunath Shetty | ||
| May 04 2026 |
Steady Q4; outlook positive
Stock trades at 48x/43x its FY27E/FY28E EPS, respectively. We retain a Buy with a revised PT of Rs. 2,690.
|
Kruttika Prabhudesai | ||
| May 04 2026 |
Strong start to FY27
April carried forward the momentum to start FY27 on a positive note, with our coverage universe clocking a 35.4% y-o-y rise in sales,
|
Automobile and Auto Components | Dhruv Joshi | |
| May 04 2026 |
Strong Q4; growth momentum to sustain high return ratios
We maintain a Buy rating with an unchanged PT of Rs. 1,900, valuing the stock at 3.1x FY28E P/BV.
|
Vijay Singh Gour | ||
| May 04 2026 |
PAT beats estimates, IT transformation to boost biz
PAT significantly beat estimates, rose by 47.8% y-o-y and 30.5% q-o-q driven by Tax refund, impact of DTA, PPOP growth and benign credit cost.
|
Vijay Singh Gour | ||
| May 04 2026 |
Transient headwinds mask stable operating performance
MTM losses supressed consolidated revenue but adjusted revenue grew ~14% y-o-y. Consolidated PAT rose 5% y-o-y to Rs. 2,539 crore.
|
Vijay Singh Gour | ||
| May 04 2026 |
Better operating leverage, credit cost fall bolster PAT
Lender is poised to post steady return ratios on calibrated growth, operating leverage and contained
|
Sameer Suhas Sawant | ||
| Apr 30 2026 |
Long term outlook remains strong
For Q4FY26, revenue/EBITDA/PAT below our expectations by 10%/7.8%/1%.
|
Akshay Raghunath Shetty | ||
| Apr 30 2026 |
Staying efficient despite headwinds
At CMP, the stock trades at 8.5x, 7x, 5.8x its CY26E, CY27E and CY28E BV. We maintain a Buy rating on the stock with a PT of Rs. 5,032 (or a 22% upside).
|
Dhruv Joshi | ||
| Apr 30 2026 |
Mixed bag Q4; yet steel demand upcycle bodes well
At CMP, MOIL trades at 6.5x/5.1x for FY27E/FY28E EV/EBITDA. We lower our PT to Rs. 360 while maintaining a Buy rating.
|
Netra Deshpande | ||
| Apr 30 2026 |
Focusing squarely on profitability
PAT grew 22.2% y-o-y driven by lower credit cost and PPOP, slightly below estimates. Asset quality improved.
|
Vijay Singh Gour | ||
| Apr 30 2026 |
Healthy Q4, Improving Outlook on Digital Scaling & Strategic Expansion
We maintain a Buy rating on stock with a PT of Rs. 345 on strong AUM (21%) and PAT (30%) CAGR over FY26-28. Stock trades at 2.0x FY28 book value.
|
Vijay Singh Gour | ||
| Apr 30 2026 |
Core numbers stable, barring one-offs
Overall, numbers were decent excluding one-offs, but valuations limit upside. Hence, we maintain a Hold rating with an unchanged PT of Rs. 310.
|
Sameer Suhas Sawant | ||
| Apr 30 2026 |
All-round strong show
We project the sales/EPS to clock a CAGR of 19% over FY26-28 and value the stock at 28X FY28EV/EBITDA to arrive at a PT of Rs. 7,800, implying a 15% upside from current levels.
|
Aditya Arora | ||
| Apr 30 2026 |
Cost Discipline and Capacity Expansion Remain Intact
We retain a Buy rating with a revised price target of Rs. 2,350; At CMP, the stock trades at a reasonable 12.8x/11.1x FY27E/FY28E EV/EBITDA.
|
Akshay Raghunath Shetty | ||
| Apr 29 2026 |
Capacity expansion to fuel next growth phase
We maintain a positive rating on the stock with a PT of Rs. 16,221 (24% upside).
|
Dhruv Joshi | ||
| Apr 28 2026 |
Strong Q1; growth momentum to sustain
VBL’s Q1CY26 numbers were strong, beating estimates on all fronts, with a volume-led revenue growth of 18.1% y-o-y and adjusted PAT rising by 20.6%. OPM improved 55 bps y-o-y to 23.3%.
|
Kruttika Prabhudesai | ||
| Apr 28 2026 |
GDV additions provided strong medium-term visibility
Pre-sales rose 22.5% y-o-y to Rs. 5,890 crore in Q4, hitting FY26 pre-sales to Rs 20,530 crore, missing by ~2% full year target of Rs.21,000 attributable to select deferral of sales in March due to th
|
Akshay Raghunath Shetty | ||
| Apr 28 2026 |
Growth Trajectory Intact
Consolidated revenues rose 11.9% y-o-y to Rs.25,799 crore, on a 9% y-o-y volume growth and a 2.6% y-o-y rise in realisation per tonne.
|
Akshay Raghunath Shetty | ||
| Apr 28 2026 |
Good quarter amidst volatile environment
Q4FY26 was an all-round strong show and NAM remains the fastest-growing AMC among India’s top 10 players.
|
Sameer Suhas Sawant | ||
| Apr 28 2026 |
Strong Q4; focus on resolving short-term uncertainties
PPOP grew 41.9% y-o-y and 3.9% (beat the estimates) on NII growth, lower opex run rate and growth in other income. RoA (as a % of AUM) rose 72 bps y-o-y and 9 bps q-o-q to 2.6%.
|
Vijay Singh Gour | ||
| Apr 28 2026 |
Strongest quarter in FY26 led by better realizations and volume growth
Q4FY26 was the strongest quarter of FY26, meeting expectations, with consolidated PAT rising 13.7% y-o-y and revenue up 36% y-o-y, driven by higher e-auction volumes, better realisations, lower employ
|
Netra Deshpande | ||
| Apr 28 2026 |
Operational performance beat, outlook encouraging
NII grew 30.9% y-o-y (largely in-line) and was bolstered by strong loan growth and rise in margins y-o-y. NIMs rose 27 bps y-o-y but fell 2 bps q-o-q as cost of deposits increased.
|
Sameer Suhas Sawant | ||
| Apr 28 2026 |
Outperformance on all fronts
NII grew 23.3% y-o-y and 10.3% q-o-q (2% beat to our estimates), driven by healthy loan growth and margin expansion.
|
Sameer Suhas Sawant | ||
| Apr 28 2026 |
Strong Q4; margins recover across segments
We value the stock at 27x PE FY28 to arrive at a PT of Rs. 7,700 implying a 15% upside from CMP.
|
Aditya Arora | ||
| Apr 28 2026 |
FY27 guidance soft, client-specific issues clouding outlook
We maintain a Buy rating, given the resilient portfolio, strong AI momentum, healthy cash flows, and high shareholder payouts, with a PT of Rs. 1380.
|
Manav Medewala | ||
| Apr 28 2026 |
Steady result, better placed for FY27
We reiterate a Buy rating with a TP of Rs. 5,050 implying an ~18% upside.
|
Manav Medewala | ||
| Apr 27 2026 |
Shielding profitability prospects
Overall, Q4FY26 was respectable in terms of core performance, with healthy momentum in credit offtake, we maintain a Buy rating with revised PT of Rs1550.
|
Sameer Suhas Sawant | ||
| Apr 24 2026 |
Strong domestic show; forex tailwinds fuel Q4
At CMP, the stock trades at 16.3x,14.8x,13.6x its CY26E, CY27E, CY28E earnings, respectively. We maintain a positive rating on the stock with a PT of Rs. 552
|
Dhruv Joshi | ||
| Apr 24 2026 |
Decent results, $2bn revenue target intact
Revenue rose 3.2% q-o-q (16.2% y-o-y) to $436 million, in line with our estimates. In CC terms, revenue grew 3.4% q-o-q.
|
Manav Medewala | ||
| Apr 24 2026 |
Guidance weak, rough road ahead
We expect growth to recover as macro headwinds ease and AI services reach inflection. We maintain a Buy rating with a revised price target of 1,380, valuing the company at 17x FY28E EPS.
|
Manav Medewala | ||
| Apr 23 2026 |
On a robust growth path
We remain positive on Sunteck Realty with a TP of Rs. 530, supported by a strong launch pipeline, robust cash flows and attractive valuation.
|
Akshay Raghunath Shetty | ||
| Apr 23 2026 |
Strong Q4
Stock trades at 31x/26x its FY27E/FY28E EV/EBITDA, respectively. We maintain a Buy with a revised SOTP-based PT of Rs. 5,070.
|
Kruttika Prabhudesai | ||
| Apr 23 2026 |
Mission margin accomplished — All eyes now on growth
Restructuring under new leadership is going on well. We maintain a Buy rating with a revised PT of Rs. 1,600, considering a higher ETR, valuing the stock 19x FY28E EPS.
|
Manav Medewala | ||
| Apr 23 2026 |
Reset complete, recovery underway
We maintain a Buy on LTTS with a PT of Rs. 3,880, valuing the company at 24x FY28E EPS.
|
Manav Medewala | ||
| Apr 22 2026 |
Mixed bag Q4; execution hols key to recovery
Revenue grew 1.4% q-o-q to $ 103.5 million; CC growth came in at 0.3% q-o-q, on strong traction in the UK and AMEA, partially offset by weakness in the US.
|
Manav Medewala | ||
| Apr 22 2026 |
All-round show; outlook bright
Nestle’s Q4FY26 numbers were strong beat on all fronts with volume-led y-o-y revenue growth of 22.6%, OPM rising 102 bps y-o-y to 26.3% and adjusted PAT up by 28.9% y-o-y.
|
Kruttika Prabhudesai | ||
| Apr 21 2026 |
Soft quarter and weak organic growth guidance
Deal TCV conversion to revenue remains the key monitorable until execution consistency improves, we see limited upside beyond our TP and maintain HOLD.
|
Manav Medewala | ||
| Apr 21 2026 |
All-round Q4
We maintain a positive view, with a revised PT of Rs. 1150 (valuing the stock at 1.3x FY28E BV) on healthy growth and steady asset quality.
|
Vijay Singh Gour | ||
| Apr 20 2026 |
Strong show on multiple fronts
Asset quality improved as both GNPA and NNPA fell. Overall, Q4 numbers beat estimates on most parameters.
|
Sameer Suhas Sawant | ||
| Apr 20 2026 |
PAT in-line, asset quality improves
Management intends to have a risk calibarated approach towards credit growth, and focus to maintain healthy levels of ROA.
|
Sameer Suhas Sawant | ||
| Apr 17 2026 |
Growth and core performance healthy
Management aims to outpace the industry and maintain VNB growth in line with APE growth in FY27; stock Life trades at ~1.7x FY28 EV and we maintain a Buy rating with a revised PT of Rs. 760.
|
Sameer Suhas Sawant | ||
| Apr 16 2026 |
Growth and core performance healthy
Business growth prospects remain positive, specifically for retail motor and health segments. We maintain a Buy rating with an unchanged PT of Rs 2,300.
|
Sameer Suhas Sawant | ||
| Apr 15 2026 |
Steady operational show
ICICI Prudential Life’s structural growth story remains intact amid near term global uncertainties along with steady returns expected in long-term
|
Sameer Suhas Sawant | ||
| Apr 13 2026 |
Scaling a wall of woes
Financial year 2025-26 came to a stormy close, as the US-Israel versus Iran conflict put global markets including that of India in doldrums.
|
Mirae Asset Research Team | ||
| Apr 13 2026 |
ValueGuide Equity - April 2026
Scaling a wall of woes
|
Mirae Asset Research Team | ||
| Apr 10 2026 |
Q4FY2026 Consumer Discretionary Results Preview
In the lifestyle fashion space, value fashion continued to outperform, footwear would be muted, while jewellery continued to post strong numbers despite gold price volatility.
|
Kruttika Prabhudesai | ||
| Apr 10 2026 |
Strong Foundation, Missing Acceleration
We roll forward our valuation to FY28E with a Buy rating and slightly raise EPS estimates on a weak rupee. Accordingly, we increase our price target to Rs 2,870, retaining our P/E multiple to 17x.
|
Manav Medewala | ||
| Apr 09 2026 |
Q4FY2026 Capital Goods Results Preview
Execution to drive Q4 show
|
Ankit Soni | ||
| Apr 08 2026 |
Q4FY2026 Cement Results Preview
Rising input costs to cap profitability even as volumes rise
|
Akshay Raghunath Shetty | ||
| Apr 08 2026 |
Q4FY2026 Consumer Goods Results Preview
Eyeing near-term volatility
|
Kruttika Prabhudesai | ||
| Apr 08 2026 |
Vigilance and proactiveness amid global uncertainties
The Reserve Bank of India’s (RBI’s) Monetary Policy Committee (MPC) unanimously decided to keep the repo rate unchanged at 5.25% and neutral stance.
|
Sameer Suhas Sawant | ||
| Apr 07 2026 |
Q4FY2026 Banking Results Preview
Credit offtake to persist, margins to be stable
|
Sameer Suhas Sawant | ||
| Apr 07 2026 |
Long-term growth story remains intact
The stock has corrected ~12% from near term highs; at 22x FY28E PE and 11.6x FY28E EV/EBITDA. Despite the near-term headwinds, we maintain a Buy on Aarti Industries with the PT of Rs. 470.
|
Aditya Arora | ||
| Apr 06 2026 |
Q4FY2026 IT Results Preview
The Nifty IT index has declined ~23%, primarily due to global AI-related shocks impacting the SaaS, IT, and ITeS sectors.
|
Manav Medewala | ||
| Apr 02 2026 |
Driving steadily ahead
We stay positive on the sector, led by sustained demand and policy changes but believe exports to be challenging due to West Asia conflict.
|
Automobile and Auto Components | Dhruv Joshi | |
| Mar 27 2026 |
CDMO business’ ramp-up awaited
Laurus continues to meet guidance and given the steady increase in margins and return ratios over the years
|
Thomas Abraham | ||
| Mar 25 2026 |
Sector tailwinds to drive growth
EBITDA/tonne has stayed above Rs. 5,000 for the past two quarters, as strong volume momentum made the management upgrade EBITDA guidance to a minimum of Rs. 5,500 and volume growth guidance to ~20%
|
Akshay Raghunath Shetty | ||
| Mar 25 2026 |
AI: Opportunity or Obstacle?
For Indian IT firms, the shift to an AI-based revenue model will not be instant – but a gradual one, depending on how new companies lay out budget cycles
|
IT & ITES | Manav Medewala | |
| Mar 25 2026 |
5 Curated Stock Ideas for March 2026
Geopolitics is turning the street fiery, but here are five stocks that could shield your portfolio in these volatile times
|
Mirae Asset Research Team | ||
| Mar 24 2026 |
Sai Parenterals Ltd
Sai Parenterals Ltd (SPL) is coming up with a book build issue of Rs. 408.79 crore.
|
Thomas Abraham | ||
| Mar 23 2026 |
Power portfolio to propel growth
We expect the company to clock a strong revenue/PAT CAGR of 30%/61% respectively over FY25-28E.
|
Ankit Soni | ||
| Mar 19 2026 |
Financial health Intact even as corporate governance sparks fly
We slightly reduce our core bank multiple to ~2xFY28 BV leading to revised PT of Rs. 1,025, maintain our BUY rating.
|
Sameer Suhas Sawant | ||
| Mar 19 2026 |
Central Mine Planning & Design Institute Ltd
Central Mine Planning & Design Institute Ltd (CMPDIL) is coming up with a book build issue of Rs. 1,842 crore.
|
Netra Deshpande | ||
| Mar 18 2026 |
Multiple growth levers in place
We stay Positive on VBL and expect an upside of 40%. Stock has corrected by ~19% from recent highs and trades at 40x/33x its CY26E/CY27E EPS, respectively.
|
Kruttika Prabhudesai | ||
| Mar 11 2026 |
Braving the storm
As war clouds darken and the tech bubble floats precariously, the markets are navigating a rough patch. The shocks was two-fold – the first involved the launch of Anthropic, an AI tool that that threa
|
Mirae Asset Research Team | ||
| Mar 11 2026 |
ValueGuide Equity - March 2026
Braving the storm
|
Mirae Asset Research Team | ||
| Mar 10 2026 |
Laying a strong growth roadmap
Consolidated PAT to post a 24% CAGR over FY25–28E. Consequently, we maintain a positive outlook with an unchanged SoTP-based price target of Rs. 407 (upside of 23%).
|
|||
| Mar 09 2026 |
RARE acquisition marks asset-light foray in experiential leisure space
Stock has corrected 26% from recent highs and trades at 7x/6x/5x its FY26E/FY27E/FY28E EV/EBITDA, respectively. We stay Positive and expect a 54% upside.
|
|||
| Mar 05 2026 |
Powergen biz driving demand
Given a rise in domestic demand on explosive growth through data center business and gradual improvement in exports business, we maintain a Buy rating with a PT of Rs 5,550.
|
|||
| Feb 27 2026 |
Q3FY2026 Pharmaceutical Results Review
Robust Q3; Outlook Positive on CDMO and complex drugs
|
|||
| Feb 26 2026 |
Capacity expansions to spur growth
At CMP, Gravita trades at a 33x/27x multiple on FY27E/FY28E EPS. We maintain a Buy rating with a PT of Rs. 2,000 (28x on FY28E EPS).
|
|||
| Feb 25 2026 |
Q3FY2026 NBFCs, Insurance, AMCs, and Diversified Financials Results Review
NBFCs and AMCs; Resilient Q3, HFC underperformed, Insurance: Mix Q3
|
|||
| Feb 25 2026 |
All-round growth: Valuation uptick eyed
We value the stock at 20x, marginally above the five-year average one-year fwd P/E on FY28E EPS of Rs.49.5 and assign HOLD with a price target of Rs. 990.
|
|||
| Feb 25 2026 |
Formulations business enlivens Q3
We value the stock at 45x, ~10% above its 5-year avg – one yr forward rating of 41.2x, on FY28E EPS of Rs. 38.4 and retain a Buy rating with a PT of Rs. 1,726.
|
|||
| Feb 24 2026 |
Q3FY2026 Consumer Goods Results Review
On a recovery path
|
|||
| Feb 23 2026 |
Q3FY2026 Capital Goods and Power Results Review
Performance in-line, overshadowed by related news flows
|
|||
| Feb 23 2026 |
Soft Q3
PFC-REC merger to create a stronger, unified balance sheet that enables larger-scale financing. We thus stay Positive on REC with an unchanged PT of Rs. 450.
|
|||
| Feb 23 2026 |
Novo phase-out a near-term blip; outlook healthy
We roll forward our valuation to FY28E and value stock at 37x on FY28E EPS of Rs. 889.1, arriving at a PT of Rs. 30,715.
|
|||
| Feb 20 2026 |
Power financing titan on anvil
GNPA fell to 1.64% (down 104 bps y-o-y and 23 bps q-o-q) and NNPA reaching a lean 0.24% due to resolution of debt on a specific case.
|
|||
| Feb 20 2026 |
Soft Q3; improving outlook
Stock trades at 52x/49x/44x its FY26E/FY27E/FY28E EPS, respectively. We retain a Buy with a revised PT of Rs. 2,750.
|
|||
| Feb 20 2026 |
Banking
Q3FY26: PSBs Lead the Charge, Systemic Stress Recedes
|
Banks | ||
| Feb 20 2026 |
IT
Solid quarter in a soft season, AI Panic push stocks to multi-year low valuation
|
IT & ITES | ||
| Feb 20 2026 |
Cement
Weak Q3 pricing impacted realizations, while volumes remained good
|
Cement | ||
| Feb 20 2026 |
Mixed Q3, capex woes to cloud near term
We value the stock near its five-year average 1-yr forward P/E of 26x and retain a Hold rating with PT of Rs. 250.
|
|||
| Feb 20 2026 |
Steady Q3; Outlook positive
We maintain a Buy with an unchanged PT of Rs. 891. Stock trades at 25x/21x/18x its FY26E/FY27E/FY28E EV/EBITDA, respectively.
|
|||
| Feb 20 2026 |
Scaling new heights
We stay positive and revise PT to Rs. 260 on strong AUM/PAT CAGR, robust sanction pipeline, continued asset quality improvement and growth in ROE. Stock trades on 1.4x FY2028 BV.
|
|||
| Feb 19 2026 |
Margins drag Q3; outlook cautious
Stock has corrected 22% over the past three months and trades at 25x/23x/20x its FY26E/FY27E/FY28E EPS, respectively. We maintain Buy with a revised PT of Rs. 315.
|
|||
| Feb 19 2026 |
Steady Q3; growth outlook intact
Stock trades at 47x/36x/29x its FY26E/FY27E/FY28E EPS, respectively. We stay Positive on the stock with an upside of 25% in 12 months.
|
|||
| Feb 19 2026 |
Better margins drive Q3; outlook improving
Stock trades at 30x/27x/24x its FY26E/FY27E/FY28E EPS, respectively. We maintain Buy on the stock with a revised PT of Rs. 1,350.
|
|||
| Feb 19 2026 |
Execution holds key post merger
We value the stock at 40x on FY28E EPS and retain a Buy rating with a PT of Rs. 466.
|
|||
| Feb 18 2026 |
Robust Q3, awaiting acquisition synergies
We roll forward our valuation to FY28E and value stock at 40x on FY28E EPS of Rs. 118.4 and retain a Buy with a revised PT of Rs. 4,735.
|
|||
| Feb 18 2026 |
Capacity additions to drive growth
We maintain a Buy rating with a revised PT of Rs. 430. Valuation of 1.6x/1.5x its FY27E/28 P/BV is reasonable given strong long-term growth prospects; Stock offers a decent dividend yield as well.
|
|||
| Feb 18 2026 |
Investor AI Day – Embracing the opportunities
Infosys is successfully bridging AI adoption gap for clients to make enterprise projects successful; it is transforming AI from commodity to defensible service.
|
|||
| Feb 17 2026 |
Paints biz in focus; long-term outlook robust
We retain a Buy with a revised SOTP-based PT of Rs. 3,424 as paints business’ momentum and operating leverage improves.
|
|||
| Feb 17 2026 |
Weak Q3; yet production and offtake recovering
Employee cost fell 3%, aided by 4% y/y manpower reduction.
|
|||
| Feb 17 2026 |
Continuing the growth momentum every quarter
We roll forward our valuation to FY28E and retain a Buy rating and value the stock at P/E of 25x, arriving at a PT of Rs. 2,542.
|
|||
| Feb 17 2026 |
One-offs hit Q3; medium-term outlook bright
We stay Positive and expect an upside of 40% in LTHL. Stock trades at 14x/12x/11x its FY26E/27E/28E EV/EBIDTA, respectively.
|
|||
| Feb 17 2026 |
Strong Q3; momentum to sustain
Stock trades at 15x/14x/14x its FY26E/FY27E/FY28E EV/EBIDTA, respectively. We stay Positive and expect an upside of 27% over the next 12 months.
|
|||
| Feb 16 2026 |
Execution to be the key growth driver
We stay Positive and expect an upside of 26% factoring a revenue/ PAT CAGR growth of 23%/18%, respectively.
|
|||
| Feb 16 2026 |
Capex plans to power growth
Strong capex expectations brightens earnings visibility. Hence, we maintain a Buy with an unchanged PT of Rs. 350. At CMP, it trades at 2.4x/2.2x its FY27/28 P/BV.
|
|||
| Feb 16 2026 |
On a sustained growth path
We value the stock at 34x on FY28E EPS of Rs. 57.9x and retain a Buy with a PT of Rs.1,968.
|
|||
| Feb 16 2026 |
Growth streak persists
We value stock at 51x on FY28E EPS of Rs. 140.3 to arrive at a PT of Rs. 7,206 and retain a Buy rating.
|
|||
| Feb 16 2026 |
Structural Moats Intact
We maintain a Buy rating but reduce PT to Rs 1,400 on AI-driven IT hiring uncertainty, but stay positive given structural drivers for Naukri biz, better B2C monetization and JobHai’s blue-collar leade
|
|||
| Feb 13 2026 |
High-end products to drive growth
We expect the company to maintain a strong long-term growth trajectory. Stock is reasonably valued at a P/E of 23/19x its FY2026/2027E earnings on CMP.
|
|||
| Feb 13 2026 |
Strong order book to drive growth
We maintain a Buy with an revised PT of Rs. 1,800, valuing it at 21x its FY28 EPS. The stock trades at a P/E of ~21x/18x its FY27E/28E EPS.
|
|||
| Feb 13 2026 |
Recovering order inflows- Maintaining Hold
We maintain a Hold rating; stock price already factors in investments in green energy. Stock trades at ~38x/29x its FY2027E and FY2028E EPS.
|
|||
| Feb 13 2026 |
Healthy Q3; stable margins to aid recovery
Stock trades at 55x/47x/41x its FY26E/FY27E/FY28E EPS, respectively. We maintain Buy on the stock with a revised PT of Rs. 7,090.
|
|||
| Feb 13 2026 |
Robust Q3; outlook bright
Stock trades at 72x/59x/49x its FY26E/FY27E/FY28E earnings, respectively. We maintain a Buy with a revised PT of Rs. 4,950.
|
|||
| Feb 12 2026 |
Plywood, MDF segments hold key to growth
We retain a Buy with a PT of Rs. 906, on strong multi-year earnings visibility led by capacity ramp-ups, improving product mix and robust cash generation.
|
|||
| Feb 12 2026 |
Outlook remains strong
We maintain a Buy with a revised PT of Rs 1,450. Stock is valued at ~14x/11x FY27E/28E P/E. Key catalysts include asset monetization and reduced promoter pledges.
|
|||
| Feb 12 2026 |
Structural story intact, growth trajectory encouraging
Q4FY26 likely to be healthy in terms of growth; long-term guidance remains well above industry. We maintain a Buy with a revised PT of Rs. 2,100.
|
|||
| Feb 12 2026 |
All-round Q3
Based on recent performance and guidance we raise our estimates expect a 26%/53% CAGR in revenue/PAT (for FY25-28E). We maintain a Buy rating with a PT of Rs 9,500.
|
|||
| Feb 12 2026 |
Lower credit costs, asset quality fuel profits
We maintain a Buy rating with an unchanged PT of Rs. 200 as the stock trades on cheap valuation (0.5x FY28E BV), stabilising MFI industry, focus on revenue diversification, improvement in asset qualit
|
|||
| Feb 12 2026 |
Strong Q3
Stock trades at 21x/18x/15x its FY26E/FY27E/FY28E consolidated EV/EBIDTA, respectively. We maintain a Buy rating with a revised PT of Rs. 700.
|
|||
| Feb 11 2026 |
Good Q3; eyeing better prospects ahead
Stock trades at 25x/23x/21x its FY26E/FY27E/FY28E EPS, respectively. We maintain a Buy with an unchanged PT of Rs. 645.
|
|||
| Feb 11 2026 |
Steady growth momentum
Stock trades at 44x/36x its CY26E/CY27E EPS, respectively. We stay Positive and expect an upside of 27% over the next 12 months.
|
|||
| Feb 10 2026 |
Long-term outlook intact
We retain a Buy rating with a PT of Rs. 1,350, supported by a healthy earnings growth trajectory in 2–3 years.
|
|||
| Feb 10 2026 |
Spotting the silver lining
January yet again tested the markets’ resilience, with the benchmark indices consolidating ahead of the Big B, the Union Budget.
|
Mirae Asset Research Team | ||
| Feb 10 2026 |
Mixed Q3; long-term outlook intact
Stock trades at 44x/25x/22x its FY26E/FY27E/FY28E EPS, respectively. We maintain a Buy with an unchanged PT of Rs. 552.
|
|||
| Feb 10 2026 |
Healthy topline, long-term outlook positive
BSE is well-positioned for sustained high revenue and margin growth. We maintain our positive view on the stock with a revised PT of Rs 3,600.
|
|||
| Feb 10 2026 |
Steady Q3, ARPU improves further
Pending tariff repair, faster 5G monetisation, expansion into high-growth adjacencies (cloud, cybersecurity, AI infrastructure partnership with Google), and potential AGR relief similar to Vodafone Id
|
|||
| Feb 10 2026 |
Steady Q3; Margin recovery ahead
Stock trades at 55x/45x/40x its FY26E/FY27E/FY28E EPS, respectively. We retain a Buy rating on the stock with a revised PT of Rs. 890.
|
|||
| Feb 09 2026 |
Strong momentum continues, solid line-up for CY26
With a strong 2026 lineup (Dhurandhar-2, Toxic, Ramayan, others), we expect higher occupancy, improved ATP and stable margins.
|
|||
| Feb 09 2026 |
On a strong growth trajectory
We remain positive with an unchanged PT of Rs.149, driven by strong margin expansion led by value-added products and better operating leverage.
|
|||
| Feb 09 2026 |
Strong Q3; momentum to sustain
Stock trades at 17x/12x/9x its FY26E/FY27E/FY28E EV/EBIDTA, respectively. We stay Positive with an unchanged PT of Rs. 2,810.
|
|||
| Feb 09 2026 |
Bright times ahead
We maintain a Buy with an unchanged PT of Rs. 1,852, supported by stabilising polymer prices and improving demand outlook.
|
|||
| Feb 09 2026 |
PAT peaks on strong operations
We maintain a Buy rating on stock with a revised PT of Rs1260.
|
|||
| Feb 09 2026 |
5 Curated Stock Ideas for February 2026
As markets navigate to eye a silver lining post the Budget and US-India trade deal, here are five stocks that could add a spark to your portfolio.
|
Mirae Asset Research Team | ||
| Feb 06 2026 |
Positioned for Strong Growth Ahead
Consolidated net revenues rose 9.6% y-o-y to Rs. 223 crore. Operating profit rose 46.5% y-o-y to Rs. 42.2 crore, while adjusted net profit increased 68.6% y-o-y to Rs. 21 crore.
|
|||
| Feb 06 2026 |
Outperforming curve; Strategic surge
AUM (NBFC+HFC) reached Rs. 190,386 crore (up 30.3% y-o-y, 7% q-o-q) with sharp improvements in asset quality and RoA.
|
|||
| Feb 06 2026 |
Core business to drive growth
Revenue stood at Rs. 260 crore, up 13.2% q-o-q (music-led) but down 46.1% y-o-y due to a 92% slump in events from one-off mega tours in Q3FY25.
|
|||
| Feb 06 2026 |
Short-term headwinds loom large
Revenue grew 24% y-o-y, beating estimates. Exports surged 54%, offsetting a 6% domestic dip. Operating profits rose 23%, though margins slightly contracted by 16bps to 21.5%.
|
|||
| Feb 06 2026 |
Good Q3; multiple growth drivers in place
TCPL’s Q3FY26 numbers were good with revenue/adjusted PAT rising 15%/23% y-o-y, respectively.
|
|||
| Feb 06 2026 |
RBI maintains status quo
Policy is neutral for lenders, as RBI looks to ensure full transmission of earlier measures rate cuts.
|
Sameer Suhas Sawant | ||
| Feb 06 2026 |
Muted quarter- positive outlook
We see the business to benefit from data centers, healthcare, infrastructure, and real estate. We maintain a Buy rating with a PT of Rs 4,950.
|
|||
| Feb 05 2026 |
On a strong growth path
Stock trades at 57x/43x/31x its FY26E/FY27E/FY28E earnings, respectively. We stay Positive and revise PT to Rs. 715.
|
|||
| Feb 05 2026 |
Capacity expansion remains intact
We retain our BUY rating on JK Lakshmi Cement while revising our target price downward to Rs. 930, reflecting moderation in near-term performance versus our earlier estimates.
|
|||
| Feb 05 2026 |
Revenue moderation continues; margins shine
We maintain a Buy with a revised SOTP-based PT of Rs. 5,220.
|
|||
| Feb 05 2026 |
One-offs hit bottomline, respectable on growth front
Results bode well for growth and we maintain a Buy rating with an unchanged PT of Rs. 2450.
|
|||
| Feb 05 2026 |
Multiple growth tailwinds
Stock has corrected 14% from recent highs and trades at 8x/7x/6x its FY26E/FY27E/FY28E EV/EBITDA, respectively. We stay Positive with a 43% upside.
|
|||
| Feb 05 2026 |
Core growth steady, one-offs hit profit
We maintain a Buy rating with an unchanged PT of Rs. 1,125. The stock trades at 4.5x and 3.7x of its FY27 and FY28 BV.
|
|||
| Feb 04 2026 |
Poised for a launch spree
We maintain a Buy with a revised PT of Rs. 450, supported by a strong launch pipeline and faster growth in the industrial & logistics segment.
|
|||
| Feb 04 2026 |
The Tide’s Turning
Following the 2026 Union Budget and pivotal US-India trade developments, the Indian equity market is transitioning from the turbulence of 2025 toward long-term capacity building.
|
Mirae Asset Research Team | ||
| Feb 03 2026 |
Strong performance on all fronts
We upgrade our rating to Buy from Hold with a revised PT of Rs. 350.
|
|||
| Feb 03 2026 |
Tepid Q3, asset quality strengthens
we maintain a Neutral rating with a revised PT of Rs. 565, as strategic initiatives may take time to drive meaningful growth of earnings.
|
|||
| Feb 03 2026 |
Muted Q3, order prospects strong
Stock trades at 14x/12x its FY2027/FY2028 EPS, respectively. We retain a Buy with a revised PT of Rs. 830.
|
|||
| Feb 03 2026 |
Strong demand to pave growth for earning
Management eyes a 19-20% organic revenue and 23-25% EBITDA growth. We model a revenue growth of 19.3% CAGR (FY26–FY28E), apply a 45x FY28 P/E, with a Rs. 2,100 price target.
|
|||
| Feb 02 2026 |
Weak revenue and margin dents performance
We have trimmed our FY27-28-E estimates and roll forward our estimates to Mar-28, with a P/E of 28x and arrive at a price target of 965.
|
|||
| Feb 02 2026 |
Volumes shine; margins miss the mark
Stock trades at 77x/64x/55x its FY26E/FY27E/FY28E EPS, respectively. We maintain a Buy rating with a revised PT of Rs. 1,500.
|
|||
| Feb 02 2026 |
In-line Q3, expect better Q4
We maintain a Buy rating with PT of Rs. 1,900, valuing the stock at 3.1x FY28E Book Value.
|
|||
| Feb 02 2026 |
Positive outlook amid headwinds
Stock trades at 48x/40x its FY2027/FY2028 EPS, respectively. We retain a Buy rating and for a revised PT of Rs. 2,100.
|
|||
| Feb 02 2026 |
Asset Stress in Micro LAP impacted Q3 Performance
we stay positive on the stock with a PT of Rs. 550 as most negatives are captured in the stock price.
|
|||
| Feb 02 2026 |
Operationally mixed Bag, healthy on growth and outlook
Net profit rose 4.5% y-o-y to Rs 5055 crore, beating estimates, owing to lower provisions. We maintain a Buy rating with an unchanged PT of Rs 320.
|
|||
| Feb 01 2026 |
Crafting new age growth story
Budget 2026 marks a clear shift from consumption boost to ensuring fiscal and policy stability, amid uncertain global waters.
|
Mirae Asset Research Team | ||
| Feb 01 2026 |
Crafting new age growth story
Budget 2026 marks a clear shift from consumption boost to ensuring fiscal and policy stability, amid uncertain global waters.
|
Mirae Asset Research Team | ||
| Jan 30 2026 |
Earnings turn positive as execution improves
We maintain a Buy rating with a revised PT of Rs. 400, factoring in downwardly revised estimates.
|
|||
| Jan 30 2026 |
Electricals segment led the growth
We retain a Buy with a revised PT of Rs. 430, given its positive business outlook factoring in the strong growth from Electricals and Electronics business.
|
|||
| Jan 30 2026 |
Strong show on all fronts
With strong numbers keeping structural story intact, we maintain a Buy with a revised PT of Rs. 1000.
|
|||
| Jan 30 2026 |
Healthy pre-sales momentum: long-term visibility improves
We maintain a “Positive” view with a revised PT of Rs. 1,400, on strong pipelines and demand.
|
|||
| Jan 30 2026 |
Weaker mobile volumes impacted performance
We retain a Buy rating with Rs. 14,500 PT, factoring 31%/38% revenue/PAT CAGR (FY25–28E). Stock trades at 40x/32x on FY26E/FY27E earnings respectively.
|
|||
| Jan 30 2026 |
On a recovery path
Stock trades at 42x/39x/36x its FY26E/FY27E/FY28E EPS, respectively. We maintain a Buy with a revised PT of Rs. 2,460.
|
|||
| Jan 30 2026 |
Healthy Cigarette and FMCG biz performance
Stock trades at 20x/18x/17x its FY26E/FY27E/FY28E EPS, respectively. We maintain a Buy with a revised PT of Rs. 400.
|
|||
| Jan 29 2026 |
Robust Q3, asset quality improved
Stock trades at reasonable valuations. We maintain a Buy with an unchanged PT of Rs. 435 on improvement in NIMs, steady asset quality and return ratios.
|
|||
| Jan 29 2026 |
Strong order prospects buoy growth momentum
Future order pipeline looks promising with large orders such as QRSAM and MRSAM are to be awarded in the coming years. we retain a Buy rating with revised PT of Rs. 525
|
|||
| Jan 29 2026 |
Remarkable order inflows
We maintain a Buy with an revised PT of Rs. 4,700, considering strong order prospects and healthy earnings growth outlook. Order prospects pipeline at Rs 5.9 lakh crore.
|
|||
| Jan 29 2026 |
Organic and Inorganic growth to drive earnings
We roll forward valuations to Dec-27; maintain PT at Rs 450 at 18x P/E multiple with a buy rating.
|
|||
| Jan 29 2026 |
Navigating headwinds, growth likely post Q2FY27
We maintain a Buy and raise PT to Rs. 465 (20x P/E). Company’s success depends on converting deal wins into timely revenue.
|
|||
| Jan 28 2026 |
Near-term stress, valuations attractive in long run
We believe valuations are attractive at current levels. We recommend Buy with a PT of Rs. 1,585.
|
|||
| Jan 28 2026 |
Soft Q3; demand to improve gradually
Stock trades at 54x/48x/42x its FY26E/FY27E/FY28E EPS, respectively. We maintain Buy on the stock with a revised PT of Rs. 3,105.
|
|||
| Jan 28 2026 |
Launches paused in Q3; activity to resume in Q4
The company is confident to achieve its full year pre-sales guidance of Rs. 20,000 crore (80% already done). Exit rental expected Rs.6400 for FY26.
|
|||
| Jan 28 2026 |
Persistent Ad Weakness; Margin Recovery Slower than Guided
Court case v/s Jio also represents operational uncertainty. Hence, we revise our price target to Rs. 1111
|
|||
| Jan 28 2026 |
Q3 growth momentum aligns with expansion plans
At CMP, JSTL trades at current valuation of 9.1x/8.2x for FY27E/FY28E EV/EBITDA. We upgrade our rating to BUY with a PT of Rs. 1360.
|
|||
| Jan 27 2026 |
India and AUM drive Q3; Indonesia stabilising
Stock trades at 54x/45x/39x its FY26E/FY27E/FY28E EPS, respectively. We maintain a Buy with a revised PT of Rs. 1,460.
|
|||
| Jan 27 2026 |
Generics drive growth in Q3, Awaiting further scale up in CDMO
With improving asset utilisations, we value the stock at 47x on FY28E earnings of 23.4 and retain the Hold rating with a PT of Rs.1,101.
|
|||
| Jan 27 2026 |
Guidance raised; demand, margin drivers intact
We maintain a Buy rating with a revised target price of Rs 2,460, driven by higher guidance, capacity ramp-up, and structural demand.
|
|||
| Jan 27 2026 |
Leadership change surprises, though outlook remains positive
Aseem Dhru, CEO & MD has stepped down, but we do not see any significant impact of the same in the medium to long term. We stay positive on the stock with a revised PT of Rs. 110.
|
|||
| Jan 27 2026 |
Strong Q3; momentum here to stay
Stock trades at 70x/53x/43x its FY26E/FY27E/FY28E earnings, respectively. We retain a Buy with an unchanged PT of Rs. 3,840.
|
|||
| Jan 27 2026 |
Robust Q3 beats estimates
We maintain a Buy with a revised price target of Rs. 14,800, backed by strong growth visibility and margin recovery.
|
|||
| Jan 27 2026 |
Decent Q3, long-term outlook stable
Bank is well capitalized with broadly stable operating metrics; we maintain BUY rating with revised PT of Rs1490.
|
|||
| Jan 27 2026 |
Operationally stable, unsecured NPAs easing
Overall numbers for Q3FY26 were steady and we maintain a Buy rating with a PT of 500.
|
|||
| Jan 23 2026 |
Growth prospects remain intact
Company likely to do well, backed by multiple tailwinds; stock trades at 35x/28x to FY27/FY28 EPS estimates. We maintain a Buy with a PT of Rs. 4,800.
|
|||
| Jan 23 2026 |
Solid momentum to drive FY27 growth
We roll forward our valuation to Dec-27 and retain a Buy rating with a price target of Rs. 2,133 at 31x P/E.
|
|||
| Jan 23 2026 |
Expected plastic piping to return to normalcy
Recommendation: BUY rating maintained with a revised target price of Rs. 4,200.
|
|||
| Jan 23 2026 |
Weak Q3, outlook stays positive
We maintain a Positive view with a PT of Rs. 1,050 (1.2x FY28E BV). Stock trades at 1.0x FY28E BVPS.
|
|||
| Jan 23 2026 |
India and Europe outperform, helps negate price erosion in USA
We expect the new launches to become more EPS accretive over the next 6-8 quarters. We value the stock at 18.5x on FY28E EPS of Rs. 71.2, and retain our Hold rating with a PT of Rs. 1,316.
|
|||
| Jan 22 2026 |
Growth traction healthy, stable operational performance
We maintain a Buy rating on the stock with a revised PT of Rs. 190.
|
|||
| Jan 22 2026 |
Cost Discipline and Capacity Expansion Remain Intact
We retain a Buy rating with a PT of Rs. 2,550, the stock trades at 14.4x/12.8x/11.6x FY26E/FY27E/FY28E EV/EBITDA, backed by high cost visibility and a strong balance sheet.
|
|||
| Jan 21 2026 |
Launch deferrals hit Q3; uptick eyed in Q4
We remain positive on the stock, expecting a ~24% upside, supported by strong launch momentum in upcoming quarters, a robust balance sheet, and favourable regional demand tailwinds.
|
|||
| Jan 21 2026 |
On a strong footing
Valuations are stiff and factor in most positives, hence we maintain our Hold rating on the stock with revised PT of Rs. 1130.
|
|||
| Jan 21 2026 |
Poised to outpace
We have rolled our valuation forward to Dec-27 and applied a P/E multiple of 44x, resulting in an unchanged price target of Rs. 7,295.
|
|||
| Jan 19 2026 |
Healthy core earnings momentum
Fundamental outlook healthy; valuations factor in positives, maintain HOLD with revised PT of Rs310.
|
|||
| Jan 19 2026 |
Robust deal wins, Sustained margin expansion, Upbeat outlook
We roll forward our valuation to Dec’27 and apply a P/E of 21.0x. Accordingly, we raise our PT to Rs. 2,000 while maintaining a Buy rating.
|
|||
| Jan 19 2026 |
Reorganising to unlock future value
We stay Positive and expect an upside of 53% in LTHL. Stock trades at 14x/12x/11x its FY26E/27E/28E EV/EBIDTA, respectively.
|
|||
| Jan 19 2026 |
In-line Q3, outlook stays strong
We maintain a Buy on the stock with a revised PT of Rs. 345, valuing it at 2.4x of FY28 BV.
|
|||
| Jan 19 2026 |
Loan growth speeding up, operational levers present
Term deposit repricing and improvement in cost ratios to aid healthy levels of PAT, maintain Buy with an unchanged PT of Rs.1150.
|
|||
| Jan 19 2026 |
Highs, Lows, and Plateaus
Bank poised for steady growth and return ratios, we maintain Buy with an unchanged PT of Rs. 1700.
|
|||
| Jan 16 2026 |
Restructuring to taper near-term growth
Revenues fell 2.8% q-o-q in CC terms, lagging estimates, primarily due to a strategic restructuring under its five-year Lakshya plan
|
|||
| Jan 16 2026 |
Margins stable, awaiting catalysts for future growth
We maintain a PT of Rs. 285 and Hold rating; after the recent rally, CMP has priced in current catalysts, with further upside requiring clear revenue acceleration.
|
|||
| Jan 16 2026 |
Stunning volume growth impacted by higher commodity prices
We expect revenue/PAT to clock a CAGR of 23%/29%, respectively from FY25-28, with a good RoCE of 34%. Hence, we maintain a Buy rating with a PT of Rs 8,800.
|
|||
| Jan 14 2026 |
Stunner Result, Guidance Raised & Strong Deal Win
We maintain a Buy rating with a price target of Rs 1,920, valuing the company at 20.6x and 19.2x respectively.
|
|||
| Jan 14 2026 |
Respectable Q3 barring one-offs; outlook steady
APE improved, beating our estimates, driven by individual policies.
|
|||
| Jan 13 2026 |
On a steady growth path
APE grew 3.6% y-o-y - within which protection APE rose 19% y-o-y, while non-linked APE was up 15.2% y-o-y.
|
|||
| Jan 12 2026 |
AI tailwinds brighten growth path
Q3FY26 revenue stood at $3,793 million, up 4.2% q-o-q (+4.8% y-o-y) in CC terms.
|
|||
| Jan 09 2026 |
Q3FY2026 NBFCs, Insurance, AMC & Diversified Financials Results Preview
NBFCs and Other diversified financials: Healthy Q3; Insurance and AMCs: Mix Q3
|
|||
| Jan 09 2026 |
Q3FY2026 Pharmaceuticals and Healthcare Results Preview
Eyeing a mixed bag Q3
|
|||
| Jan 09 2026 |
Q3FY2026 Consumer Discretionary Results Preview
Some hits; some misses
|
|||
| Jan 09 2026 |
Q3FY2026 Cement Results Preview
Volume-led growth offsets weak pricing
|
|||
| Jan 08 2026 |
Q3FY2026 Consumer Goods Results Preview
Improving volumes as tax disruptions fade; margins recovering
|
|||
| Jan 08 2026 |
Q3FY2026 Capital Goods Results Preview
Sector comfortably placed
|
|||
| Jan 07 2026 |
5 Curated Stock Ideas for January 2026
As we set foot into 2026, here are five stocks to help your portfolio stay afloat
|
Mirae Asset Research Team | ||
| Jan 07 2026 |
Q3FY2026 Banking Results Preview
Growth momentum, stable operating metrics to aid return ratios
|
|||
| Jan 06 2026 |
Eyeing volume and store-driven growth
Jubilant Foodworks (JFL) continues to focus on free delivery, loyalty programs, product innovation, value offerings and faster delivery to drive growth.
|
|||
| Jan 06 2026 |
Q3FY2026 IT Results Preview
Q3 Muted by Seasonality; Eyes on CY26 Demand Outlook
|
|||
| Dec 12 2025 |
On steady growth path
Chalet Hotels has de-risked its portfolio by diversifying in terms of asset class and asset category.
|
|||
| Dec 12 2025 |
A year of domestic resilience
In 2025, Indian equities navigated a stormy path
|
Mirae Asset Research Team | ||
| Dec 11 2025 |
Outlook strong, lending biz returns to pick up
NBFC business’ returns to improve to 2.4% in Q4FY26, and that of HFC business to 2-2.2% in 7-8 quarters.
|
|||
| Dec 09 2025 |
ICICI Prudential AMC Ltd
ICICI Prudential Asset Management Company (AMC) is set to launch its Initial Public Offering (IPO) of ~ Rs. 10,603 crore (as an OFS).
|
|||
| Dec 05 2025 |
‘Growth First’, echoes Mint St
RBI wraps up 2025 with 25-bps repo rate cut, liquidity boosters
|
Sameer Suhas Sawant | ||
| Dec 04 2025 |
5 Curated Stock Ideas for December 2025
As curtains prepare to drop on 2025, this edition of Vantage presents five stocks to help your portfolio end the year on a cheery crescendo
|
Mirae Asset Research Team | ||
| Dec 03 2025 |
Rupee set to be Asian laggard
Indian Rupee to be among the worst-performing Asian currencies
|
Mohammed Imran | ||
| Dec 01 2025 |
Q2 GDP at 8.2%; growth momentum affirmed
India’s GDP accelerated sharply, growing at 8.2% in Q2FY26
|
Sameer Suhas Sawant | ||
| Nov 26 2025 |
Q2FY2026 Pharmaceuticals and Healthcare Results Review
Robust Q2; Outlook Positive on CDMO and complex drugs
|
|||
| Nov 25 2025 |
Q2FY2026 IT Review Results Review
Demand condition stabilizing, execution up, attractive valuation
|
|||
| Nov 25 2025 |
Tailwinds galore
RBI’s recent regulatory changes to boost growth; improving outlook on NIMs and asset quality,
|
Banks | ||
| Nov 21 2025 |
Hotels on a strong growth trajectory
Hotel companies’ Q2FY26 was affected by heavy rainfall, a high base, room renovations, domestic air travel slowdown and geopolitical tensions.
|
Consumer Discretionary | ||
| Nov 13 2025 |
At a crossroads
Multiple tailwinds were at play in October, propelling the Indian stock markets to fresh highs
|
Mirae Asset Research Team | ||
| Nov 13 2025 |
CPI inflation plunges further
CPI inflation rose just 0.25% in October y-o-y, the lowest in the current 2012 series
|
Mohammed Imran | ||
| Nov 07 2025 |
Debuts: 5 Curated Stock Ideas for November 2025
It's time again to give your portfolio that edge, with yet another edition of Vantage.
|
Mirae Asset Research Team | ||
| Oct 29 2025 |
IIP print stays steady
India’s Index of Industrial Production (IIP) rose 4.0% y-o-y in September 2025
|
Mohammed Imran | ||
| Oct 14 2025 |
Diwali Picks - 2025
The Nifty 50 has navigated a year of instability since last Diwali, trading in a narrow range of 24000-25000 and delivering near-zero net returns during the period.
|
Mirae Asset Research Team | ||
| Oct 14 2025 |
CPI inflation slumps to historical low
The benchmark Consumer Price Index (CPI) inflation, plummeted to 1.54% in September 2025
|
Mohammed Imran | ||
| Oct 10 2025 |
Festive cheer beckons
September was a tough month for Indian stock markets, yet resilience was the flavour as the benchmark indices ended the month with modest gains, braving intense global headwinds.
|
Mirae Asset Research Team | ||
| Oct 06 2025 |
LG Electronics India Ltd
LG Electronics Inda Ltd. (LGEIL) is coming up with a book build issue of Rs. 11,605 crore
|
|||
| Oct 03 2025 |
Tata Capital Ltd
Tata Capital Ltd. is coming up with a book build issue of Rs. 15,512 crore.
|
|||
| Sep 22 2025 |
Anand Rathi Share and Stock Brokers Limited
Anand Rathi Share and Stock Brokers Limited (ARSSBL) is an established, over three-decade old, full-service brokerage house in India with over three decades of experience. It operates in highly compet
|
|||
| Sep 11 2025 |
‘G’ for GDP, GST…Good News?
The Indian stock markets climbed a wall of worries in August, with the Nifty and Sensex plummeting after being in the green for the previous four months.
|
Mirae Asset Research Team | ||
| Aug 20 2025 |
Braving multiple headwinds
Globally, as well as at home, the Street’s battling the aftermath of US President Donald Trump’s tariff tantrums.
|
Mirae Asset Research Team | ||
| Jul 28 2025 |
National Securities Depository Limited (NSDL)
NSDL is coming with an IPO of Rs. 4,012 crore that is entirely an offer for sale of 5.01 crore shares
|
|||
| Jul 17 2025 |
Turnaround Times
Indian equities continued to rise for the fourth consecutive month in June, with the Sensex and Nifty rising 2.6-3%
|
Mirae Asset Research Team | ||
| Jun 23 2025 |
HDB Financial Services
HDB Financial is coming with an IPO of Rs. 12,500 crore. The issue is a combination of a fresh issue of Rs. 2,500 crore
|
|||
| Feb 01 2025 |
Focus shifts to consumption
Budget 2025-26 was a well-balanced one, meeting market expectations on fiscal consolidation
|
Mirae Asset Research Team | ||
| Dec 17 2024 |
“It’s just a pause”
Equity markets remained upbeat in CY2024 despite an eventful year with elections in India and the U.S., rising geopolitical conflicts, and beginning of the interest rate reversal cycle.
|
Mirae Asset Research Team |
WIPRO
Oct 22, 2026
Recovery yet to fully materialise
Wipro guided Q3FY27 IT Services revenue growth at -1.5% to +0.5% q-o-q in constant currency
SRF
Oct 22, 2026
Soft Q2; Specialty chemicals to support H2 growth
Q2FY27 numbers missed our estimates, on reversal of gains in PFB business
M&MFIN
Oct 22, 2026
Steady Q2, policy headwinds shrink valuations
Q2 numbers were steady, though policy changes and higher interest rates pose risks;
LTTS
Oct 22, 2026
Strong execution reflected in valuations
Demand across AI infrastructure, semiconductors, telecom, and AI/EI-led solutions remains robust, supporting stronger growth ahead.
INDHOTEL
Oct 22, 2026
Record Q2; guidance raised as fee engine accelerates
Stock trades at 24x/20.4x its FY27E/FY28E EV/EBITDA, respectively. We maintain a Buy with a revised PT of Rs. 928.
OBEROIRLTY
Oct 21, 2026
NCR foray opens fresh growth avenue
We stay positive on the stock and assign a PT of Rs. 2,122. This is based on strong launch momentum, steady rentals and a healthy balance sheet.
ULTRACEMCO
Oct 21, 2026
Q2 braves rising costs
Management expects to enter H2FY27 with better prices, enhanced capacity and the benefit of operating leverage
PERSISTENT
Oct 21, 2026
Large deal ramp-up fuels growth; Nagarro integration key catalyst
We view the Nagarro acquisition as the key catalyst to watch, given its potential to drive cross-selling opportunities, scale benefits
GRWRHITECH
Oct 21, 2026
Growth path steady; yet stock’s run out of steam
FY27 revenue guidance retained at ~Rs. 2,500 crore, with EBITDA margin seen at ~25% +/- 2%.
LTM
Oct 21, 2026
Growth to recover in H2
Margins would stay in line with FY26 levels. However, higher margin AI revenues should support gradual margin expansion with faster revenue conversion, partly offset by continued investments in AI cap
BAJFINANCE
Oct 21, 2026
Steady Q2, Outlook positive despite policy headwinds
AUM surged to Rs. 584,564 up 26.5% y-o-y, but NIM fell to 9.12% due to rise in the borrowing costs on sequential basis.
DLF
Oct 19, 2026
Strong premium demand; new launches to drive pre-sales
Dahlias’ ultra-luxury continues to see strong demand, with prices increasing 10% during the quarter.
FEDERALBNK
Oct 19, 2026
Record profit, but valuations cap upside
NII grew 26% y-o-y led by a strong 22% loan growth, while NIM was broadly stable q-o-q at 3.32%.
LTF
Oct 19, 2026
Q2 braves headwinds
NIM rose 36 bps y-o-y to 9.33% due to lower cost of borrowings. Asset quality improved.
TECHM
Oct 19, 2026
Growth Accelerates, Margins Improve
TECHM remains confident of further rise in gross margins despite higher utilisation levels and recent headcount additions.
PNB
Oct 19, 2026
Steady quarter; margins on the mend
Other income fell 17.1% y-o-y as treasury gains slumped, though fee income was healthy and grew 16% y-o-y.
ICICIBANK
Oct 19, 2026
FCNR fuels growth, margin dip temporary
PAT of Rs. 14,843 crore grew 20.1% y-o-y, 3.6% above our estimate, helped by low provisions; GNPA declined 18 bps q-o-q to 1.20% and NNPA eased 5 bps to 0.30%.
HDFCBANK
Oct 19, 2026
Steady quarter, margins have bottomed out
PAT grew 4.7% y-o-y to Rs 19,510 crore, 2.0% above our estimate; excluding trading gains, PAT grew 12.6%.
AXISBANK
Oct 19, 2026
Asset quality shines, business traction garners momentum
Asset quality improved, with GNPA and NNPA fell 12 bps and 4 bps q-o-q, and net credit cost falling to 0.45%.
Oct 16, 2026
Jio Platforms Limited
Jio Platforms Limited is the digital and telecom arm of Reliance Industries built on a proprietary technology stack that the company designed
POLYCAB
Oct 16, 2026
Strong performance amid noisy headlines
OPM fell 139 bps to 14.4% versus our expectations of 14%. FMEG margins reached 10% vs a flat trend in Q2FY26.
NESTLEIND
Oct 16, 2026
Strong volume-led quarter; brand push paying off
Stock trades at 60.4x/53.4x its FY27E/FY28E EPS, respectively. We retain a Buy rating with a revised PT of Rs. 1,437.
HDFCLIFE
Oct 16, 2026
Growth returns, regulatory overhang lingers
PAT grew 13.6% y-o-y to Rs. 508 crore, but fell sequentially as stronger sales meant higher new business strain.
ICICIGI
Oct 15, 2026
Better Q2, but not out of woods yet
PAT grew 15.5% y-o-y to Rs. 946 crore, beating our estimate of Rs. 697 crore, chiefly fuelled by higher capital gains.
ICICIPRULI
Oct 14, 2026
Regulatory developments warrant caution; Downgrade to Hold
The IRDAI consultation paper on distribution economics is still evolving, and margins may ease mildly in H2FY27 as a high protection base kicks in.
CANFINHOME
Oct 13, 2026
Mixed bag Q2; strong AUM growth eyed
PAT slightly exceeded estimates, rising 9.2% y-o-y and 2.5% q-o-q to Rs. 275 crore.
Oct 13, 2026
ValueGuide Equity - October 2026
Eyeing value in volatile times
Oct 13, 2026
Eyeing value in volatile times
Dalal Street has been beset with a barrage of worries lately – geopolitical tensions, oil on the boil, inflationary concerns, trade tariff woes and a lot more. And yet, what seems as a troublesome pha
HCLTECH
Oct 13, 2026
Strong execution, Limited Headroom
We introduce FY29 earnings and roll forward our valuation to Sep’28 on EPS of Rs 78, accordingly we raise our price target to Rs 1,310, valuing the stock at 17x with a HOLD rating
TCS
Oct 09, 2026
Attractive yields cushion margin stress
Continued investments, higher external consultant fees and rising project and software costs would stress near-term margins.
Oct 09, 2026
Q2FY2027 NBFCs, Insurance, AMC & Diversified Financials Results Preview
Strong growth persists; margins under pressure
Oct 09, 2026
Q2FY2027 Capital Goods Results Preview
Strong order inflows; execution and margins remains key
Oct 09, 2026
Q2FY2027 Automobile Results Preview
Growth intact, margins under watch
Oct 08, 2026
Q2FY2027 Pharma & Healthcare Results Preview
Embarking on fresh growth phase
Oct 08, 2026
Q2FY2027 Consumer Goods Results Preview
Strong sales growth, but cost pressure remains
Oct 08, 2026
Q2FY2027 Chemicals Results Preview
In a selective growth phase
Oct 08, 2026
Q2FY2027 Metals & Mining Results Preview
Steeling up for strong Q2
Oct 08, 2026
Q2FY2027 Cement Results Preview
Steady volumes; margins face pressure
Oct 08, 2026
Q2FY2027 Banking Results Preview
Robust credit growth to drive earnings
JTLIND
Oct 08, 2026
Capacity doubling to unlock the next leg of growth
JTL is doubling pipe capacity to ~2 million tonnes by FY28, with a major focus on value-added products (VAPs), including galvanised, colour-coated and API-grade products.
Oct 07, 2026
Mint St turns up the heat
The RBI ended a long pause, hiking the repo rate by 25 bps to 5.5% and shifted its stance to calibrated tightening given persistent inflation.
Oct 06, 2026
Strong growth after base scare
CV sales soared on rising mining, infrastructure and commercial operations across the country.
Oct 06, 2026
Q2FY2027 IT Results Preview
Another muted quarter, deferred recovery
KTKBANK
Sep 24, 2026
Growth engine accelerating, profitability to follow
We initiate with a BUY rating on Karnataka Bank with a PT of Rs 415, ~22% above the CMP
Sep 16, 2026
National Stock Exchange of India Limited
Established in November 1992, NSE stands as the nation’s premier capital market infrastructure provider.
FINCABLES
Sep 11, 2026
Optic fibres to add growth spark
Strong demand in the OFC space bodes well for its long-term growth
Sep 10, 2026
ValueGuide Equity - September 2026
Coursing through a transition
Sep 10, 2026
Coursing through a transition
August cleared the picture on how investor preferences within Indian markets are changing. The benchmark indices may not tell the full story. Benchmark indices ended August in the red, bringing a two-
Sep 03, 2026
Preparing for festive season inventory
CV growth cycle is rising, two-wheeler players are seen riding the export wave besides robust domestic demand; only PV players face supply constraints.
GRAVITA
Sep 03, 2026
Eyeing a high-margin growth mix
At CMP, Gravita trades at a 28x/21x multiple on FY27E/FY28E EPS. We maintain a Buy rating with a PT of Rs. 2,100.
ROLEXRINGS
Aug 31, 2026
Precision in every revolution
Rolex affirms guidance for mid-teens revenue growth while newer products would drive up margins.
WELCORP
Aug 24, 2026
Record order win boosts growth prospects
At CMP, Welspun Corp trades at a 19x/15x multiple on FY27E/FY28E EV/EBITDA, we maintain a Buy rating with a revised PT of Rs. 2800.
Aug 21, 2026
Q1FY2027 Pharma & Healthcare Results Review
India pharma & CDMO cushion us pain; hospitals ride the volume wave
Aug 21, 2026
Q1FY2027 Consumer Goods Results Review
Growth prospects intact, margin risks persist
Aug 21, 2026
Q1FY2027 Metals & Mining Results Review
Growth steady; long-term outlook stable
Aug 21, 2026
Q1FY2027 NBFCs, Insurance, AMCs, and Diversified Financials Results Review
NBFCs & AMCs shine; insurers a mixed bag
Aug 21, 2026
Q1FY2027 Automobiles Results Review
Strong volumes; relief expected from H2
ZYDUSLIFE
Aug 20, 2026
Multiple tailwinds offset weak US biz
India formulations biz revenue rose ~20% y-o-y, while global revenue rose 34% y-o-y; driving growth
APOLLOHOSP
Aug 20, 2026
Core hospitals power Q1; HealthCo to break even by Q3FY27
Apollo Hospitals delivered a strong Q1FY27, with healthy growth across revenue, EBITDA and PAT.
Aug 19, 2026
Q1FY2027 Capital Goods and Power Results Review
Orderbook stays strong; margins seen stressed in the short run
V2RETAIL
Aug 19, 2026
Robust growth continues; FY27 store expansion on track
Q1FY27 consolidated revenue grew 58% y-o-y to Rs. 997 crore, driven by rapid store expansion, healthy customer traction, and 56% y-o-y volume growth.
SUDARSCHEM
Aug 19, 2026
Profitability brightens Q1; Outlook healthy
Q1FY27 saw healthy profitability gains, led by steady legacy performance and improving Heubach operations, while Rieco remained hit by execution issues.
ASHOKLEY
Aug 18, 2026
Cost pressures persist
Domestic volumes continue to shine, while export volumes declined by 18% y-o-y during Q1FY27.
TMPV
Aug 18, 2026
JLR headwinds weigh heavily
Guidance remains unchanged despite a challenging Q1 indicating a stronger H2 .
NMDC
Aug 18, 2026
Record output; tepid sales
Consolidated net profit for the Q1FY27 was Rs. 1,976 crore, up 0.4% y-o-y and down 2.5% q-o-q.
INDIGOPNTS
Aug 17, 2026
Strong Q1; margins expand
Consolidated revenue grew 19.7% y-o-y to Rs. 370 crore, supported by double-digit growth across product categories and network expansion.
Aug 17, 2026
Q1FY2027 Banking Results Review
Loan growth holds firm, margins ease
YATHARTH
Aug 17, 2026
Record ramp-up underscores demand tailwinds
The rapid ramp-up also strengthens confidence in the scaling trajectory of upcoming assets like the Gurugram hospital.
TATAMOTORS
Aug 17, 2026
Growth momentum persists
Health domestic demand, product launches, stable exports and increasing EV penetration to help company grow in FY27 and beyond.
HAL
Aug 17, 2026
Outlook remains strong
Revenues grew 14% y-o-y supported by execution from RoH and manufacturing of helicopters and engines
AMBER
Aug 17, 2026
Electronics segment led the performance
Revenues grew 13% y-o-y, lagging estimates on a tepid show by the consumer durables segment.
Aug 17, 2026
Q1FY2027 IT Results Review
Recovery gaining pace, execution critical
HITECH
Aug 17, 2026
Volumes strong, value-added products to drive margins
We remain positive on the stock and revised PT to Rs. 110, considering the current challenging environment and growth factors.
JUBLFOOD
Aug 17, 2026
Strong start to FY27; Popeyes emerges as second growth engine
We maintain a Buy rating with a revised PT of Rs. 580.
SATIN
Aug 14, 2026
Stellar Q1, outlook getting better
We maintain a positive view with unchanged PT of Rs. 260. The stocks trade at an attractive valuation of 0.6x FY28 BV.
JYOTHYLAB
Aug 14, 2026
Margins miss mark; H2 recovery hopes limit downside
Q1FY27 performance was weak on profitability, with revenue growing 3.0% y-o-y to Rs. 773 crore,
WABAG
Aug 14, 2026
MEA market to drive growth
We maintain a Buy with a revised PT of Rs. 2,350, valuing it at 20x its FY28 EPS. Stock trades at a P/E of ~19x/16x its FY27E/28E EPS.
LUMAXTECH
Aug 14, 2026
Margins intact, riding steadily on growth path
Increasing wallet share of existing OEMs, premiumisation and scaling of business across categories aided strong Q1 numbers.
FINCABLES
Aug 14, 2026
Low-cost inventory gains power Q1
We believe company to benefit from the OFC sector tailwinds. We maintain a Buy rating for a revised PT of Rs 1,450. At CMP, the stock trades at a valuation of 18x on FY27 earnings.
GRASIM
Aug 14, 2026
Paints biz in focus; long-term outlook robust
We retain Buy with a revised SOTP-based PT of Rs. 3681, supported by sustained momentum in paints and improving operating leverage.
CARYSIL
Aug 13, 2026
On a strong growth path
Management indicated that Carysil is currently sitting on its highest-ever export order book, supported by Home Depot
ABFRL
Aug 13, 2026
Investment phase continues; growth steady but profitability recovery delayed
Q1FY27 revenue growth was steady, but profitability remained weak as higher depreciation, finance cost and investments in newer platforms weighed on earnings.
PIIND
Aug 13, 2026
Weakness persists
Exports remained weak amid a prolonged industry downturn, and steady pricing pressure further weighed on performance,
FLUOROCHEM
Aug 13, 2026
Healthy Q1; Stretched valuations limit upside
We maintain a Hold rating with a PT of Rs. 5,000, as current valuations largely reflect the company’s long-term growth
TRITURBINE
Aug 13, 2026
Margins hit by adverse product mix
Revenue grew 19% y-o-y, beating estimates. Exports/ domestic sales surged 11%/27%, respectively.
BECTORFOOD
Aug 13, 2026
Strong Q1; growth momentum accelerates with margin expansion
Stock trades at 40.9x/33.2x its FY27E/FY28E EPS, respectively. We stay Positive on the stock and expect an upside of 15%.
LEMONTREE
Aug 12, 2026
Q1 – A tactical, transient pause
Q1FY27 revenue grew 9% y-o-y to Rs. 344.6 crore, EBITDA up 6.5% y-o-y to Rs. 149.7 crore and PAT up 19% y-o-y to Rs. 57.3 crore.
RATNAMANI
Aug 12, 2026
Steady Q1; eyeing a diversified play
Consolidated revenue declined 15.6% y-o-y to Rs. 971.63 crore and 10.4% q-o-q due to sluggish demand
KEC
Aug 12, 2026
Lacklustre Q1, yet downside limited
Management refrained from margin guidance but stated that they would inch up from Q3 and peak only after FY28.
KPIL
Aug 12, 2026
Resilient show in challenging times
We maintain a Buy with a revised PT of Rs 1,750. Stock is valued at ~15x/13x FY27E/28E P/E.
APOLLOTYRE
Aug 12, 2026
Well-balanced ride
Robust demand turned Q1 numbers stellar, while operational efficiency and price hikes arrested the fall in margins caused by raw material price
GODREJCP
Aug 12, 2026
Healthy Q1; RM costs stress margins
We maintain a Buy with a revised PT of Rs. 1,270.
Aug 11, 2026
Opportunity amid volatility
July brought in a ray of optimism in these challenging times - with the narrative gradually shifting from concerns around inflation and global uncertainty to improving domestic fundamentals.
NAUKRI
Aug 11, 2026
AI monetisation offsets hiring headwinds
We believe current valuations already reflect most near-term growth drivers, limiting further upside. Accordingly, we downgrade the stock to HOLD.
BIOCON
Aug 11, 2026
Strong Q1; launch line-up strong
We retain a Buy rating with a revised PT of Rs. 498 (44x FY28E EPS of Rs 11.6), on account of refinancing-led margin visibility and a strong H2 launch pipeline.
TITAN
Aug 11, 2026
Q1 growth broad-based, one-offs aid margins
Stock trades at 72.2x/59.8x its FY27E/FY28E earnings, respectively. We maintain a Buy with an unchanged PT of Rs. 5,671.
SKYGOLD
Aug 11, 2026
Growth story stays gleamy
Sky Gold & Diamonds trades at a 28x/20x multiple on FY27E/FY28E EPS. We maintained a Buy rating with a revised PT of Rs. 920.
Aug 11, 2026
ValueGuide Equity - August 2026
Opportunity amid volatility
PFC
Aug 11, 2026
Soft Q1, profitability stays resilient
Despite soft Q1 numbers and EPS cuts, negative credit costs, asset quality will lead for healthy return ratios, hence we maintain positive view with a revised SoTP PT of Rs. 500.
SBIN
Aug 11, 2026
Growth, margins and profitability all click
We maintain a Buy with a revised PT of Rs. 1,265.
KIRLOSENG
Aug 11, 2026
Strong growth prospects
We maintain a Buy rating for a PT of Rs 2,600, expecting company to maintain a strong long-term growth trajectory.
BRITANNIA
Aug 11, 2026
Strong Q1; volume recovery encouraging, margin watch remains
We maintain Buy on the stock with a revised PT of Rs. 6,353.
BLUESTARCO
Aug 11, 2026
Margins recovery seen in H2
While we remain cautious, we retain a positive view with a revised PT of Rs 1,800.
WONDERLA
Aug 10, 2026
Strong Q1; Chennai scales up faster than expected
Q1FY27 revenue grew 44% y-o-y to Rs. 243 crores, EBIDTA grew 39% y-o-y with EBIDTA margin standing s
JKLAKSHMI
Aug 10, 2026
Cost pressures bite, yet expansion story intact
Management reiterated its long-term capacity target of 30 MTPA by FY30.
HEROMOTOCO
Aug 10, 2026
Set for a smooth ride ahead
FY27 margin guidance stays at 14-16% led by easing commodity price inflation, price hikes, wider scale and an improving product mix.
AFFLE
Aug 10, 2026
Robust Q1 Performance Driven by Broad-Based Growth
APAT stood at Rs 128.4 crore, up 7.5% q-o-q (+21.7% y-o-y), with PAT margin at 17.2% (+69bps q-o-q/+19bps y-o-y).
DEEDEV
Aug 10, 2026
Eye on debt cuts; outlook bright
We remain positive and assign a PT of Rs. 740.
TRENT
Aug 10, 2026
Strong Q1FY27
Stock trades at 70.7x/55.1x its FY27E/FY28E EV/EBITDA, respectively. We maintain a Buy with a revised SOTP-based PT of Rs. 3,390.
ARTEMISMED
Aug 07, 2026
Strong domestic show offsets dull global scene
Management is expected to renew its focus on international patients, as Q1 is largely seen as a one-off.
IKS
Aug 07, 2026
Revenue in-line, PAT missed due to margin compression
We stay positive on stock with an unchanged PT of Rs. 2,020 based on FY28E EPS of 61.0. TruBridge integration remains the key watchpoint.
CENTURYPLY
Aug 07, 2026
Capacity expansion to drive growth
Quarterly revenue came in at record highs, rising 33.5% y-o-y, while EBITDA grew 54% y-o-y
CUMMINSIND
Aug 07, 2026
Supply chain disruptions impacted performance
Q1 numbers were a mixed bag as revenue beat estimates but margins disappointed.
DLF
Aug 07, 2026
FY27 launches to help meet pre-sales target
We stay Positive with a price target of Rs. 800, backed by steady residential demand and continued scale-up of the rental portfolio.
SUNDRMFAST
Aug 07, 2026
Fastened to growth
We value the company at 31x its EPS of FY28E and maintain a positive rating while raising PT to Rs. 1,251.
SUNPHARMA
Aug 07, 2026
Steady domestic momentum, US overhang persists
Led by the rising share of innovative drugs, we maintain a Buy rating with a PT of Rs.2,253, valuing the stock at 34x FY28E EPS of Rs.58.8.
BHARTIARTL
Aug 07, 2026
Strong Q1FY27, ARPU gains & Africa growth drive momentum
We maintain a Buy with an SOTP-based price target of Rs 2,350; valuation rolled forward to Mar’28.
Aug 06, 2026
Domestic demand tailwinds continue
Sequential performance reflected seasonal trends with passenger vehicles recovering and tractor volumes facing a temporary post-sowing cyclical pullback.
BSE
Aug 06, 2026
Record Q1, regulatory reset bites
Stock trades at 35xFY28E EPS, we stay positive on the stock and revise PT to Rs. 4100.
NAVINFLUOR
Aug 06, 2026
CDMO, HPP and specialty chemicals delivered strong growth, driving consolidated revenue growth of 44
We maintain our BUY rating on NFIL and raise our TP to Rs 8,850.
POCL
Aug 06, 2026
Supply-chain challenges hit volumes, long-term outlook intact
We maintain our BUY rating with a price target of Rs 680.
PNBHOUSING
Aug 06, 2026
Soft Q1, outlook improving
We maintain a positive view with a revised PT of Rs. 1350 on strong AUM growth, improvement in NIMs and steady asset quality.
SAREGAMA
Aug 05, 2026
Music segment makes Q1 a melody
We value the stock on a P/E multiple of 42x on FY28E EPS of Rs 15.1 and a price target of Rs. 640.
MARICO
Aug 05, 2026
Strong start to FY27; guidance intact with upside bias
Stock trades at 50.6x/44.2x its FY27E/FY28E EPS, respectively. We retain a Buy rating with a revised PT of Rs. 986.
Aug 05, 2026
Extended pause; data to guide rate re-calibration
Stable rates should continue to support NIM visibility across banks, NBFCs and other rate-sensitive sectors like housing, infrastructure, etc.
TCI
Aug 05, 2026
Multimodal expansion to drive growth
Revenue rose 9.6% y-o-y to Rs. 1,248.5 crore, operating profit up 11.7% y-o-y to Rs. 135.2 crore.
EMAMILTD
Aug 05, 2026
Domestic growth strong; margin pressure persists on input inflation and mix
Strategic investments remained the key growth driver, rising 61% on a like-to-like basis and contributing 18% of domestic business.
ZYDUSWELL
Aug 05, 2026
Diversified portfolio cushions weak summer demand
Consolidated revenue grew 66.9% y-o-y to Rs. 1,437 crore, led by consolidation of Comfort Click and healthy growth in non-seasonal domestic portfolios.
PERSISTENT
Aug 05, 2026
Strong deal wins ensure revenue visibility
Deal wins remain robust with $ 1,146.2 million, up 90.8% q-o-q (120.1% y-o-y), largely driven by $650 million from a global US technology leader.
KEI
Aug 05, 2026
Capex announcements and margins upgrade
Revenue rose 23% y-o-y, beating our estimates majorly driven by higher realisations due to price hikes and very minimal volume growth.
Aug 05, 2026
5 Curated Stock Ideas for August 2026
Corporate earnings is the flavour on the street and we bring you a curated bouquet of five stocks that could give your portfolio an edge. Each idea combines technical and fundamental growth drivers.
SAMHI
Aug 04, 2026
Strong Q1; operating resilience braves geopolitical headwinds
Operational performance remained healthy despite West Asia-related disruptions, with same-store RevPAR growing 9.6% y-o-y to Rs. 5,219/night and occupancy improving to 79.3%.
INTELLECT
Aug 04, 2026
Expanding AI adoption
Revenue fell 0.8% q-o-q (up 20.6% y-o-y) to Rs 845.2 crore; license and implementation revenues saw steady traction.
DIVISLAB
Aug 04, 2026
CDMO mix shift drives margin beat in Q1FY27
Q1FY27 numbers very strong, with revenue up 24.3% y-o-y, PAT up 65.5% y-o-y, and EBITDA margin rising to 38.5%.
ABCAPITAL
Aug 04, 2026
Robust Q1, Outlook bright
Consolidated PAT grew 43.3% y-o-y and 16.9% q-o-q led by strong momentum in the lending businesses.
RBA
Aug 04, 2026
India momentum accelerates
Stock trades at 10.1x/8.5x its FY27E/FY28E EV/EBIDTA, respectively. We maintain a Buy with a revised PT of Rs. 105.
MEDANTA
Aug 04, 2026
Patient volume gush powers Q1
Q1FY27 was a record quarter, with revenue rising 26.5% y-o-y to Rs.1,304.05 crore, while EBITDA grew 23.5% to Rs.315.3 crore.
APLAPOLLO
Aug 04, 2026
Capacity expansion and Focus on VAP to boost profitability
Consolidated revenue/EBITDA/PAT beat estimates by 11% / 1.1% / 2.0%, respectively.
THERMAX
Aug 03, 2026
A muted quarter
With stock prices, order book visibility and premium multiples having already run up, we maintain a Hold rating; for a price target of Rs 4,300
MOIL
Aug 03, 2026
Strong Q1; capacity expansions to drive growth
Revenue rose 7% to Rs. 370.88 crore., compared with Rs. 370.52 crore, total revenue increased 6% to Rs. 391.13 crore.
BAJAJFINSV
Aug 03, 2026
Lending business scaling, quality improving in insurance segment
Consolidated PAT rose 12% y-o-y to Rs. 3,132 crore as total income grew 19% y-o-y to Rs. 42,037 crore.
SHREECEM
Aug 03, 2026
Volume growth healthy, medium-term outlook intact
Revenue was broadly in line with our estimate, while EBITDA and PAT missed estimates by 7.6% and 21%, respectively, due to hight operating costs caused by spike in fuel costs.
RAINBOW
Aug 03, 2026
Volumes firm, new hospitals in ramp-up mode
ARPOB rose 6% y-o-y to Rs. 67,256 and occupancy improved 3 pps y-o-y to 41.2%, led by mature hospitals at 45% occupancy, and 34.4% occupancy for new hospitals.
DIXON
Aug 03, 2026
Strong show in challenging times
We retain a Buy rating with a PT of Rs. 16,300, factoring in a 24%/6% revenue/PAT CAGR (FY26–28E). Stock trades at 49x FY27E and 34x FY28E earnings.
MARUTI
Aug 03, 2026
Higher costs dent profitability
Stock trades at 31.1x, 24.5x, 21.1x it’s FY26, FY27E and FY28E earnings respectively. We stay positive rating on the stock for a PT of Rs. 16,221.
ITC
Aug 03, 2026
Tax shock weighs on cigarettes; other segments sustain momentum
Stock trades at 17.6x/16.3x its FY27E/FY28E EPS, respectively. We maintain a Buy with a revised PT of Rs. 341.
CHALET
Jul 31, 2026
On a strong growth path
Stock trades at 14x/11.7x its FY27E/FY28E EV/EBIDTA, respectively. We stay Positive and expect an upside of 27% over the next 12 months.
LICHSGFIN
Jul 31, 2026
Decent profitability in mixed bag Q1
We maintain a HOLD rating with a revised PT of Rs. 600, as the growth-versus-margin trade-off remains the key monitorable
HONAUT
Jul 31, 2026
Margin trend continues; Maintain Hold
We retain a Hold rating on Honeywell with a revised PT of Rs.41,000. The stock is expected to report a revenue/PAT CAGR of 12%/22%, respectively,
COALINDIA
Jul 31, 2026
Healthy Q1; subsidiary listing to unlock value
CIL trades at 4.8x/4.3x FY27E/FY28E EV/EBITDA; Buy maintained with revised PT of Rs. 530.
AARTIIND
Jul 31, 2026
Temporary volatility, structural growth drivers unchanged
Q1FY27 delivered a strong beat aided by product mix optimization, inventory gains and forex tailwinds despite supply chain disruptions and lower volumes
M&M
Jul 31, 2026
Tighter purse-strings brighten Q1
Revenue grew 23% y-o-y and 6% q-o-q to Rs 41,959 crore led by strong volume growth across the automobile and farm divisions.
BAJFINANCE
Jul 31, 2026
PAT surges on lower costs; robust operating profits
We project a 26.2% PAT CAGR over FY26–FY28 and maintain a BUY rating with a revised PT of Rs. 1,250 on strong profitability growth
CIPLA
Jul 31, 2026
Strong top line, margin pressure from North America
We value the stock at 1-year fwd avg P/E on FY28E EPS of Rs. 64.7 and retain our Buy rating with a PT of Rs. 1,623.
VGUARD
Jul 31, 2026
Price hikes power Q1
We retain a Buy with a unchanged PT of Rs. 430, given a positive business outlook factoring in strong growth from the electricals & electronics businesses.
VINATIORGA
Jul 30, 2026
Margins slide on RM inflation; Recovery hinges on 2H27
Revenue grew 28% y-o-y to Rs 696 crore, supported by higher AO volumes and export benefits from a weak rupee. However, EBITDA margin fell 497 bps y-o-y to 24.5% due to sharp raw material inflation and
GRAVITA
Jul 30, 2026
Healthy Q1; non-lead businesses next growth engine
Revenue rose 42% y-o-y and 26% q-o-q to Rs. 1,475 crore. Copper segment generated Rs. 376 crore in revenue, compared to Rs. 51.78 crore a year ago.
EICHERMOT
Jul 30, 2026
Q1 a steady cruise
Best-ever Q1, with record volumes and EBITDA for VECV led by strong demand.
DABUR
Jul 30, 2026
FY27 growth path intact
Operating performance was strong, with consolidated revenue growing 10.6% y-o-y to Rs. 3,764 crore, driven by broad-based growth across India and global businesses.
PCBL
Jul 30, 2026
Retain caution despite robust Q1
We maintain our HOLD rating while raising our price target to Rs 376.
RADICO
Jul 30, 2026
Sparkling Q1; premiumisation drives earnings momentum
Stock trades at 66x/53.7x its FY27E/FY28E earnings, respectively. We retain a Buy with a revised PT of Rs. 5,010.
TATAPOWER
Jul 29, 2026
Capacity additions to drive growth
Revenue grew 6% led by positive performances across segments. Adj EBITDA decline 3% y-o-y and adjusted PAT was higher 11%.
SUPREMEIND
Jul 29, 2026
Polymer prices stabilising; long-term outlook strong
Revenue grew 4% y-o-y on better realisations and a favourable product mix, even as volume fell 14% y-o-y on channel destocking.
DEVYANI
Jul 29, 2026
Margins brighten Q1
Consolidated revenue grew 16.5% y-o-y to Rs. 1,581 crore, driven by healthy growth in KFC India,
COLPAL
Jul 29, 2026
Reinvesting margin gains to fuel growth
Stock trades at 40.3x/36.1x its FY27E/FY28E EPS, respectively. We maintain a Buy with a revised PT of Rs. 2,426.
SAIL
Jul 29, 2026
Margins expanded despite lower volumes
The net profit (attributable to the parent’s owners) in Q1FY27 increased by 120.8% y-o-y to Rs. 1,644 crore and was down 10.4% q-o-q.
CHOLAFIN
Jul 29, 2026
Earnings beat estimates; growth rides on multiple drivers
GNPA rose 13 bps y-o-y and 24 bps q-o-q to 3.29%, though credit costs remained controlled at 1.58%.
BSOFT
Jul 29, 2026
Weak revenue visibility
Maintain HOLD with a price target of Rs 320.
CUB
Jul 29, 2026
Execution stays steady; RoA, asset quality shining
We maintain a Buy with an revised PT of Rs. 275.
VBL
Jul 29, 2026
Bubbly Q2; strong volumes beat dull weather
We stay Positive and expect an upside of 32% over the next 12 months, implying a price target of Rs. 561.
HINDUNILVR
Jul 29, 2026
Strong Q1; growth at multi-quarter high
Stock trades at 41.5x/37.2x its FY27E/FY28E EPS, respectively. We retain a Buy with a revised PT of Rs. 2503.
HUDCO
Jul 29, 2026
Record Disbursements and Solid Asset Quality Drive Momentum; Outlook Strong
Hence, we maintain a Positive view with a revised price target of Rs. 250.
LT
Jul 29, 2026
Resilient performance amid volatile times
LODHA
Jul 28, 2026
Residential demand Intact; Palava data center to unlock long-term value
We maintain a “Positive” view with a revised PT of Rs. 1,465, on a strong pipeline and steady demand.
COFORGE
Jul 28, 2026
Robust Q1; management commentary bright
Strong deal ramp-ups, accelerated Encora integration, and operating leverage opportunities support sustained growth and margin expansion.
Jul 28, 2026
Manipal Hospitals
At Rs.560-590 per share, Manipal is being offered at ~80x FY26 PAT on post-issue equity.
WELCORP
Jul 28, 2026
Core earnings better, one-offs power PAT
At CMP, Welspun Corp trades at 14x/13x multiple on FY27E/FY28E EV/EBITDA, we maintain a Buy rating with a revised PT of Rs. 1850.
FIVESTAR
Jul 28, 2026
Asset quality stress easing; AUM growth to speed up
Hence, we upgrade to Buy from Hold with a price target of Rs. 620, trading at an attractive 1.6x FY28E P/BV.
BEL
Jul 28, 2026
Sustained growth guidance
With a promising order pipeline, we retain a Buy rating with a revised PT of Rs. 510. At CMP, the stock trades at 41x/35x its FY2027/FY2028 earnings estimates
NTPC
Jul 27, 2026
Steady capacity additions and higher demand led the growth
We maintain a Buy rating with an unchanged PT of Rs. 430; valuations are reasonable given strong long-term growth prospects
LAURUSLABS
Jul 27, 2026
CDMO biz drives Q1 earnings, growth drivers intact
Q1FY27 numbers were stellar, with revenue rising 29.1% y-o-y and PAT more than doubling
DALBHARAT
Jul 27, 2026
JP integration starts; capacity expansion plans on track
We maintain a Buy rating with a price target of Rs. 2,350; At CMP, Dalmia trades at a reasonable 11.7x/9.8x FY27E/FY28E EV/EBITDA.
COROMANDEL
Jul 27, 2026
Margin pressure persists amid subsidy and raw material headwinds
We maintain a Buy rating with a PT of Rs 2,380 based on 25x FY28E EPS, led by a better business mix
TATACONSUM
Jul 27, 2026
Growth businesses put up strong show, margin expansion continues
Stock trades at 56.1x/47.8x its FY27E/FY28E EPS, respectively. We maintain a Buy with a revised PT of Rs. 1,321.
SBFC
Jul 27, 2026
In-line Q1; eyeing steady growth and consolidation
NII beat estimates by 4.0% as NIM expanded on improved portfolio yields and lower funding costs.
ABDL
Jul 27, 2026
Premiumisation intact; supply chain disruption hits margins
Stock trades at 53.5x/35.5x FY27E/FY28E EPS; Positive stance maintained with PT of Rs. 718.
ATUL
Jul 27, 2026
Exceptionally Strong Q1; stable margins hold key
We maintain PT at Rs. 7,716 based on 27x FY28 EPS. FY27 should benefit from favourable pricing, while FY28 growth should be driven by higher utilisation and new products.
BANKINDIA
Jul 27, 2026
Core performance intact, credit-off take garners traction
The bank is poised to post steady ROA of ~1% mark for FY27. We maintain a Buy rating with unchanged PT of Rs175.
BANKBARODA
Jul 27, 2026
Mixed bag Q1, one-off dents profitability
Overall, we believe banks financials are healthy and profitability to be maintained at respectable levels going ahead. We maintain BUY with unchanged PT of Rs. 320.
AUBANK
Jul 27, 2026
Robust performance; growth-profitability flywheel intact
With improving profitability prospects, the bank is set to pose healthy performance over medium term. We maintain BUY with unchanged PT of Rs1225.
PVRINOX
Jul 27, 2026
Strong performance and solid lineup ahead in FY27
We maintain a Buy rating with a price target of Rs 1,250.
CIEINDIA
Jul 24, 2026
Long-term growth concerns persist
Revenue grew 10.6% y-o-y to Rs. 2,621crores led by strong performance in the domestic business of the company.
NIITMTS
Jul 24, 2026
Steady performance in Q1
Revenue rose 7.6% q-o-q and 25.2% y-o-y to Rs 565.1 crore; excluding MST and SweetRush, growth was 11% y-o-y
INFY
Jul 24, 2026
FY27 Outlook Turns Cautious as Organic Growth Weakens
We slash our FY28E EPS estimate by 2.5%, lower target P/E to 14x on FY28E EPS of Rs. 79.2, revise the PT to Rs. 1,110, and downgrade to HOLD.
DRREDDY
Jul 23, 2026
Sequential recovery underway, GLP-1 India delay a setback
Q1FY27 net revenue fell 5.6% y-o-y to Rs. 8,070.5 crore, though this marked a 7.4% sequential improvement over Q4FY26.
SUNTECK
Jul 23, 2026
On a robust growth path
We remain positive on Sunteck Realty, with a revised PT of Rs. 444, supported by a strong launch pipeline, robust cash flows and attractive valuation.
SRF
Jul 23, 2026
All-round beat in Q1; H2 outlook better
Q1FY27 numbers beat estimates, led by robust growth in PFB and better-than-seasonal performance in the chemical segment.
SCHAEFFLER
Jul 23, 2026
Revenue growth offsets cost pressures
Revenues grew by 17.5% y-o-y and 7% q-o-q to Rs. 2,681 crores led by strong performance in automotive technologies division
NESTLEIND
Jul 23, 2026
Volumes, margins shine despite higher brand spends
Q1FY27 numbers were strong, with net sales growing 25.4% y-o-y to Rs. 6,363.3 crore
NAM-INDIA
Jul 23, 2026
Strong AUM growth leads to market share gains
Structural growth story continues, aided by consistent market share gains, Maintain BUY with revised PT of Rs. 1,315.
Jul 23, 2026
Indian Pharma & US Tariffs: A Bird’s eye view
A similar route could plausibly be explored by generic manufacturers, several of which have already announced or expanded US manufacturing investments.
MAHLOG
Jul 23, 2026
Robust Q1; margin levers ahead
We retain a Buy rating with a revised PT of Rs. 480, given the visible turnaround and improving profitability.
MASTEK
Jul 23, 2026
Order book momentum builds; execution holds the key to recovery
We maintain a Buy rating and revise PT to Rs. 2,000 (13x FY28E EPS of Rs 155.1).
TVSMOTOR
Jul 22, 2026
On a sharp growth run
Revenue rose 38% y-o-y and 9% q-o-q to Rs.13,896 crore, led by healthy volume growth of 28% y-o-y an
BAJAJ-AUTO
Jul 22, 2026
Exports and operational efficiency protect margins
Revenue grew 37% y-o-y and 8% q-o-q to Rs. 17,244 crore as volumes grew 29% y-o-y and 5% q-o-q, aided by price hikes, which helped improve realisations.
Jul 22, 2026
Indo-MIM
Indo-MIM is being offered at ~42.7x to 44.9x FY26 PAT on post-issue equity
M&MFIN
Jul 22, 2026
Stellar PAT beat, return ratios to gain strength
PAT beat estimates by 16.4%, surging 69.8% y-o-y and 3.0% q-o-q to Rs. 899 crore.
INDHOTEL
Jul 22, 2026
Domestic biz shines; asset-light growth accelerates
Stock trades at 23.8x/20.1x its FY27E/FY28E EV/EBITDA, respectively. We maintain a Buy rating with a revised PT of Rs. 860.
SAGILITY
Jul 22, 2026
Q1 trumps seasonality
We reduce our FY28E EPS to Rs 2.9 valuing the company at 18x to arrive at a price target of Rs 52 with a Buy rating on the stock.
OBEROIRLTY
Jul 21, 2026
Launch momentum stays strong
We remain positive on the stock with a revised PT of Rs. 2,122 on strong project launch momentum, healthy rentals and a comfortable balance sheet.
ULTRACEMCO
Jul 21, 2026
Strong Q1; Growth trajectory intact
We maintain a Buy rating with a revised price target of Rs. 14,200, supported by strong volume growth, capacity expansion and improving acquired assets.
CANFINHOME
Jul 21, 2026
Healthy Q1, IT transformation to drive operational efficiencies
We maintain a Buy rating with a PT of Rs. 1,100.
JSWSTEEL
Jul 21, 2026
Better realisations, favourable product mix power Q1
At CMP, JSW Steel trades at 10.5x/8.2x for FY27E/FY28E EV/EBITDA. We maintain our Buy rating with PT of Rs. 1500.
KOTAKBANK
Jul 20, 2026
Stable operating metrics and lower provisions propel PAT
Sharp 44.7% y-o-y decline in provisions drove up PAT by 25.6% y-o-y to Rs. 4,123 crore, ~3.8% ahead of estimates.
HDFCBANK
Jul 20, 2026
Growth trajectory improves, modest operational show
GNPA and NNPA ratios rose by 2 bps and 3 bps, q-o-q, respectively to 1.17% and 0.41% respectively,
FEDERALBNK
Jul 20, 2026
Strong Q1, yet valuations limit upside
Advances grew 15.0% y-o-y, while deposits grew 11.4% y-o-y.
AXISBANK
Jul 20, 2026
Business growth strong; margins contract
NII rose 8.0% y-o-y despite NIM contraction on account of uptick in growth momentum for Q1FY27.
POLYCAB
Jul 20, 2026
Firing on all cylinders
Continued momentum in government and private capex, besides real estate sector’s growth augurs well. We expect revenue/PAT to clock a CAGR of 24%/30%, respectively from FY26-28, with a good RoCE of 36
PNB
Jul 20, 2026
Benign credit cost helps PAT beat estimates
Overall, the bank is well place to put stable operational performance in FY27, thus we maintain a Buy with an unchanged PT of Rs. 130.
ICICIBANK
Jul 20, 2026
Q1 fires on all cylinders
We maintain a Buy with revised PT of Rs. 1,750.
WIPRO
Jul 17, 2026
Weak Q1
We maintain a Hold rating and price target of Rs. 185, based on a 13x FY28E EPS of Rs. 14.1.
ICICIGI
Jul 17, 2026
Retail Shines, Reserve Bites
With near-term earnings visibility reduced and the risk-reward more balanced after a period of outperformance.
TECHM
Jul 17, 2026
Strong start to FY27
Accordingly, we raise our target price to Rs 1,700 on better than expected revenue growth, valuing the stock at 19x on FY28E EPS of Rs 89, retaining our buy rating.
ICICIPRULI
Jul 16, 2026
Protection segment powers VNB growth; margins
Strategic focus remains centred on growing absolute VNB over margin maximisation, ensuring sustainable profitability across changing market cycles
HDFCLIFE
Jul 16, 2026
Broad-based growth; resilient margins
We maintain a Buy rating with a revised PT of Rs. 715 as long-term growth prospects remain intact as banking channel volumes revive and margins stay stable.
LTTS
Jul 15, 2026
Improving growth and margins largely priced
However, considering that much of the improvement is already reflected in valuations, we retain a HOLD rating on the stock, valuing the stock at 3,600 on FY28E EPS of 155.7.
SKYGOLD
Jul 14, 2026
Designed to shine
We initiate coverage on Sky Gold & Diamonds (SKYGOLD) with a Buy, assigning a price target of Rs. 850. Stock trading at 22.6x/16.8x its FY27E/FY28E earnings.
HCLTECH
Jul 14, 2026
Growth largely priced in; upside limited
Adjusting for slightly higher margins in Q1FY27, we raise our price target to Rs 1,300 on FY28E EPS of 76.3, valuing the stock at 17x with a HOLD rating.
Jul 14, 2026
Q1FY2027 Automobile Results Preview
In a strong growth phase; macro risks persist
LTF
Jul 13, 2026
Stellar Q1; long-term growth path intact
PAT stood at Rs. 916 crore, beating estimates by 6.4%, growing by 30.7% y-o-y and 13.2% q-o-q.
Jul 13, 2026
Resilience amid crosswinds
June 2026 was a reminder that markets rarely follow a straight path. It was a month where optimism and caution took turns driving sentiment. While global headlines kept investors on edge, India’s unde
Jul 13, 2026
SBI Funds Management Limited
India’s largest asset management company by quarterly average AUM is coming out with its IPO, entirely structured as an Offer for Sale
Jul 13, 2026
Q1FY2027 Pharma & Healthcare Results Preview
Pharma at an inflection point while hospitals continue to grow
Jul 13, 2026
Q1FY2027 Consumer Goods Results Preview
Gradual, broad-based normalisation
LTM
Jul 13, 2026
Steady start for F27
We maintain a Buy rating and raise PT to Rs 4,450 (19.5x FY28E EPS of Rs 231.6).
Jul 13, 2026
Q1FY2027 NBFCs, Insurance, AMC & Diversified Financials Results Preview
NBFCs and diversified players face resilient Q1; AMCs to see mixed nos
Jul 13, 2026
ValueGuide Equity - July 2026
Resilience amid crosswinds
Jul 10, 2026
Q1FY2027 Metals & Mining Results Preview
Firm realizations to keep earnings growth intact
Jul 10, 2026
Q1FY2027 Chemicals Results Preview
Eyeing a mixed bag quarter
TCS
Jul 10, 2026
No major surprises, recovery momentum building
At 13.0x/12.6x FY27/FY28 earnings, valuations remain attractive. We retain Buy with a Rs2,400 target price (15x FY28E EPS of Rs162.8).
Jul 09, 2026
Q1FY2027 Banking Results Preview
Business growth to accelerate, profitability to stay stable
Jul 09, 2026
Q1FY2027 Cement Results Preview
Higher Input Costs to Weigh on Profitability
Jul 07, 2026
Q1FY2027 IT Results Preview
Growth, Multiple and Valuation Reset
Jul 03, 2026
Macro headwinds ease
With the West Asia crisis cooling off, correction in fuel prices, easing of supply chain and raw material price concerns along with strong domestic demand, all factors lead to a help with positive tra
POCL
Jul 02, 2026
A Scrap to Sustainability growth story
Pondy Oxides & Chemicals Ltd (POCL) is poised for a steady growth run, led by capacity expansions, regulatory tailwinds and thrust on the copper recycling business.
KOTAKBANK
Jul 01, 2026
Eyeing a wider “affluent” pool
We maintain a Buy with an unchanged PT of Rs. 500
PERSISTENT
Jun 30, 2026
Closer to $5-bn revenue goal
Accordingly, we assign a 30x FY28E P/E multiple and arrive at a revised price target of Rs 5,200, while retaining a Buy rating.
ASTRAL
Jun 30, 2026
Business restructuring to unlock value
We expect revenue, operating profit and net profit CAGR of 15%, 18% and 30%, respectively, over FY26–FY28E. At 47.2x/40.6x FY27E/FY28E earnings, we maintain a Buy rating with a revised PT of Rs. 1,750
Jun 24, 2026
A Goal for Global Growth
The US-Iran war has been one of the most important geopolitical events affecting global financial markets.
KEI
Jun 22, 2026
Expansion to drive growth and margins
Management guided for an over 17-18% volume growth and OPM of 10.5-11% for FY27.
IKS
Jun 22, 2026
Inventurus Knowledge Solutions Ltd
We initiate coverage with a Buy rating and a PT of Rs. 2,020 (32x FY28E EPS).
SAGILITY
Jun 22, 2026
Sagility Ltd
Sagility is a pure-play BPO services provider with an exclusive focus on the US healthcare market and is primed to benefit from the huge outsourcing opportunities arising from that market
Jun 22, 2026
A pill to bill growth story
A significant growth opportunity in the US healthcare industry, warrants initiation of coverage on Sagility and IKS – two companies positioned to capitalise on the growing opportunities in the US heal
Jun 11, 2026
ValueGuide Equity - June 2026
Wading through stormy times
Jun 11, 2026
Wading through stormy times
May was a month of mayhem, after a sharp recovery in April. At a time, when domestic GDP growth was steady and SIP flows were at all-time highs, a cocktail of headwinds rocked the markets - Soaring cr
IPCALAB
Jun 11, 2026
Unichem ramp-up holds key; valuations favourable
We value the stock closer (marginally above) to its historic average + 1-SD standard deviation, at 32x on FY28E EPS of Rs. 57.8 and retain a Buy rating and a price target of Rs. 1,850.
Jun 10, 2026
5 Curated Stock Ideas for June 2026
Corporate earnings is the flavour on the street and we bring you a curated bouquet of five stocks that could give your portfolio an edge. Each idea combines technical and fundamental growth drivers.
DIVISLAB
Jun 09, 2026
Aggressive capex additions on the back increased order inflow
We value the stock at 52x on FY28E EPS of Rs. 143.9 and arrive at PT of Rs. 7,482 and retain Buy rating.
Jun 08, 2026
Q4FY2026 Metals & Mining Results Review
Steady growth persists; constructive outlook in the long run
LAURUSLABS
Jun 08, 2026
Valuations at a premium; business improving
With CDMO business aiding in margin improvements, we increase the valuation multiple to 60x and reta
Jun 08, 2026
Q4FY2026 Consumer Discretionary Results Review
Mixed bag Q4
Jun 05, 2026
Navigating global headwinds; attracting foreign flows
The RBI kept the repo rate unchanged at 5.25% at its June monetary policy and maintained a neutral stance.
BIOCON
Jun 05, 2026
Mixed Q4; focus shifts to execution
We continue to value the stock at 40x on FY28E EPS of 11.7 and retain a price target of Rs. 467 with a Buy rating.
Jun 04, 2026
Q4FY2026 Capital Goods and Power Results Review
Data centre boom in spotlight
Jun 03, 2026
Demand continues, but signs of stress visible
Despite global headwinds, Indian automakers continue to register good dispatches in May 2026
Jun 03, 2026
Q4FY2026 Consumer Goods Results Review
Steady Q4; near-term outlook cautious
SUNPHARMA
Jun 03, 2026
Robust Q4; Organon deal a key monitorable
Q4FY26 numbers were robust, with consolidated net profit rising 26% y-o-y, though earnings slipped q-o-q.
LEMONTREE
Jun 02, 2026
Multiple growth engines at play
We stay Positive and expect an upside of 38% over the next 12 months. Stock trades at 11x/10x its FY27E/FY28E EV/EBIDTA, respectively.
V2RETAIL
Jun 02, 2026
Robust numbers; growth momentum to sustain
Stock trades at 14x/10x its FY27E/FY28E EV/EBIDTA, respectively. We maintain a Positive view and revise PT to Rs. 300 (Upside of 25%).
SBFC
Jun 02, 2026
Steady Q4, operating efficiencies improving
We maintain a positive view with an unchanged PT of Rs. 110 (a 21% upside) backed by expanding balance sheet, improving operating efficiencies and profitability.
FLUOROCHEM
Jun 02, 2026
Mixed bag quarter, battery segment ramping up
With battery segment still ramping up, we expect it to start contributing meaningfully only in FY29. We downgrade the stock to HOLD with a PT of Rs 3,880.
LUMAXTECH
Jun 02, 2026
Strong show in tough times
We maintain a Buy rating with a price target of Rs. 2,130.
NMDC
Jun 02, 2026
Transformation into new geographies unlocks growth value
At CMP, NMDC trades at 5.8x/6x of FY27E/FY28E EV/EBITDA. We maintain a Buy rating with a revised PT of Rs.105.
Jun 02, 2026
Q4FY2026 Cement Results Review
Volume-led growth; margins to be stressed in near term
BECTORFOOD
Jun 01, 2026
Steady Q4; positive growth outlook
Stock trades at 34x/27x its FY27E/FY28E EPS, respectively. We stay Positive on the stock with an upside of 32% in 12 months.
YATHARTH
Jun 01, 2026
New hospitals contibuting well to long term growth
We value the stock at 35x, and arrive at a price target of Rs. 1,036, and retain our Buy rating.
KPRMILL
Jun 01, 2026
Decent Q4; outlook positive
Stock trades at 33x/28x its FY27E/FY28E EPS and 21x/18x its FY27E/FY28E EV/EBITDA, respectively. We retain Buy with a revised PT of Rs. 1,175.
CUMMINSIND
Jun 01, 2026
Consistent performer
We expect a 17%/16% CAGR in revenue/PAT (for FY26-28E). We see the business to benefit from data centers, healthcare, infrastructure.
ASIANPAINT
Jun 01, 2026
Strong Q4
Stock trades at 50x/44x its FY27E/FY28E EPS, respectively. We maintain a Buy rating with a revised PT of Rs. 2,965.
RAINBOW
May 29, 2026
Q4 on expected lines, capex to fuel medium term growth
Q4FY26 numbers were strong as in-patient and outpatient volumes saw strong growth.
CENTURYPLY
May 29, 2026
Capacity expansion to drive growth
We retain a Buy rating with a PT of Rs. 906, on strong multi-year earnings visibility.
ASHOKLEY
May 29, 2026
Powering through in tough times
Strong domestic demand and rising contribution of exports boost volumes to all time. Defence and EV business provide support.
ABFRL
May 27, 2026
Near-medium term outlook bleak; downgrade to Hold
In view of the near to medium term uncertainty, we downgrade the stock from Buy to Hold with a revised SOTP-based PT of Rs. 70.
ARTEMISMED
May 27, 2026
Strong Q4; Valuation upside limited
The valuation run-up does not leave room for significant upside in the current market scenario. Thus, we retain a neutral rating with a target price of Rs. 302.
ZYDUSLIFE
May 27, 2026
Global biz, acquisitions key to long-term growth
We value the stock at 24x, near the historic average 1-year fwd P/E, with an FY28E EPS of Rs.49.7. We retain a Hold rating and revise our price target upwards to Rs. 1,193.
CARYSIL
May 26, 2026
On a growth track
The stock trades at 26.8x/20.2x FY27/FY28 EPS. We remain positive on the stock, and revised our TP to Rs. 1,374.
SATIN
May 26, 2026
Strong Q4, return ratios improving
We maintain a positive view on the stock with a revised price target of Rs. 260 as it trades at an attractive 0.6x FY28E BV.
INDIGOPNTS
May 26, 2026
Decent Q4; eyeing rapid growth and market share gains
Stock trades at 26x/23x its FY27E/FY28E EPS, respectively. We maintain Buy on the stock with a revised PT of Rs. 1,260.
COLPAL
May 26, 2026
Eyeing balanced growth
Stock trades at 39x/35x its FY27E/FY28E EPS, respectively. We maintain a Buy with a revised PT of Rs. 2,340.
WABAG
May 26, 2026
Robust order book brightens outlook
We maintain a Buy with a revised PT of Rs. 1,900, valuing it at 20x its FY28 EPS. Stock trades at a P/E of ~19x/16x its FY27E/28E EPS.
NTPC
May 26, 2026
Capacity boost to power growth
We maintain a Buy rating with a revised PT of Rs. 450. Valuation of 1.7x/1.6x its FY27E/28 P/BV is reasonable given strong long-term growth prospects; Stock offers a decent dividend yield as well.
SAMHI
May 25, 2026
Soft Q4; outlook stays bright
Stock trades at 7x/6x its FY27E/FY28E EV/EBITDA, respectively. We stay Positive with a 29% upside.
EMAMILTD
May 25, 2026
Seasonality, geopolitical disruptions hit Q4
Stock trades at 19x/17x its FY27E/FY28E EPS, respectively. We maintain a Buy with a revised PT of Rs. 520.
JKLAKSHMI
May 25, 2026
Capacity expansions plans intact
We maintain our Buy rating while lowering our price target to Rs. 770, reflecting moderation in near-term performance due to cost pressure.
EICHERMOT
May 25, 2026
Firing on all cylinders
We maintain a Buy rating with an SOTP-based price target of Rs. 8,830.
HUDCO
May 25, 2026
Mixed bag Q4, AUM growth story intact
We stay positive with unchanged PT of Rs. 260 on strong AUM/PAT CAGR, robust sanction pipeline, continued asset quality improvement and healhty return ratios.
PFC
May 25, 2026
Strong asset quality offsets disbursement decline
PFC-REC merger will boost financial scale and lower borrowing costs.
NAUKRI
May 25, 2026
Navigating near-term headwinds, structural positive intact
We reduce our price target to Rs 1,360 and lower the valuation multiple given emerging AI-led disruptions.
MFSL
May 25, 2026
Quality on growth along with strong margin performance
The company is demonstrating high-quality, sustainable growth along with strong margin profile. Maintain BUY with revised PT of Rs. 2,000.
WELCORP
May 25, 2026
Revenues stay robust braving global headwinds
At CMP, Welspun Corp trades at an 11x/10x multiple on FY27E/FY28E EV/EBITDA, we maintain a Buy rating with revised PT of Rs. 1500.
DEEDEV
May 25, 2026
Growth prospects stay strong
We expect the company to deliver a strong revenue/PAT CAGR growth of 26%/55% respectively over FY26-28E. At CMP, the stock trades at a P/E of 27x/19x its FY2027E/FY2028E EPS, presenting an attractive
ITC
May 25, 2026
Cigarette, agri business to stay stressed in near term
Stock trades at 19x/17x its FY27E/FY28E EPS, respectively. We maintain a Buy with a revised PT of Rs. 355.
HONAUT
May 22, 2026
Margins surprise; Maintain Hold
We retain a Hold rating on Honeywell with a revised PT of Rs. 39,000. The stock is expected to report a revenue/PAT CAGR of 12%/22%, respectively, over FY2026-FY2028E.
APOLLOHOSP
May 22, 2026
Robust Q4; strategic expansions to drive growth
We value the stock at ~45x FY28E EPS of Rs.215, implying a price target of Rs. 9,677, with a Buy rating.
GRASIM
May 22, 2026
Paints biz in focus; long-term outlook robust
We retain Buy with a revised SOTP-based PT of Rs. 3,530, supported by sustained momentum in paints and improving operating leverage.
May 22, 2026
Q4FY2026 IT Results Review
AI dims tier 1 cos’ performance; mid-tier shine
JUBLFOOD
May 22, 2026
Muted Q4; near-term outlook bleak
Stock trades at 15x/13x its FY27E/FY28E consolidated EV/EBIDTA, respectively. We maintain a Buy rating with a revised PT of Rs. 545.
ASTRAL
May 21, 2026
Bright times ahead
We maintain a Buy with an unchanged PT of Rs. 1,850, on rising polymer prices and improving demand outlook.
BEL
May 21, 2026
Sustained Growth Guidance
With a promising order pipeline, we retain a Buy rating with a revised PT of Rs. 510. At CMP, the stock trades at 41x/35x its FY2027/FY2028 earnings estimates.
PIIND
May 21, 2026
On a weak footing
We maintain a Hold rating with a PT of Rs 3,100.
ZYDUSWELL
May 20, 2026
India biz hit by muted seasonal demand
Long-term OPM guidance maintained at 17-18% under normal seasonal conditions.
AMBER
May 20, 2026
Growth outlook intact
We reduce our estimates due to a lower-than-expected guidance but maintain a Buy rating with a lower price target of Rs 8,800.
DEVYANI
May 20, 2026
KFC drives growth; Pizza Hut weighs on performance
Stock trades at 12x/9x its FY27E/FY28E EV/EBITDA, respectively. We maintain Hold with a revised PT of Rs. 135 on near-term concerns.
TMPV
May 20, 2026
New launches, strong demand to smoothen ride
We maintain a Buy rating with an SOTP-based price target of Rs. 419.
DRREDDY
May 20, 2026
Europe and Emerging Markets shine, price erosion a current headwind in US
We continue to value the stock at 18.5x on FY28E earnings and retain our HOLD rating with a revised target price of Rs. 1,415.
TRITURBINE
May 20, 2026
Robust outlook visible in enquiry pipeline
We reiterate a Buy rating with a revised PT of Rs. 750, modeling a 14% revenue and 21% PAT CAGR through FY28E.
RBA
May 19, 2026
India biz shines
Stock trades at 9x/8x its FY27E/FY28E EV/EBIDTA, respectively. We maintain a Buy with a revised PT of Rs. 85.
RATNAMANI
May 19, 2026
Resilient margins; revenue impacted by geopolitical headwinds
At CMP, RMTL trades at a 25.5x/22.7x multiple on FY27E/FY28E EPS, we maintain our Buy rating with PT of Rs. 2900.
BHARTIARTL
May 19, 2026
Promoter stake strategy in focus
We maintain a BUY rating with an SOTP-based price target of Rs 2,350.
May 19, 2026
Q4FY2026 Banking Results Review
Growth momentum strong, stress on book eases
HAL
May 19, 2026
Muted Q4; faster execution a key monitorable
The stock trades at 25x its FY2028E EPS. With the strong order book with a strong inquiry pipeline, we maintain our Buy rating with a price target of Rs. 5,500 factoring a revenue/ PAT CAGR growth of
KPIL
May 19, 2026
Outlook remains strong
We maintain a Buy with a revised PT of Rs 1,500. Stock is valued at ~16x/13x FY27E/28E P/E. Key catalysts include asset monetisation and reduced promoter pledges.
POWERGRID
May 19, 2026
Capex plans to power growth
Strong capex expectations brightens earnings visibility. Hence, we maintain a Buy with an unchanged PT of Rs. 350. At CMP, it trades at 2.6x/2.4x its FY26/27 P/BV.
May 19, 2026
Riding a long growth runway
We value the stock at 45x on FY28E EPS of Rs 33.2, with a Buy rating and price target of Rs 1,494, contingent on a steady ramp-up over the next 2-3 quarters.
CHALET
May 18, 2026
On a strong growth path
Management eyes mid-double-digit room revenue growth for FY27, driven by mid-high single-digit RevPAR growth.
SAIL
May 18, 2026
Sectoral tailwinds and higher steel prices inflecting margins
At CMP, SAIL trades at 6.3x/6.1x for FY27E/FY28E EV/EBITDA, we upgrade our rating to Buy with revised PT of Rs. 220.
SAREGAMA
May 18, 2026
Music vertical surprises on strong margin
We maintain a Buy rating with a price target of Rs 450 valuing the company at 30x P/E on FY28E EPS.
ABDL
May 18, 2026
Strong growth momentum to sustain
Stock trades at 46x/30x its FY27E/FY28E EPS, respectively. We stay Positive and maintain PT at Rs. 715.
KIRLOSENG
May 18, 2026
High-end products to drive growth
We maintain our BUY rating for a TP of Rs 2,000, expecting company to maintain a strong long-term growth trajectory.
NIITMTS
May 18, 2026
Near-term headwinds to delay recovery
Revenue grew 5.1% q-o-q (up 22.2% y-o-y) to Rs. 525.2 crore, below expectations as a few clients slashed year-end budgets amid macro uncertainties.
TATAPOWER
May 18, 2026
Weak Q4, yet outlook promising
Tata Power has a well-planned strategy to shift towards clean energy and targets a 2.5x rise in PAT by FY2030E over FY2024.
TATAMOTORS
May 18, 2026
Demand remains strong, supply concerns loom
We maintain a Buy rating with a PT of Rs. 439.
DLF
May 15, 2026
Launches lined up for FY27
We stay Positive on the stock and revise the price target to Rs. 800, led by sustained residential momentum and continued scaling up of the rental portfolio.
JSWSTEEL
May 15, 2026
Forging a steady growth path
At CMP, JSW Steel trades at 9.1x/7.2x for FY27E/FY28E EV/EBITDA, we maintain our BUY rating with revised PT of Rs.1500.
LUPIN
May 15, 2026
Robust Q4; niche products drive growth
We value the stock at 22x on FY28E EPS of Rs. 121.3 to arrive at price target of Rs. 2,669.
TVSMOTOR
May 15, 2026
Firing on multiple cylinders
We maintain a Buy rating with a PT of Rs. 4,086.
INDHOTEL
May 14, 2026
Strong Q4; growth momentum to sustain
Consolidated revenues grew 14% y-o-y, EBITDA margins stood flat y-o-y at 35.2%, while adjusted PAT grew 15% y-o-y.
VGUARD
May 13, 2026
Positive outlook going forward
We retain a Buy with a revised PT of Rs. 430, given a positive business outlook factoring in the strong growth from the electricals & electronics businesses.
DABUR
May 13, 2026
Steady Q4
Stock trades at 39x/35x its FY27E/FY28E earnings, respectively. We maintain a Buy rating with an unchanged PT of Rs. 560.
VGUARD
May 13, 2026
Positive outlook going forward
We retain a Buy with a revised PT of Rs. 430, given a positive business outlook factoring in the strong growth from the electricals & electronics businesses.
DIXON
May 13, 2026
Mobile volumes drag the overall performance
We retain a Buy rating with Rs. 13,000 PT, factoring 24%/6% revenue/PAT CAGR (FY26–28E). Stock trades at 49x FY27E and 34x FY28E earnings.
TATACONSUM
May 13, 2026
Healthy Q4; outlook bright
Stock trades at 65x/55x its FY27E/FY28E EPS, respectively. We maintain a Buy with an unchanged PT of Rs. 1,425.
OBEROIRLTY
May 12, 2026
On a launch spree in FY27
Revenue was in line with our estimates, while EBITDA/PAT lagged by 6.2%/5.6% versus our forecasts.
WONDERLA
May 12, 2026
Good Q4; Chennai ramp-up on track
Stock trades at 10x/7x its FY27E/FY28E EV/EBIDTA, respectively. We maintain a Buy with a revised PT of Rs. 650.
PVRINOX
May 12, 2026
Deleveraged Balance Sheet, Strong Cash Generation
Q4 saw 31 million footfalls (y-o-y growth of 1.5%) with an average ticket price of Rs. 315 (y-o-y growth of 22.4%) and spend per head of Rs. 165 (up 32.3% y-o-y).
AFFLE
May 12, 2026
AI-led growth run
We factor in a ~19.5% revenue CAGR over FY26–FY28E, and value the company at 40x FY28E earnings, implying a price target of Rs 1,900, with inorganic growth providing a further upside.
BANKINDIA
May 12, 2026
Robust Q4 on most parameters
The bank is poised to post steady return ratios and respectable growth. We thus maintain a Buy rating with revised PT of Rs175.
INTELLECT
May 12, 2026
AI focus to broaden growth horizons
Accordingly, we increase our price target to Rs 885 at 24x P/E on FY28E EPS with a Buy rating.
THERMAX
May 12, 2026
Order inflow prospects stay strong; execution a key catalyst
With stock prices, order book visibility and premium multiples having already run up, we maintain a Hold rating;. Thermax trades at ~64x/49x its FY2027E and FY2028E EPS.
TITAN
May 12, 2026
Good Q4; positive guidance maintained
Stock trades at 62x/48x its FY27E/FY28E earnings, respectively. We maintain a Buy with an unchanged PT of Rs. 4,950.
May 11, 2026
Comeback amid Chaos
After the rout in March, April turned out to be the strongest month for the benchmark indices in over two years. The Nifty rose 7.46% and the Sensex 6.90% in April, clocking their best show since Dece
BRITANNIA
May 11, 2026
Soft Q4; recovery to be gradual
Stock trades at 47x/40x its FY27E/FY28E EPS, respectively. We maintain Buy on the stock with a revised PT of Rs. 6,550.
BANKBARODA
May 11, 2026
Operational performance and growth remains strong
Overall, the outlook for the bank remains positive supported by healthy business momentum and stable operating metrics. We maintain BUY with unchanged PT of Rs. 320.
May 11, 2026
ValueGuide Equity - May 2026
Comeback amid Chaos
SBIN
May 11, 2026
Mixed bag Q4
Overall, Q4 was a mixed bag, even as the long-term outlook remains stable considering the bank’s strong balance sheet. We maintain a Buy rating with a revised PT of Rs. 1200.
GRAVITA
May 08, 2026
Backward integration improves efficiency
RMIL acquisition consolidated from March 12, 2026, adding Rs. 51.78 crore to Q4 revenue.
RADICO
May 08, 2026
Strong Q4; outlook positive
The stock trades at 59x/47x its FY27E/FY28E earnings, respectively. We retain a Buy with a revised PT of Rs. 4,050.
BAJAJ-AUTO
May 08, 2026
Adding muscle for a steady ride
We maintain a Buy rating with a PT of Rs. 12,500.
May 08, 2026
On an expansion spree
Rising per-capita income, better insurance penetration, an ageing population and other tailwinds place India’s private hospitals at a critical juncture, as the market for quality tertiary care widens
BSE
May 08, 2026
Trade volumes fuel growth
The stock trades at 31xFY28E EPS, we stay positive on the stock and revise PT to Rs. 4400.
BLUESTARCO
May 08, 2026
Summer Season to drive the growth
Stock trades at 48x/40x its FY2027/FY2028 EPS, respectively. We retain a Buy rating with a revised PT of Rs. 2,000.
YATHARTH
May 08, 2026
Better patient mix, new hospitals to sustain growth momentum
Yatharth Hospitals remains on a strong growth trajectory, as patient mix improves
RAINBOW
May 08, 2026
Niche player, strong financials to support expansion plans
Rainbow Children’s Medicare is yet another convincing long term investment pick
MEDANTA
May 08, 2026
Consistent performance, strategic expansion to drive growth
Global Health Ltd (Medanta) looks attractive as a long-term investment because it combines a strong brand with an expansion strategy.
APOLLOHOSP
May 08, 2026
Brand value and presence warrants premium valuation
The company presents a compelling investment case as India’s leading private healthcare provider
BSOFT
May 07, 2026
Turnaround still uncertain amid weak revenue visibility
As a recovery may be prolonged, we reduce our price target on the stock to Rs 380 with a HOLD rating, valuing the stock at 15x on FY28E EPS
M&M
May 07, 2026
Racing ahead in top gear
We maintain a Buy rating with an SOTP based PT of Rs. 4120 (25% upside).
SRF
May 07, 2026
Refrigerants continue to do the heavy lifting
We remain positive on SRF given multiple tailwinds. We maintain a Buy rating with a SOTP-based TP of Rs 3,170.
POLYCAB
May 07, 2026
On a consistent growth track
We expect revenue/PAT to clock a CAGR of 25%/31%, respectively from FY26-28, with a good RoCE of 35%. Hence, we maintain a Buy rating with a PT of Rs 9.800..
MARICO
May 06, 2026
Healthy Q4; guidance optimistic
Q4FY26 revenue grew 22.1% y-o-y, while OPM fell 114 bps y-o-y to 15.6%, leading to PAT growth of 18.3%.
May 06, 2026
5 Curated Stock Ideas for May 2026
Corporate earnings is the flavour on the street and we bring you a curated bouquet of five stocks that could give your portfolio an edge
KEI
May 06, 2026
Growth prospects remain intact
OPM rose 64 bps to 11%, led by healthy gross profit margins expansion.
COFORGE
May 06, 2026
Steady quarter, strong margin, brighter outlook ahead
Revenue grew 1.7% q-o-q (21.2% y-o-y) to $489 million and by 2% in CC terms. Rupee revenue rose 5.2% q-o-q (30% y-o-y) to Rs. 4,450 crore, led by healthcare & hitech and govt outside India. EBIT margi
LT
May 06, 2026
Growth visibility amid volatile times
We maintain a Buy with a revised PT of Rs. 4,700, on strong order prospects and healthy earnings growth outlook.
SUNDRMFAST
May 06, 2026
Domestic markets, forex gains and other income comfort Q4
Consolidated revenue grew 11% y-o-y and 10% q-o-q to Rs. 1693 crore in Q4FY26, while for FY26 it rose 6% y-o-y to Rs. 6289 crore.
PNB
May 06, 2026
Mixed Bag quarter, long term outlook stable
Long-term growth outlook remains stable, while near term uncertainties warrant caution and thus we maintain a Buy with a revised PT of Rs. 130.
ABCAPITAL
May 06, 2026
Strong Q4; Growth story in full swing
Consolidated PAT grew 31.5% y-o-y and 20.6% q-o-q as businesses grew strongly.
JYOTHYLAB
May 06, 2026
Weak Q4; dull outlook warrants downgrade
We downgrade the stock from Buy to Hold with a revised PT of Rs. 285 on weak Q4 numbers and a bleak outlook.
AARTIIND
May 06, 2026
FY27 begins on tough note; Long-term levers intact
Short-term woes but a strong long-term growth story make us cautiously optimistic; We value the stock 15x FY28 EV/EBITDA to get a PT of Rs. 570 with a Buy rating.
PCBL
May 05, 2026
Sluggish Q4; all eyes on FY27
We maintain a Hold rating with a PT of Rs 340.
APLAPOLLO
May 05, 2026
Focus on sustaining margins
We maintain a Buy rating with a revised PT of Rs. 2,327, capacity ramp up visibility, and structural demand drivers.
HINDUNILVR
May 04, 2026
Steady Q4; outlook positive
Stock trades at 48x/43x its FY27E/FY28E EPS, respectively. We retain a Buy with a revised PT of Rs. 2,690.
May 04, 2026
Strong start to FY27
April carried forward the momentum to start FY27 on a positive note, with our coverage universe clocking a 35.4% y-o-y rise in sales,
CHOLAFIN
May 04, 2026
Strong Q4; growth momentum to sustain high return ratios
We maintain a Buy rating with an unchanged PT of Rs. 1,900, valuing the stock at 3.1x FY28E P/BV.
CANFINHOME
May 04, 2026
PAT beats estimates, IT transformation to boost biz
PAT significantly beat estimates, rose by 47.8% y-o-y and 30.5% q-o-q driven by Tax refund, impact of DTA, PPOP growth and benign credit cost.
BAJAJFINSV
May 04, 2026
Transient headwinds mask stable operating performance
MTM losses supressed consolidated revenue but adjusted revenue grew ~14% y-o-y. Consolidated PAT rose 5% y-o-y to Rs. 2,539 crore.
KOTAKBANK
May 04, 2026
Better operating leverage, credit cost fall bolster PAT
Lender is poised to post steady return ratios on calibrated growth, operating leverage and contained
SUPREMEIND
Apr 30, 2026
Long term outlook remains strong
For Q4FY26, revenue/EBITDA/PAT below our expectations by 10%/7.8%/1%.
SCHAEFFLER
Apr 30, 2026
Staying efficient despite headwinds
At CMP, the stock trades at 8.5x, 7x, 5.8x its CY26E, CY27E and CY28E BV. We maintain a Buy rating on the stock with a PT of Rs. 5,032 (or a 22% upside).
MOIL
Apr 30, 2026
Mixed bag Q4; yet steel demand upcycle bodes well
At CMP, MOIL trades at 6.5x/5.1x for FY27E/FY28E EV/EBITDA. We lower our PT to Rs. 360 while maintaining a Buy rating.
BAJFINANCE
Apr 30, 2026
Focusing squarely on profitability
PAT grew 22.2% y-o-y driven by lower credit cost and PPOP, slightly below estimates. Asset quality improved.
LTF
Apr 30, 2026
Healthy Q4, Improving Outlook on Digital Scaling & Strategic Expansion
We maintain a Buy rating on stock with a PT of Rs. 345 on strong AUM (21%) and PAT (30%) CAGR over FY26-28. Stock trades at 2.0x FY28 book value.
FEDERALBNK
Apr 30, 2026
Core numbers stable, barring one-offs
Overall, numbers were decent excluding one-offs, but valuations limit upside. Hence, we maintain a Hold rating with an unchanged PT of Rs. 310.
NAVINFLUOR
Apr 30, 2026
All-round strong show
We project the sales/EPS to clock a CAGR of 19% over FY26-28 and value the stock at 28X FY28EV/EBITDA to arrive at a PT of Rs. 7,800, implying a 15% upside from current levels.
DALBHARAT
Apr 30, 2026
Cost Discipline and Capacity Expansion Remain Intact
We retain a Buy rating with a revised price target of Rs. 2,350; At CMP, the stock trades at a reasonable 12.8x/11.1x FY27E/FY28E EV/EBITDA.
MARUTI
Apr 29, 2026
Capacity expansion to fuel next growth phase
We maintain a positive rating on the stock with a PT of Rs. 16,221 (24% upside).
VBL
Apr 28, 2026
Strong Q1; growth momentum to sustain
VBL’s Q1CY26 numbers were strong, beating estimates on all fronts, with a volume-led revenue growth of 18.1% y-o-y and adjusted PAT rising by 20.6%. OPM improved 55 bps y-o-y to 23.3%.
LODHA
Apr 28, 2026
GDV additions provided strong medium-term visibility
Pre-sales rose 22.5% y-o-y to Rs. 5,890 crore in Q4, hitting FY26 pre-sales to Rs 20,530 crore, missing by ~2% full year target of Rs.21,000 attributable to select deferral of sales in March due to th
ULTRACEMCO
Apr 28, 2026
Growth Trajectory Intact
Consolidated revenues rose 11.9% y-o-y to Rs.25,799 crore, on a 9% y-o-y volume growth and a 2.6% y-o-y rise in realisation per tonne.
NAM-INDIA
Apr 28, 2026
Good quarter amidst volatile environment
Q4FY26 was an all-round strong show and NAM remains the fastest-growing AMC among India’s top 10 players.
M&MFIN
Apr 28, 2026
Strong Q4; focus on resolving short-term uncertainties
PPOP grew 41.9% y-o-y and 3.9% (beat the estimates) on NII growth, lower opex run rate and growth in other income. RoA (as a % of AUM) rose 72 bps y-o-y and 9 bps q-o-q to 2.6%.
COALINDIA
Apr 28, 2026
Strongest quarter in FY26 led by better realizations and volume growth
Q4FY26 was the strongest quarter of FY26, meeting expectations, with consolidated PAT rising 13.7% y-o-y and revenue up 36% y-o-y, driven by higher e-auction volumes, better realisations, lower employ
CUB
Apr 28, 2026
Operational performance beat, outlook encouraging
NII grew 30.9% y-o-y (largely in-line) and was bolstered by strong loan growth and rise in margins y-o-y. NIMs rose 27 bps y-o-y but fell 2 bps q-o-q as cost of deposits increased.
AUBANK
Apr 28, 2026
Outperformance on all fronts
NII grew 23.3% y-o-y and 10.3% q-o-q (2% beat to our estimates), driven by healthy loan growth and margin expansion.
ATUL
Apr 28, 2026
Strong Q4; margins recover across segments
We value the stock at 27x PE FY28 to arrive at a PT of Rs. 7,700 implying a 15% upside from CMP.
HCLTECH
Apr 28, 2026
FY27 guidance soft, client-specific issues clouding outlook
We maintain a Buy rating, given the resilient portfolio, strong AI momentum, healthy cash flows, and high shareholder payouts, with a PT of Rs. 1380.
LTIM
Apr 28, 2026
Steady result, better placed for FY27
We reiterate a Buy rating with a TP of Rs. 5,050 implying an ~18% upside.
AXISBANK
Apr 27, 2026
Shielding profitability prospects
Overall, Q4FY26 was respectable in terms of core performance, with healthy momentum in credit offtake, we maintain a Buy rating with revised PT of Rs1550.
CIEINDIA
Apr 24, 2026
Strong domestic show; forex tailwinds fuel Q4
At CMP, the stock trades at 16.3x,14.8x,13.6x its CY26E, CY27E, CY28E earnings, respectively. We maintain a positive rating on the stock with a PT of Rs. 552
PERSISTENT
Apr 24, 2026
Decent results, $2bn revenue target intact
Revenue rose 3.2% q-o-q (16.2% y-o-y) to $436 million, in line with our estimates. In CC terms, revenue grew 3.4% q-o-q.
INFY
Apr 24, 2026
Guidance weak, rough road ahead
We expect growth to recover as macro headwinds ease and AI services reach inflection. We maintain a Buy rating with a revised price target of 1,380, valuing the company at 17x FY28E EPS.
SUNTECK
Apr 23, 2026
On a robust growth path
We remain positive on Sunteck Realty with a TP of Rs. 530, supported by a strong launch pipeline, robust cash flows and attractive valuation.
TRENT
Apr 23, 2026
Strong Q4
Stock trades at 31x/26x its FY27E/FY28E EV/EBITDA, respectively. We maintain a Buy with a revised SOTP-based PT of Rs. 5,070.
TECHM
Apr 23, 2026
Mission margin accomplished — All eyes now on growth
Restructuring under new leadership is going on well. We maintain a Buy rating with a revised PT of Rs. 1,600, considering a higher ETR, valuing the stock 19x FY28E EPS.
LTTS
Apr 23, 2026
Reset complete, recovery underway
We maintain a Buy on LTTS with a PT of Rs. 3,880, valuing the company at 24x FY28E EPS.
MASTEK
Apr 22, 2026
Mixed bag Q4; execution hols key to recovery
Revenue grew 1.4% q-o-q to $ 103.5 million; CC growth came in at 0.3% q-o-q, on strong traction in the UK and AMEA, partially offset by weakness in the US.
NESTLEIND
Apr 22, 2026
All-round show; outlook bright
Nestle’s Q4FY26 numbers were strong beat on all fronts with volume-led y-o-y revenue growth of 22.6%, OPM rising 102 bps y-o-y to 26.3% and adjusted PAT up by 28.9% y-o-y.
WIPRO
Apr 21, 2026
Soft quarter and weak organic growth guidance
Deal TCV conversion to revenue remains the key monitorable until execution consistency improves, we see limited upside beyond our TP and maintain HOLD.
PNBHOUSING
Apr 21, 2026
All-round Q4
We maintain a positive view, with a revised PT of Rs. 1150 (valuing the stock at 1.3x FY28E BV) on healthy growth and steady asset quality.
ICICIBANK
Apr 20, 2026
Strong show on multiple fronts
Asset quality improved as both GNPA and NNPA fell. Overall, Q4 numbers beat estimates on most parameters.
HDFCBANK
Apr 20, 2026
PAT in-line, asset quality improves
Management intends to have a risk calibarated approach towards credit growth, and focus to maintain healthy levels of ROA.
HDFCLIFE
Apr 17, 2026
Growth and core performance healthy
Management aims to outpace the industry and maintain VNB growth in line with APE growth in FY27; stock Life trades at ~1.7x FY28 EV and we maintain a Buy rating with a revised PT of Rs. 760.
ICICIGI
Apr 16, 2026
Growth and core performance healthy
Business growth prospects remain positive, specifically for retail motor and health segments. We maintain a Buy rating with an unchanged PT of Rs 2,300.
ICICIPRULI
Apr 15, 2026
Steady operational show
ICICI Prudential Life’s structural growth story remains intact amid near term global uncertainties along with steady returns expected in long-term
Apr 13, 2026
Scaling a wall of woes
Financial year 2025-26 came to a stormy close, as the US-Israel versus Iran conflict put global markets including that of India in doldrums.
Apr 13, 2026
ValueGuide Equity - April 2026
Scaling a wall of woes
Apr 10, 2026
Q4FY2026 Consumer Discretionary Results Preview
In the lifestyle fashion space, value fashion continued to outperform, footwear would be muted, while jewellery continued to post strong numbers despite gold price volatility.
TCS
Apr 10, 2026
Strong Foundation, Missing Acceleration
We roll forward our valuation to FY28E with a Buy rating and slightly raise EPS estimates on a weak rupee. Accordingly, we increase our price target to Rs 2,870, retaining our P/E multiple to 17x.
Apr 09, 2026
Q4FY2026 Capital Goods Results Preview
Execution to drive Q4 show
Apr 08, 2026
Q4FY2026 Cement Results Preview
Rising input costs to cap profitability even as volumes rise
Apr 08, 2026
Q4FY2026 Consumer Goods Results Preview
Eyeing near-term volatility
Apr 08, 2026
Vigilance and proactiveness amid global uncertainties
The Reserve Bank of India’s (RBI’s) Monetary Policy Committee (MPC) unanimously decided to keep the repo rate unchanged at 5.25% and neutral stance.
Apr 07, 2026
Q4FY2026 Banking Results Preview
Credit offtake to persist, margins to be stable
AARTIIND
Apr 07, 2026
Long-term growth story remains intact
The stock has corrected ~12% from near term highs; at 22x FY28E PE and 11.6x FY28E EV/EBITDA. Despite the near-term headwinds, we maintain a Buy on Aarti Industries with the PT of Rs. 470.
Apr 06, 2026
Q4FY2026 IT Results Preview
The Nifty IT index has declined ~23%, primarily due to global AI-related shocks impacting the SaaS, IT, and ITeS sectors.
Apr 02, 2026
Driving steadily ahead
We stay positive on the sector, led by sustained demand and policy changes but believe exports to be challenging due to West Asia conflict.
LAURUSLABS
Mar 27, 2026
CDMO business’ ramp-up awaited
Laurus continues to meet guidance and given the steady increase in margins and return ratios over the years
APLAPOLLO
Mar 25, 2026
Sector tailwinds to drive growth
EBITDA/tonne has stayed above Rs. 5,000 for the past two quarters, as strong volume momentum made the management upgrade EBITDA guidance to a minimum of Rs. 5,500 and volume growth guidance to ~20%
Mar 25, 2026
AI: Opportunity or Obstacle?
For Indian IT firms, the shift to an AI-based revenue model will not be instant – but a gradual one, depending on how new companies lay out budget cycles
Mar 25, 2026
5 Curated Stock Ideas for March 2026
Geopolitics is turning the street fiery, but here are five stocks that could shield your portfolio in these volatile times
Mar 24, 2026
Sai Parenterals Ltd
Sai Parenterals Ltd (SPL) is coming up with a book build issue of Rs. 408.79 crore.
DEEDEV
Mar 23, 2026
Power portfolio to propel growth
We expect the company to clock a strong revenue/PAT CAGR of 30%/61% respectively over FY25-28E.
HDFCBANK
Mar 19, 2026
Financial health Intact even as corporate governance sparks fly
We slightly reduce our core bank multiple to ~2xFY28 BV leading to revised PT of Rs. 1,025, maintain our BUY rating.
Mar 19, 2026
Central Mine Planning & Design Institute Ltd
Central Mine Planning & Design Institute Ltd (CMPDIL) is coming up with a book build issue of Rs. 1,842 crore.
VBL
Mar 18, 2026
Multiple growth levers in place
We stay Positive on VBL and expect an upside of 40%. Stock has corrected by ~19% from recent highs and trades at 40x/33x its CY26E/CY27E EPS, respectively.
Mar 11, 2026
Braving the storm
As war clouds darken and the tech bubble floats precariously, the markets are navigating a rough patch. The shocks was two-fold – the first involved the launch of Anthropic, an AI tool that that threa
Mar 11, 2026
ValueGuide Equity - March 2026
Braving the storm
ABCAPITAL
Mar 10, 2026
Laying a strong growth roadmap
Consolidated PAT to post a 24% CAGR over FY25–28E. Consequently, we maintain a positive outlook with an unchanged SoTP-based price target of Rs. 407 (upside of 23%).
SAMHI
Mar 09, 2026
RARE acquisition marks asset-light foray in experiential leisure space
Stock has corrected 26% from recent highs and trades at 7x/6x/5x its FY26E/FY27E/FY28E EV/EBITDA, respectively. We stay Positive and expect a 54% upside.
CUMMINSIND
Mar 05, 2026
Powergen biz driving demand
Given a rise in domestic demand on explosive growth through data center business and gradual improvement in exports business, we maintain a Buy rating with a PT of Rs 5,550.
Feb 27, 2026
Q3FY2026 Pharmaceutical Results Review
Robust Q3; Outlook Positive on CDMO and complex drugs
GRAVITA
Feb 26, 2026
Capacity expansions to spur growth
At CMP, Gravita trades at a 33x/27x multiple on FY27E/FY28E EPS. We maintain a Buy rating with a PT of Rs. 2,000 (28x on FY28E EPS).
Feb 25, 2026
Q3FY2026 NBFCs, Insurance, AMCs, and Diversified Financials Results Review
NBFCs and AMCs; Resilient Q3, HFC underperformed, Insurance: Mix Q3
ZYDUSLIFE
Feb 25, 2026
All-round growth: Valuation uptick eyed
We value the stock at 20x, marginally above the five-year average one-year fwd P/E on FY28E EPS of Rs.49.5 and assign HOLD with a price target of Rs. 990.
IPCALAB
Feb 25, 2026
Formulations business enlivens Q3
We value the stock at 45x, ~10% above its 5-year avg – one yr forward rating of 41.2x, on FY28E EPS of Rs. 38.4 and retain a Buy rating with a PT of Rs. 1,726.
Feb 24, 2026
Q3FY2026 Consumer Goods Results Review
On a recovery path
Feb 23, 2026
Q3FY2026 Capital Goods and Power Results Review
Performance in-line, overshadowed by related news flows
RECLTD
Feb 23, 2026
Soft Q3
PFC-REC merger to create a stronger, unified balance sheet that enables larger-scale financing. We thus stay Positive on REC with an unchanged PT of Rs. 450.
ABBOTINDIA
Feb 23, 2026
Novo phase-out a near-term blip; outlook healthy
We roll forward our valuation to FY28E and value stock at 37x on FY28E EPS of Rs. 889.1, arriving at a PT of Rs. 30,715.
PFC
Feb 20, 2026
Power financing titan on anvil
GNPA fell to 1.64% (down 104 bps y-o-y and 23 bps q-o-q) and NNPA reaching a lean 0.24% due to resolution of debt on a specific case.
HINDUNILVR
Feb 20, 2026
Soft Q3; improving outlook
Stock trades at 52x/49x/44x its FY26E/FY27E/FY28E EPS, respectively. We retain a Buy with a revised PT of Rs. 2,750.
Feb 20, 2026
Banking
Q3FY26: PSBs Lead the Charge, Systemic Stress Recedes
Feb 20, 2026
IT
Solid quarter in a soft season, AI Panic push stocks to multi-year low valuation
Feb 20, 2026
Cement
Weak Q3 pricing impacted realizations, while volumes remained good
ARTEMISMED
Feb 20, 2026
Mixed Q3, capex woes to cloud near term
We value the stock near its five-year average 1-yr forward P/E of 26x and retain a Hold rating with PT of Rs. 250.
INDHOTEL
Feb 20, 2026
Steady Q3; Outlook positive
We maintain a Buy with an unchanged PT of Rs. 891. Stock trades at 25x/21x/18x its FY26E/FY27E/FY28E EV/EBITDA, respectively.
HUDCO
Feb 20, 2026
Scaling new heights
We stay positive and revise PT to Rs. 260 on strong AUM/PAT CAGR, robust sanction pipeline, continued asset quality improvement and growth in ROE. Stock trades on 1.4x FY2028 BV.
JYOTHYLAB
Feb 19, 2026
Margins drag Q3; outlook cautious
Stock has corrected 22% over the past three months and trades at 25x/23x/20x its FY26E/FY27E/FY28E EPS, respectively. We maintain Buy with a revised PT of Rs. 315.
BECTORFOOD
Feb 19, 2026
Steady Q3; growth outlook intact
Stock trades at 47x/36x/29x its FY26E/FY27E/FY28E EPS, respectively. We stay Positive on the stock with an upside of 25% in 12 months.
INDIGOPNTS
Feb 19, 2026
Better margins drive Q3; outlook improving
Stock trades at 30x/27x/24x its FY26E/FY27E/FY28E EPS, respectively. We maintain Buy on the stock with a revised PT of Rs. 1,350.
BIOCON
Feb 19, 2026
Execution holds key post merger
We value the stock at 40x on FY28E EPS and retain a Buy rating with a PT of Rs. 466.
TORNTPHARM
Feb 18, 2026
Robust Q3, awaiting acquisition synergies
We roll forward our valuation to FY28E and value stock at 40x on FY28E EPS of Rs. 118.4 and retain a Buy with a revised PT of Rs. 4,735.
NTPC
Feb 18, 2026
Capacity additions to drive growth
We maintain a Buy rating with a revised PT of Rs. 430. Valuation of 1.6x/1.5x its FY27E/28 P/BV is reasonable given strong long-term growth prospects; Stock offers a decent dividend yield as well.
INFY
Feb 18, 2026
Investor AI Day – Embracing the opportunities
Infosys is successfully bridging AI adoption gap for clients to make enterprise projects successful; it is transforming AI from commodity to defensible service.
GRASIM
Feb 17, 2026
Paints biz in focus; long-term outlook robust
We retain a Buy with a revised SOTP-based PT of Rs. 3,424 as paints business’ momentum and operating leverage improves.
COALINDIA
Feb 17, 2026
Weak Q3; yet production and offtake recovering
Employee cost fell 3%, aided by 4% y/y manpower reduction.
LUPIN
Feb 17, 2026
Continuing the growth momentum every quarter
We roll forward our valuation to FY28E and retain a Buy rating and value the stock at P/E of 25x, arriving at a PT of Rs. 2,542.
LEMONTREE
Feb 17, 2026
One-offs hit Q3; medium-term outlook bright
We stay Positive and expect an upside of 40% in LTHL. Stock trades at 14x/12x/11x its FY26E/27E/28E EV/EBIDTA, respectively.
CHALET
Feb 17, 2026
Strong Q3; momentum to sustain
Stock trades at 15x/14x/14x its FY26E/FY27E/FY28E EV/EBIDTA, respectively. We stay Positive and expect an upside of 27% over the next 12 months.
HAL
Feb 16, 2026
Execution to be the key growth driver
We stay Positive and expect an upside of 26% factoring a revenue/ PAT CAGR growth of 23%/18%, respectively.
POWERGRID
Feb 16, 2026
Capex plans to power growth
Strong capex expectations brightens earnings visibility. Hence, we maintain a Buy with an unchanged PT of Rs. 350. At CMP, it trades at 2.4x/2.2x its FY27/28 P/BV.
SUNPHARMA
Feb 16, 2026
On a sustained growth path
We value the stock at 34x on FY28E EPS of Rs. 57.9x and retain a Buy with a PT of Rs.1,968.
DIVISLAB
Feb 16, 2026
Growth streak persists
We value stock at 51x on FY28E EPS of Rs. 140.3 to arrive at a PT of Rs. 7,206 and retain a Buy rating.
NAUKRI
Feb 16, 2026
Structural Moats Intact
We maintain a Buy rating but reduce PT to Rs 1,400 on AI-driven IT hiring uncertainty, but stay positive given structural drivers for Naukri biz, better B2C monetization and JobHai’s blue-collar leade
KIRLOSENG
Feb 13, 2026
High-end products to drive growth
We expect the company to maintain a strong long-term growth trajectory. Stock is reasonably valued at a P/E of 23/19x its FY2026/2027E earnings on CMP.
WABAG
Feb 13, 2026
Strong order book to drive growth
We maintain a Buy with an revised PT of Rs. 1,800, valuing it at 21x its FY28 EPS. The stock trades at a P/E of ~21x/18x its FY27E/28E EPS.
THERMAX
Feb 13, 2026
Recovering order inflows- Maintaining Hold
We maintain a Hold rating; stock price already factors in investments in green energy. Stock trades at ~38x/29x its FY2027E and FY2028E EPS.
BRITANNIA
Feb 13, 2026
Healthy Q3; stable margins to aid recovery
Stock trades at 55x/47x/41x its FY26E/FY27E/FY28E EPS, respectively. We maintain Buy on the stock with a revised PT of Rs. 7,090.
TITAN
Feb 13, 2026
Robust Q3; outlook bright
Stock trades at 72x/59x/49x its FY26E/FY27E/FY28E earnings, respectively. We maintain a Buy with a revised PT of Rs. 4,950.
CENTURYPLY
Feb 12, 2026
Plywood, MDF segments hold key to growth
We retain a Buy with a PT of Rs. 906, on strong multi-year earnings visibility led by capacity ramp-ups, improving product mix and robust cash generation.
KPIL
Feb 12, 2026
Outlook remains strong
We maintain a Buy with a revised PT of Rs 1,450. Stock is valued at ~14x/11x FY27E/28E P/E. Key catalysts include asset monetization and reduced promoter pledges.
MFSL
Feb 12, 2026
Structural story intact, growth trajectory encouraging
Q4FY26 likely to be healthy in terms of growth; long-term guidance remains well above industry. We maintain a Buy with a revised PT of Rs. 2,100.
AMBER
Feb 12, 2026
All-round Q3
Based on recent performance and guidance we raise our estimates expect a 26%/53% CAGR in revenue/PAT (for FY25-28E). We maintain a Buy rating with a PT of Rs 9,500.
SATIN
Feb 12, 2026
Lower credit costs, asset quality fuel profits
We maintain a Buy rating with an unchanged PT of Rs. 200 as the stock trades on cheap valuation (0.5x FY28E BV), stabilising MFI industry, focus on revenue diversification, improvement in asset qualit
JUBLFOOD
Feb 12, 2026
Strong Q3
Stock trades at 21x/18x/15x its FY26E/FY27E/FY28E consolidated EV/EBIDTA, respectively. We maintain a Buy rating with a revised PT of Rs. 700.
EMAMILTD
Feb 11, 2026
Good Q3; eyeing better prospects ahead
Stock trades at 25x/23x/21x its FY26E/FY27E/FY28E EPS, respectively. We maintain a Buy with an unchanged PT of Rs. 645.
VBL
Feb 11, 2026
Steady growth momentum
Stock trades at 44x/36x its CY26E/CY27E EPS, respectively. We stay Positive and expect an upside of 27% over the next 12 months.
TCI
Feb 10, 2026
Long-term outlook intact
We retain a Buy rating with a PT of Rs. 1,350, supported by a healthy earnings growth trajectory in 2–3 years.
Feb 10, 2026
Spotting the silver lining
January yet again tested the markets’ resilience, with the benchmark indices consolidating ahead of the Big B, the Union Budget.
ZYDUSWELL
Feb 10, 2026
Mixed Q3; long-term outlook intact
Stock trades at 44x/25x/22x its FY26E/FY27E/FY28E EPS, respectively. We maintain a Buy with an unchanged PT of Rs. 552.
BSE
Feb 10, 2026
Healthy topline, long-term outlook positive
BSE is well-positioned for sustained high revenue and margin growth. We maintain our positive view on the stock with a revised PT of Rs 3,600.
BHARTIARTL
Feb 10, 2026
Steady Q3, ARPU improves further
Pending tariff repair, faster 5G monetisation, expansion into high-growth adjacencies (cloud, cybersecurity, AI infrastructure partnership with Google), and potential AGR relief similar to Vodafone Id
MARICO
Feb 10, 2026
Steady Q3; Margin recovery ahead
Stock trades at 55x/45x/40x its FY26E/FY27E/FY28E EPS, respectively. We retain a Buy rating on the stock with a revised PT of Rs. 890.
PVRINOX
Feb 09, 2026
Strong momentum continues, solid line-up for CY26
With a strong 2026 lineup (Dhurandhar-2, Toxic, Ramayan, others), we expect higher occupancy, improved ATP and stable margins.
HITECH
Feb 09, 2026
On a strong growth trajectory
We remain positive with an unchanged PT of Rs.149, driven by strong margin expansion led by value-added products and better operating leverage.
V2RETAIL
Feb 09, 2026
Strong Q3; momentum to sustain
Stock trades at 17x/12x/9x its FY26E/FY27E/FY28E EV/EBIDTA, respectively. We stay Positive with an unchanged PT of Rs. 2,810.
ASTRAL
Feb 09, 2026
Bright times ahead
We maintain a Buy with an unchanged PT of Rs. 1,852, supported by stabilising polymer prices and improving demand outlook.
SBIN
Feb 09, 2026
PAT peaks on strong operations
We maintain a Buy rating on stock with a revised PT of Rs1260.
Feb 09, 2026
5 Curated Stock Ideas for February 2026
As markets navigate to eye a silver lining post the Budget and US-India trade deal, here are five stocks that could add a spark to your portfolio.
CARYSIL
Feb 06, 2026
Positioned for Strong Growth Ahead
Consolidated net revenues rose 9.6% y-o-y to Rs. 223 crore. Operating profit rose 46.5% y-o-y to Rs. 42.2 crore, while adjusted net profit increased 68.6% y-o-y to Rs. 21 crore.
ABCAPITAL
Feb 06, 2026
Outperforming curve; Strategic surge
AUM (NBFC+HFC) reached Rs. 190,386 crore (up 30.3% y-o-y, 7% q-o-q) with sharp improvements in asset quality and RoA.
SAREGAMA
Feb 06, 2026
Core business to drive growth
Revenue stood at Rs. 260 crore, up 13.2% q-o-q (music-led) but down 46.1% y-o-y due to a 92% slump in events from one-off mega tours in Q3FY25.
TRITURBINE
Feb 06, 2026
Short-term headwinds loom large
Revenue grew 24% y-o-y, beating estimates. Exports surged 54%, offsetting a 6% domestic dip. Operating profits rose 23%, though margins slightly contracted by 16bps to 21.5%.
TATACONSUM
Feb 06, 2026
Good Q3; multiple growth drivers in place
TCPL’s Q3FY26 numbers were good with revenue/adjusted PAT rising 15%/23% y-o-y, respectively.
Feb 06, 2026
RBI maintains status quo
Policy is neutral for lenders, as RBI looks to ensure full transmission of earlier measures rate cuts.
CUMMINSIND
Feb 06, 2026
Muted quarter- positive outlook
We see the business to benefit from data centers, healthcare, infrastructure, and real estate. We maintain a Buy rating with a PT of Rs 4,950.
ABDL
Feb 05, 2026
On a strong growth path
Stock trades at 57x/43x/31x its FY26E/FY27E/FY28E earnings, respectively. We stay Positive and revise PT to Rs. 715.
JKLAKSHMI
Feb 05, 2026
Capacity expansion remains intact
We retain our BUY rating on JK Lakshmi Cement while revising our target price downward to Rs. 930, reflecting moderation in near-term performance versus our earlier estimates.
TRENT
Feb 05, 2026
Revenue moderation continues; margins shine
We maintain a Buy with a revised SOTP-based PT of Rs. 5,220.
BAJAJFINSV
Feb 05, 2026
One-offs hit bottomline, respectable on growth front
Results bode well for growth and we maintain a Buy rating with an unchanged PT of Rs. 2450.
SAMHI
Feb 05, 2026
Multiple growth tailwinds
Stock has corrected 14% from recent highs and trades at 8x/7x/6x its FY26E/FY27E/FY28E EV/EBITDA, respectively. We stay Positive with a 43% upside.
BAJFINANCE
Feb 05, 2026
Core growth steady, one-offs hit profit
We maintain a Buy rating with an unchanged PT of Rs. 1,125. The stock trades at 4.5x and 3.7x of its FY27 and FY28 BV.
MAHLIFE
Feb 04, 2026
Poised for a launch spree
We maintain a Buy with a revised PT of Rs. 450, supported by a strong launch pipeline and faster growth in the industrial & logistics segment.
Feb 04, 2026
The Tide’s Turning
Following the 2026 Union Budget and pivotal US-India trade developments, the Indian equity market is transitioning from the turbulence of 2025 toward long-term capacity building.
CUB
Feb 03, 2026
Strong performance on all fronts
We upgrade our rating to Buy from Hold with a revised PT of Rs. 350.
LICHSGFIN
Feb 03, 2026
Tepid Q3, asset quality strengthens
we maintain a Neutral rating with a revised PT of Rs. 565, as strategic initiatives may take time to drive meaningful growth of earnings.
KEC
Feb 03, 2026
Muted Q3, order prospects strong
Stock trades at 14x/12x its FY2027/FY2028 EPS, respectively. We retain a Buy with a revised PT of Rs. 830.
AFFLE
Feb 03, 2026
Strong demand to pave growth for earning
Management eyes a 19-20% organic revenue and 23-25% EBITDA growth. We model a revenue growth of 19.3% CAGR (FY26–FY28E), apply a 45x FY28 P/E, with a Rs. 2,100 price target.
INTELLECT
Feb 02, 2026
Weak revenue and margin dents performance
We have trimmed our FY27-28-E estimates and roll forward our estimates to Mar-28, with a P/E of 28x and arrive at a price target of 965.
NESTLEIND
Feb 02, 2026
Volumes shine; margins miss the mark
Stock trades at 77x/64x/55x its FY26E/FY27E/FY28E EPS, respectively. We maintain a Buy rating with a revised PT of Rs. 1,500.
CHOLAFIN
Feb 02, 2026
In-line Q3, expect better Q4
We maintain a Buy rating with PT of Rs. 1,900, valuing the stock at 3.1x FY28E Book Value.
BLUESTARCO
Feb 02, 2026
Positive outlook amid headwinds
Stock trades at 48x/40x its FY2027/FY2028 EPS, respectively. We retain a Buy rating and for a revised PT of Rs. 2,100.
FIVESTAR
Feb 02, 2026
Asset Stress in Micro LAP impacted Q3 Performance
we stay positive on the stock with a PT of Rs. 550 as most negatives are captured in the stock price.
BANKBARODA
Feb 02, 2026
Operationally mixed Bag, healthy on growth and outlook
Net profit rose 4.5% y-o-y to Rs 5055 crore, beating estimates, owing to lower provisions. We maintain a Buy rating with an unchanged PT of Rs 320.
Feb 01, 2026
Crafting new age growth story
Budget 2026 marks a clear shift from consumption boost to ensuring fiscal and policy stability, amid uncertain global waters.
Feb 01, 2026
Crafting new age growth story
Budget 2026 marks a clear shift from consumption boost to ensuring fiscal and policy stability, amid uncertain global waters.
MAHLOG
Jan 30, 2026
Earnings turn positive as execution improves
We maintain a Buy rating with a revised PT of Rs. 400, factoring in downwardly revised estimates.
VGUARD
Jan 30, 2026
Electricals segment led the growth
We retain a Buy with a revised PT of Rs. 430, given its positive business outlook factoring in the strong growth from Electricals and Electronics business.
NAM-INDIA
Jan 30, 2026
Strong show on all fronts
With strong numbers keeping structural story intact, we maintain a Buy with a revised PT of Rs. 1000.
LODHA
Jan 30, 2026
Healthy pre-sales momentum: long-term visibility improves
We maintain a “Positive” view with a revised PT of Rs. 1,400, on strong pipelines and demand.
DIXON
Jan 30, 2026
Weaker mobile volumes impacted performance
We retain a Buy rating with Rs. 14,500 PT, factoring 31%/38% revenue/PAT CAGR (FY25–28E). Stock trades at 40x/32x on FY26E/FY27E earnings respectively.
COLPAL
Jan 30, 2026
On a recovery path
Stock trades at 42x/39x/36x its FY26E/FY27E/FY28E EPS, respectively. We maintain a Buy with a revised PT of Rs. 2,460.
ITC
Jan 30, 2026
Healthy Cigarette and FMCG biz performance
Stock trades at 20x/18x/17x its FY26E/FY27E/FY28E EPS, respectively. We maintain a Buy with a revised PT of Rs. 400.
M&MFIN
Jan 29, 2026
Robust Q3, asset quality improved
Stock trades at reasonable valuations. We maintain a Buy with an unchanged PT of Rs. 435 on improvement in NIMs, steady asset quality and return ratios.
BEL
Jan 29, 2026
Strong order prospects buoy growth momentum
Future order pipeline looks promising with large orders such as QRSAM and MRSAM are to be awarded in the coming years. we retain a Buy rating with revised PT of Rs. 525
LT
Jan 29, 2026
Remarkable order inflows
We maintain a Buy with an revised PT of Rs. 4,700, considering strong order prospects and healthy earnings growth outlook. Order prospects pipeline at Rs 5.9 lakh crore.
NIITMTS
Jan 29, 2026
Organic and Inorganic growth to drive earnings
We roll forward valuations to Dec-27; maintain PT at Rs 450 at 18x P/E multiple with a buy rating.
BSOFT
Jan 29, 2026
Navigating headwinds, growth likely post Q2FY27
We maintain a Buy and raise PT to Rs. 465 (20x P/E). Company’s success depends on converting deal wins into timely revenue.
CIPLA
Jan 28, 2026
Near-term stress, valuations attractive in long run
We believe valuations are attractive at current levels. We recommend Buy with a PT of Rs. 1,585.
ASIANPAINT
Jan 28, 2026
Soft Q3; demand to improve gradually
Stock trades at 54x/48x/42x its FY26E/FY27E/FY28E EPS, respectively. We maintain Buy on the stock with a revised PT of Rs. 3,105.
DLF
Jan 28, 2026
Launches paused in Q3; activity to resume in Q4
The company is confident to achieve its full year pre-sales guidance of Rs. 20,000 crore (80% already done). Exit rental expected Rs.6400 for FY26.
ZEEL
Jan 28, 2026
Persistent Ad Weakness; Margin Recovery Slower than Guided
Court case v/s Jio also represents operational uncertainty. Hence, we revise our price target to Rs. 1111
JSWSTEEL
Jan 28, 2026
Q3 growth momentum aligns with expansion plans
At CMP, JSTL trades at current valuation of 9.1x/8.2x for FY27E/FY28E EV/EBITDA. We upgrade our rating to BUY with a PT of Rs. 1360.
GODREJCP
Jan 27, 2026
India and AUM drive Q3; Indonesia stabilising
Stock trades at 54x/45x/39x its FY26E/FY27E/FY28E EPS, respectively. We maintain a Buy with a revised PT of Rs. 1,460.
LAURUSLABS
Jan 27, 2026
Generics drive growth in Q3, Awaiting further scale up in CDMO
With improving asset utilisations, we value the stock at 47x on FY28E earnings of 23.4 and retain the Hold rating with a PT of Rs.1,101.
APLAPOLLO
Jan 27, 2026
Guidance raised; demand, margin drivers intact
We maintain a Buy rating with a revised target price of Rs 2,460, driven by higher guidance, capacity ramp-up, and structural demand.
SBFC
Jan 27, 2026
Leadership change surprises, though outlook remains positive
Aseem Dhru, CEO & MD has stepped down, but we do not see any significant impact of the same in the medium to long term. We stay positive on the stock with a revised PT of Rs. 110.
RADICO
Jan 27, 2026
Strong Q3; momentum here to stay
Stock trades at 70x/53x/43x its FY26E/FY27E/FY28E earnings, respectively. We retain a Buy with an unchanged PT of Rs. 3,840.
ULTRACEMCO
Jan 27, 2026
Robust Q3 beats estimates
We maintain a Buy with a revised price target of Rs. 14,800, backed by strong growth visibility and margin recovery.
AXISBANK
Jan 27, 2026
Decent Q3, long-term outlook stable
Bank is well capitalized with broadly stable operating metrics; we maintain BUY rating with revised PT of Rs1490.
KOTAKBANK
Jan 27, 2026
Operationally stable, unsecured NPAs easing
Overall numbers for Q3FY26 were steady and we maintain a Buy rating with a PT of 500.
KEI
Jan 23, 2026
Growth prospects remain intact
Company likely to do well, backed by multiple tailwinds; stock trades at 35x/28x to FY27/FY28 EPS estimates. We maintain a Buy with a PT of Rs. 4,800.
COFORGE
Jan 23, 2026
Solid momentum to drive FY27 growth
We roll forward our valuation to Dec-27 and retain a Buy rating with a price target of Rs. 2,133 at 31x P/E.
SUPREMEIND
Jan 23, 2026
Expected plastic piping to return to normalcy
Recommendation: BUY rating maintained with a revised target price of Rs. 4,200.
PNBHOUSING
Jan 23, 2026
Weak Q3, outlook stays positive
We maintain a Positive view with a PT of Rs. 1,050 (1.2x FY28E BV). Stock trades at 1.0x FY28E BVPS.
DRREDDY
Jan 23, 2026
India and Europe outperform, helps negate price erosion in USA
We expect the new launches to become more EPS accretive over the next 6-8 quarters. We value the stock at 18.5x on FY28E EPS of Rs. 71.2, and retain our Hold rating with a PT of Rs. 1,316.
BANKINDIA
Jan 22, 2026
Growth traction healthy, stable operational performance
We maintain a Buy rating on the stock with a revised PT of Rs. 190.
DALBHARAT
Jan 22, 2026
Cost Discipline and Capacity Expansion Remain Intact
We retain a Buy rating with a PT of Rs. 2,550, the stock trades at 14.4x/12.8x/11.6x FY26E/FY27E/FY28E EV/EBITDA, backed by high cost visibility and a strong balance sheet.
OBEROIRLTY
Jan 21, 2026
Launch deferrals hit Q3; uptick eyed in Q4
We remain positive on the stock, expecting a ~24% upside, supported by strong launch momentum in upcoming quarters, a robust balance sheet, and favourable regional demand tailwinds.
AUBANK
Jan 21, 2026
On a strong footing
Valuations are stiff and factor in most positives, hence we maintain our Hold rating on the stock with revised PT of Rs. 1130.
PERSISTENT
Jan 21, 2026
Poised to outpace
We have rolled our valuation forward to Dec-27 and applied a P/E multiple of 44x, resulting in an unchanged price target of Rs. 7,295.
FEDERALBNK
Jan 19, 2026
Healthy core earnings momentum
Fundamental outlook healthy; valuations factor in positives, maintain HOLD with revised PT of Rs310.
TECHM
Jan 19, 2026
Robust deal wins, Sustained margin expansion, Upbeat outlook
We roll forward our valuation to Dec’27 and apply a P/E of 21.0x. Accordingly, we raise our PT to Rs. 2,000 while maintaining a Buy rating.
LEMONTREE
Jan 19, 2026
Reorganising to unlock future value
We stay Positive and expect an upside of 53% in LTHL. Stock trades at 14x/12x/11x its FY26E/27E/28E EV/EBIDTA, respectively.
LTF
Jan 19, 2026
In-line Q3, outlook stays strong
We maintain a Buy on the stock with a revised PT of Rs. 345, valuing it at 2.4x of FY28 BV.
HDFCBANK
Jan 19, 2026
Loan growth speeding up, operational levers present
Term deposit repricing and improvement in cost ratios to aid healthy levels of PAT, maintain Buy with an unchanged PT of Rs.1150.
ICICIBANK
Jan 19, 2026
Highs, Lows, and Plateaus
Bank poised for steady growth and return ratios, we maintain Buy with an unchanged PT of Rs. 1700.
LTTS
Jan 16, 2026
Restructuring to taper near-term growth
Revenues fell 2.8% q-o-q in CC terms, lagging estimates, primarily due to a strategic restructuring under its five-year Lakshya plan
WIPRO
Jan 16, 2026
Margins stable, awaiting catalysts for future growth
We maintain a PT of Rs. 285 and Hold rating; after the recent rally, CMP has priced in current catalysts, with further upside requiring clear revenue acceleration.
POLYCAB
Jan 16, 2026
Stunning volume growth impacted by higher commodity prices
We expect revenue/PAT to clock a CAGR of 23%/29%, respectively from FY25-28, with a good RoCE of 34%. Hence, we maintain a Buy rating with a PT of Rs 8,800.
INFY
Jan 14, 2026
Stunner Result, Guidance Raised & Strong Deal Win
We maintain a Buy rating with a price target of Rs 1,920, valuing the company at 20.6x and 19.2x respectively.
HDFCLIFE
Jan 14, 2026
Respectable Q3 barring one-offs; outlook steady
APE improved, beating our estimates, driven by individual policies.
ICICIPRULI
Jan 13, 2026
On a steady growth path
APE grew 3.6% y-o-y - within which protection APE rose 19% y-o-y, while non-linked APE was up 15.2% y-o-y.
HCLTECH
Jan 12, 2026
AI tailwinds brighten growth path
Q3FY26 revenue stood at $3,793 million, up 4.2% q-o-q (+4.8% y-o-y) in CC terms.
Jan 09, 2026
Q3FY2026 NBFCs, Insurance, AMC & Diversified Financials Results Preview
NBFCs and Other diversified financials: Healthy Q3; Insurance and AMCs: Mix Q3
Jan 09, 2026
Q3FY2026 Pharmaceuticals and Healthcare Results Preview
Eyeing a mixed bag Q3
Jan 09, 2026
Q3FY2026 Consumer Discretionary Results Preview
Some hits; some misses
Jan 09, 2026
Q3FY2026 Cement Results Preview
Volume-led growth offsets weak pricing
Jan 08, 2026
Q3FY2026 Consumer Goods Results Preview
Improving volumes as tax disruptions fade; margins recovering
Jan 08, 2026
Q3FY2026 Capital Goods Results Preview
Sector comfortably placed
Jan 07, 2026
5 Curated Stock Ideas for January 2026
As we set foot into 2026, here are five stocks to help your portfolio stay afloat
Jan 07, 2026
Q3FY2026 Banking Results Preview
Growth momentum, stable operating metrics to aid return ratios
JUBLFOOD
Jan 06, 2026
Eyeing volume and store-driven growth
Jubilant Foodworks (JFL) continues to focus on free delivery, loyalty programs, product innovation, value offerings and faster delivery to drive growth.
Jan 06, 2026
Q3FY2026 IT Results Preview
Q3 Muted by Seasonality; Eyes on CY26 Demand Outlook
CHALET
Dec 12, 2025
On steady growth path
Chalet Hotels has de-risked its portfolio by diversifying in terms of asset class and asset category.
Dec 12, 2025
A year of domestic resilience
In 2025, Indian equities navigated a stormy path
ABCAPITAL
Dec 11, 2025
Outlook strong, lending biz returns to pick up
NBFC business’ returns to improve to 2.4% in Q4FY26, and that of HFC business to 2-2.2% in 7-8 quarters.
Dec 09, 2025
ICICI Prudential AMC Ltd
ICICI Prudential Asset Management Company (AMC) is set to launch its Initial Public Offering (IPO) of ~ Rs. 10,603 crore (as an OFS).
Dec 05, 2025
‘Growth First’, echoes Mint St
RBI wraps up 2025 with 25-bps repo rate cut, liquidity boosters
Dec 04, 2025
5 Curated Stock Ideas for December 2025
As curtains prepare to drop on 2025, this edition of Vantage presents five stocks to help your portfolio end the year on a cheery crescendo
Dec 03, 2025
Rupee set to be Asian laggard
Indian Rupee to be among the worst-performing Asian currencies
Dec 01, 2025
Q2 GDP at 8.2%; growth momentum affirmed
India’s GDP accelerated sharply, growing at 8.2% in Q2FY26
Nov 26, 2025
Q2FY2026 Pharmaceuticals and Healthcare Results Review
Robust Q2; Outlook Positive on CDMO and complex drugs
Nov 25, 2025
Q2FY2026 IT Review Results Review
Demand condition stabilizing, execution up, attractive valuation
Nov 25, 2025
Tailwinds galore
RBI’s recent regulatory changes to boost growth; improving outlook on NIMs and asset quality,
Nov 21, 2025
Hotels on a strong growth trajectory
Hotel companies’ Q2FY26 was affected by heavy rainfall, a high base, room renovations, domestic air travel slowdown and geopolitical tensions.
Nov 13, 2025
At a crossroads
Multiple tailwinds were at play in October, propelling the Indian stock markets to fresh highs
Nov 13, 2025
CPI inflation plunges further
CPI inflation rose just 0.25% in October y-o-y, the lowest in the current 2012 series
Nov 07, 2025
Debuts: 5 Curated Stock Ideas for November 2025
It's time again to give your portfolio that edge, with yet another edition of Vantage.
Oct 29, 2025
IIP print stays steady
India’s Index of Industrial Production (IIP) rose 4.0% y-o-y in September 2025
Oct 14, 2025
Diwali Picks - 2025
The Nifty 50 has navigated a year of instability since last Diwali, trading in a narrow range of 24000-25000 and delivering near-zero net returns during the period.
Oct 14, 2025
CPI inflation slumps to historical low
The benchmark Consumer Price Index (CPI) inflation, plummeted to 1.54% in September 2025
Oct 10, 2025
Festive cheer beckons
September was a tough month for Indian stock markets, yet resilience was the flavour as the benchmark indices ended the month with modest gains, braving intense global headwinds.
Oct 06, 2025
LG Electronics India Ltd
LG Electronics Inda Ltd. (LGEIL) is coming up with a book build issue of Rs. 11,605 crore
Oct 03, 2025
Tata Capital Ltd
Tata Capital Ltd. is coming up with a book build issue of Rs. 15,512 crore.
Sep 22, 2025
Anand Rathi Share and Stock Brokers Limited
Anand Rathi Share and Stock Brokers Limited (ARSSBL) is an established, over three-decade old, full-service brokerage house in India with over three decades of experience. It operates in highly compet
Sep 11, 2025
‘G’ for GDP, GST…Good News?
The Indian stock markets climbed a wall of worries in August, with the Nifty and Sensex plummeting after being in the green for the previous four months.
Aug 20, 2025
Braving multiple headwinds
Globally, as well as at home, the Street’s battling the aftermath of US President Donald Trump’s tariff tantrums.
Jul 28, 2025
National Securities Depository Limited (NSDL)
NSDL is coming with an IPO of Rs. 4,012 crore that is entirely an offer for sale of 5.01 crore shares
Jul 17, 2025
Turnaround Times
Indian equities continued to rise for the fourth consecutive month in June, with the Sensex and Nifty rising 2.6-3%
Jun 23, 2025
HDB Financial Services
HDB Financial is coming with an IPO of Rs. 12,500 crore. The issue is a combination of a fresh issue of Rs. 2,500 crore
Feb 01, 2025
Focus shifts to consumption
Budget 2025-26 was a well-balanced one, meeting market expectations on fiscal consolidation
Dec 17, 2024
“It’s just a pause”
Equity markets remained upbeat in CY2024 despite an eventful year with elections in India and the U.S., rising geopolitical conflicts, and beginning of the interest rate reversal cycle.
